RESULT_COUNT: 545,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
TSRO,TSRO:UW,BBG002S9PQF4,"Notable Friday Option Activity: VFC, TSRO, NNI",2017-10-20 20:59:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/muRW2vmCQkY/notable-friday-option-activity-vfc-tsro-nni-cm862907,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in VF Corp Symbol VFC where a total volume of 14 463 contracts has been traded thus far today a contract volume which is representative of approximately 1 4 million
TSRO,TSRO:UW,BBG002S9PQF4,AstraZeneca's sNDA for Two Cancer Drugs Gets Priority Review,2017-10-19 15:49:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LH0cVOpVksY/astrazenecas-snda-for-two-cancer-drugs-gets-priority-review-cm861975,AstraZeneca plc AZN and partner Merck MRK announced that the FDA has granted priority review to its supplemental New Drug Application sNDA for Lynparza With this sNDA AstraZeneca and Merck are looking to expand the label of Lynparza presently marketed for advanced ovarian cancer to
TSRO,TSRO:UW,BBG002S9PQF4,The Foundation for Women’s Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women’s Cancer,2017-10-18 12:00:00 +0000,https://finance.yahoo.com/news/foundation-women-cancer-tesaro-announce-120000225.html?.tsrc=rss,"CHICAGO and WALTHAM, Mass., Oct. 18, 2017-- The Foundation for Women’ s Cancer, the official foundation of the Society of Gynecologic Oncology, and TESARO, Inc., an oncology-focused biopharmaceutical company, ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : October 13, 2017",2017-10-13 12:12:41 +0000,http://finance.yahoo.com/r/cda6e407-90ed-3d06-ba81-4232d9836452/tesaro-inc-breached-its-50-day-moving-average-in-a-bullish-manner-tsro-us-october-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for TESARO, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,See what the IHS Markit Score report has to say about TESARO Inc.,2017-10-11 12:04:17 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120417382.html?.tsrc=rss,Short interest is high for TSRO with between 15 and 20% of shares on loan.  This means that investors who seek to profit from falling equity prices are currently targeting TSRO.  The net inflows of $2.53 billion over the last one-month into ETFs that hold TSRO are not among the highest of the last year and have been slowing.
TSRO,TSRO:UW,BBG002S9PQF4,"Noteworthy Tuesday Option Activity: REN, DAL, TSRO",2017-10-10 21:11:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eLSwKktfoe8/noteworthy-tuesday-option-activity-ren-dal-tsro-cm857785,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Resolute Energy Corp Symbol REN where a total of 4 684 contracts have traded so far representing approximately 468 400 underlying shares That amounts to about 72 4 of REN s
TSRO,TSRO:UW,BBG002S9PQF4,Clovis (CLVS) Submits sNDA for Ovarian Cancer Drug Rubraca,2017-10-10 17:13:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bydfe26UkKw/clovis-clvs-submits-snda-for-ovarian-cancer-drug-rubraca-cm857687,Clovis Oncology 160 CLVS announced the submission of a supplemental New Drug Application sNDA for Rubraca rucaparib to the FDA The sNDA is looking to expand Rubraca s label as a maintenance treatment for patients with platinum sensitive recurrent ovarian cancer We remind investors
TSRO,TSRO:UW,BBG002S9PQF4,See what the IHS Markit Score report has to say about TESARO Inc.,2017-10-10 12:04:57 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120457906.html?.tsrc=rss,Short interest is high for TSRO with between 15 and 20% of shares on loan.  This means that investors who seek to profit from falling equity prices are currently targeting TSRO.  The net inflows of $1.69 billion over the last one-month into ETFs that hold TSRO are among the lowest of the last year and appear to be slowing.
TSRO,TSRO:UW,BBG002S9PQF4,Are Options Traders Betting on a Big Move in Tesaro (TSRO) Stock?,2017-10-05 12:44:12 +0000,https://finance.yahoo.com/news/options-traders-betting-big-move-124412548.html?.tsrc=rss,Investors in Tesaro (TSRO) need to pay close attention to the stock based on moves in the options market lately.
TSRO,TSRO:UW,BBG002S9PQF4,These Biotechs Slump As Report Suggests Discounting Their Drugs,2017-10-03 20:55:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kiLx0teHeWw/these-biotechs-slump-as-report-suggests-discounting-their-drugs-cm854716,AstraZeneca AZN and Tesaro TSRO stocks were in a slump Tuesday a day after an institute doubted the cost effectiveness of their drugs known as PARP inhibitors in ovarian cancer ibd display video id 2326102 width 50 float left autostart true But RBC
TSRO,TSRO:UW,BBG002S9PQF4,"The Zacks Analyst Blog Highlights: Flexion Therapeutics, Alexion Pharmaceuticals, PTC Therapeutics, Johnson & Johnson and TESARO",2017-10-03 13:52:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T2OqzRFWOvs/the-zacks-analyst-blog-highlights-flexion-therapeutics-alexion-pharmaceuticals-ptc-therapeutics-johnson-johnson-and-tesaro-cm854479,For Immediate Release Chicago IL October 03 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the
TSRO,TSRO:UW,BBG002S9PQF4,"The Zacks Analyst Blog Highlights: Flexion Therapeutics, Alexion Pharmaceuticals, PTC Therapeutics, Johnson & Johnson and TESARO",2017-10-03 12:14:12 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-flexion-121412027.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Flexion Therapeutics, Alexion Pharmaceuticals, PTC Therapeutics, Johnson & Johnson and TESARO"
TSRO,TSRO:UW,BBG002S9PQF4,3 Biotech and Pharma Stocks with Key FDA Catalysts this October,2017-10-02 15:52:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vpm4aImX2pY/3-biotech-and-pharma-stocks-with-key-fda-catalysts-this-october-cm853958,The FDA which approved 22 novel drugs last year has given its approval to 34 drugs so far in 2017 including three in September Key approvals this year include Novartis s Kymriah the first gene therapy in the United States Lilly s Verzenio advanced or metastatic breast cancer Gilead
TSRO,TSRO:UW,BBG002S9PQF4,First Week of TSRO November 17th Options Trading,2017-10-02 15:48:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eWQcgLJbcKI/first-week-of-tsro-november-17th-options-trading-cm853902,Investors in Tesaro Inc Symbol TSRO saw new options become available this week for the November 17th expiration At Stock Options Channel our YieldBoost formula has looked up and down the TSRO options chain for the new November 17th contracts and identified one put and one call contract
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. – Value Analysis (NASDAQ:TSRO) : October 2, 2017",2017-10-02 15:25:23 +0000,http://finance.yahoo.com/r/6577c2fd-1185-3b30-9381-c757aa4e6841/tesaro-inc-value-analysis-nasdaqtsro-october-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives TESARO, Inc. a score of 25. Our analysis is based on comparing TESARO, Inc. with the following peers – Clovis Oncology, Inc., ZIOPHARM Oncology, Inc., Amgen Inc., Dare Bioscience, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Insys Therapeutics, Inc. and Pfizer Inc. (CLVS-US, ZIOP-US, AMGN-US, DARE-US, ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : September 29, 2017",2017-09-29 12:08:10 +0000,http://finance.yahoo.com/r/7a0dafa3-5495-358f-92bf-71c2969c33df/tesaro-inc-breached-its-50-day-moving-average-in-a-bullish-manner-tsro-us-september-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for TESARO, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,Biotech Stocks Facing FDA Decision In October,2017-09-29 07:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nmihicMyCXk/biotech-stocks-facing-fda-decision-in-october-20170929-00332,Biotech Stocks Facing FDA Decision In October
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Expands Our Way Forward Program for the Ovarian Cancer Community and Partners With Olympic Gymnast Shannon Miller,2017-09-28 20:30:00 +0000,https://finance.yahoo.com/news/tesaro-expands-way-forward-program-203000331.html?.tsrc=rss,"WALTHAM, Mass., Sept. 28, 2017-- TESARO﻿, Inc., an oncology-focused biopharmaceutical company, announced today the availability of a number of new support resources and services that address unmet educational ..."
TSRO,TSRO:UW,BBG002S9PQF4,See what the IHS Markit Score report has to say about TESARO Inc.,2017-09-27 12:05:07 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120507900.html?.tsrc=rss,TESARO Inc NASDAQ/NGS:TSRO
TSRO,TSRO:UW,BBG002S9PQF4,"Cancer Space Update: Mixed Week for Pfizer, Roche Falters",2017-09-22 14:39:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2GaW6xvfumQ/cancer-space-update-mixed-week-for-pfizer-roche-falters-cm849500,While last week was eventful with European Society for Medical Oncology ESMO congress taking place this week saw the approval of Pfizer Inc s PFE Bavencio in Europe On the one hand TESARO Inc s TSRO Zejula received positive CHMP opinion in the EU while on the other Pfizer s Sutent
TSRO,TSRO:UW,BBG002S9PQF4,"Cancer Space Update: Mixed Week for Pfizer, Roche Falters",2017-09-22 12:58:12 +0000,https://finance.yahoo.com/news/cancer-space-mixed-week-pfizer-125812221.html?.tsrc=rss,Roche again disappointed this week with two studies on Tecentriq being put on partial hold while Pfizer&apos;s Bavencio received approval in Europe. TESARO&apos;s Zejula moved a step closer to approval.
TSRO,TSRO:UW,BBG002S9PQF4,"Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised Outlook",2017-09-20 12:45:12 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-fda-nod-124512730.html?.tsrc=rss,"Data presentations, regulatory updates and licensing deals were among the key highlights this week with the focus being on the FDA approval of the first cancer biosimilar - Amgen&apos;s (AMGN) Mvasi."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion,2017-09-18 16:41:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WMbS6WM3VRU/tesaro-ovarian-cancer-drug-zejula-gets-positive-chmp-opinion-cm847213,TESARO Inc 160 TSRO announced that the Committee for Medicinal Products for Human Use CHMP has recommended marketing approval of its ovarian cancer drug Zejula niraparib TESARO is seeking approval of the oral once daily poly ADP ribose polymerase PARP inhibitor as monotherapy
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion,2017-09-18 14:01:02 +0000,https://finance.yahoo.com/news/tesaro-ovarian-cancer-drug-zejula-140102900.html?.tsrc=rss,TESARO&apos;s (TSRO) marketing application for approval of its PARP-inhbitor Zejula as monotherapy for the maintenance treatment of ovarian cancer gets positive CHMP opinion.
TSRO,TSRO:UW,BBG002S9PQF4,Corporate News Blog - EMA Grants Positive CHMP Opinion to Tesaro’s Ovarian Cancer Drug,2017-09-18 11:30:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-ema-grants-113000667.html?.tsrc=rss,"Research Desk Line-up: Advaxis Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 18, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Tesaro, ..."
TSRO,TSRO:UW,BBG002S9PQF4,"FDA Nod For NEOS, One Step Closer To EU Approval Are GSK, TSRO, On Watch Is MTFB",2017-09-17 23:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sj0CBpkf7lQ/fda-nod-for-neos-one-step-closer-to-eu-approval-are-gsk-tsro-on-watch-is-mtfb-20170917-00103,"FDA Nod For NEOS, One Step Closer To EU Approval Are GSK, TSRO, On Watch Is MTFB"
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Receives Positive CHMP Opinion for ZEJULA®,2017-09-15 12:38:01 +0000,https://finance.yahoo.com/news/tesaro-receives-positive-chmp-opinion-123801369.html?.tsrc=rss,"ZUG, Switzerland, Sept. 15, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the European Medicines Agency`s (EMA) Committee for ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Receives Positive CHMP Opinion for ZEJULA®,2017-09-15 11:45:50 +0000,https://finance.yahoo.com/news/tesaro-receives-positive-chmp-opinion-114550328.html?.tsrc=rss,"ZUG, Switzerland, Sept. 15, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that the European Medicines Agency’ s Committee for Medicinal Products for Human Use has ..."
TSRO,TSRO:UW,BBG002S9PQF4,"ETFs with exposure to TESARO, Inc. : September 12, 2017",2017-09-12 05:38:22 +0000,http://finance.yahoo.com/r/f0b626c4-fdb7-36e0-b3ef-31792b252fbb/etfs-with-exposure-to-tesaro-inc-september-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TESARO, Inc. Here are 5 ETFs with the largest exposure to TSRO-US. Comparing the performance and risk of TESARO, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Summarizes ZEJULA and TSR-042 Data Presented at the 2017 ESMO Annual Meeting,2017-09-11 12:01:00 +0000,https://finance.yahoo.com/news/tesaro-summarizes-zejula-tsr-042-120100412.html?.tsrc=rss,"MADRID, Spain, Sept. 11, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today provided a summary of ZEJULA and TSR-042, an anti-PD-1 antibody, data ..."
TSRO,TSRO:UW,BBG002S9PQF4,See what the IHS Markit Score report has to say about TESARO Inc.,2017-09-06 12:06:51 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120651170.html?.tsrc=rss,Short interest is high for TSRO with between 15 and 20% of shares on loan.  This means that investors who seek to profit from falling equity prices are currently targeting TSRO.  ETFs that hold TSRO had net inflows of $1.56 billion over the last one-month.
TSRO,TSRO:UW,BBG002S9PQF4,See what the IHS Markit Score report has to say about TESARO Inc.,2017-09-05 12:06:17 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120617229.html?.tsrc=rss,Short interest is high for TSRO with between 15 and 20% of shares on loan.  This means that investors who seek to profit from falling equity prices are currently targeting TSRO.  The net inflows of $1.41 billion over the last one-month into ETFs that hold TSRO are among the lowest of the last year and appear to be slowing.
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : September 1, 2017",2017-09-01 14:07:06 +0000,http://finance.yahoo.com/r/dc6ad5d8-a2c2-37cd-bf3f-1760b76558a0/tesaro-inc-breached-its-50-day-moving-average-in-a-bullish-manner-tsro-us-september-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for TESARO, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,"ETFs with exposure to TESARO, Inc. : September 1, 2017",2017-09-01 01:44:18 +0000,http://finance.yahoo.com/r/aea95f3c-a1e7-3e6c-a2e5-0bd672e32ed8/etfs-with-exposure-to-tesaro-inc-september-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TESARO, Inc. Here are 5 ETFs with the largest exposure to TSRO-US. Comparing the performance and risk of TESARO, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,We Got It Wrong With OPKO Health -- Now What?,2017-08-29 01:49:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F4gurui-Uqk/we-got-it-wrong-with-opko-health-now-what-cm838244,In our These Legendary CEO s Could Catch Lightning in a Bottle Again episode Motley Fool Industry Focus Healthcare contributor Todd Campbell picked OOKO Health NASDAQ OPK 160 as a stock to buy Since then setbacks including a disappointing phase 3
TSRO,TSRO:UW,BBG002S9PQF4,We Got It Wrong With OPKO Health -- Now What?,2017-08-28 23:45:00 +0000,http://finance.yahoo.com/r/d293cbe8-034e-3e4f-99b9-f95f0eaf9b4b/we-got-it-wrong-with-opko-health-now-what.aspx?yptr=yahoo&.tsrc=rss,"OPKO Health’s been dealt setbacks that have caused its shares to nose-dive, rather than head higher. Is that about to change?"
TSRO,TSRO:UW,BBG002S9PQF4,See what the IHS Markit Score report has to say about TESARO Inc.,2017-08-25 12:04:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120407194.html?.tsrc=rss,TESARO Inc NASDAQ/NGS:TSRO
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Nine Data Presentations at the 2017 European Society for Medical Oncology (ESMO) Annual Meeting,2017-08-25 12:02:01 +0000,https://finance.yahoo.com/news/tesaro-announces-nine-data-presentations-120201682.html?.tsrc=rss,"    WALTHAM, Mass., Aug. 25, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that data from nine abstracts will be presented at the 2017 ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. :TSRO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017",2017-08-24 15:34:20 +0000,http://finance.yahoo.com/r/69bebfa8-d989-3c91-8946-e4226aa2b151/tesaro-inc-tsro-us-earnings-analysis-q2-2017-by-the-numbers-august-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis TESARO, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of TESARO, Inc. – Clovis Oncology, Inc., ZIOPHARM Oncology, Inc., Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Insys Therapeutics, Inc. and Pfizer Inc. (CLVS-US, ZIOP-US, AMGN-US, MRK-US, BMY-US, ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,Here's Why Clovis Stock Is Up Almost 60% So Far in 2017,2017-08-23 22:37:44 +0000,,Shares of Clovis Oncology Inc CLVS have witnessed a continuous upside this year Shares of this small biotech company are up 62 3 so far this year outperforming the 7 2 increase registered by the industry 160 during this period Let s analyze the factors that have driven the rally so
TSRO,TSRO:UW,BBG002S9PQF4,Here's Why Clovis Stock Is Up Almost 60% So Far in 2017,2017-08-23 22:37:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ktsBJoVZK2E/heres-why-clovis-stock-is-up-almost-60-so-far-in-2017-cm836233,Shares of Clovis Oncology Inc CLVS have witnessed a continuous upside this year Shares of this small biotech company are up 62 3 so far this year outperforming the 7 2 increase registered by the industry 160 during this period Let s analyze the factors that have driven the rally so
TSRO,TSRO:UW,BBG002S9PQF4,TESARO﻿ Announces Participation at Four Investor Conferences,2017-08-23 20:15:00 +0000,https://finance.yahoo.com/news/tesaro-announces-participation-four-investor-201500532.html?.tsrc=rss,"WALTHAM, Mass., Aug. 23, 2017--﻿ TESARO﻿, Inc., an oncology-focused biopharmaceutical company, today announced its participation in four upcoming investor conferences. The Wells Fargo Global Healthcare ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro: Losing Its Edge?,2017-08-18 22:33:00 +0000,http://finance.yahoo.com/r/811a1dff-85c7-3abe-ad3b-4246de1671e5/tesaro-losing-its-edge-1503088809?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The FDA decided yesterday to expand the use of the ovarian cancer drug Lynparza, sold by AstraZeneca (AZN) and Merck (MRK).  The two drugs belong to a class known as PARP inhibitors.  Approved in 2014, AstraZeneca's Lynparza was the first such drug to make its way through the FDA."
TSRO,TSRO:UW,BBG002S9PQF4,Ovarian Cancer Market Still Up For Grabs,2017-08-18 20:27:00 +0000,http://finance.yahoo.com/r/64a747af-2f4e-32c8-945b-4a168b4ac8ab/ovarian-cancer-market-still-up-for-grabs-1503088077?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The Food and Drug Administration approved a broader label for AstraZeneca’s (AZN) breast cancer drug Lynparza to be used in ovarian cancer patients.  Morgan Stanley’s Andrew Berens and his team are updating their models following the news, writing that he expects the three major players—AstraZeneca, Clovis Oncology (CLVS), and Tesaro (TSRO)—will likely split the market for second line (2L) treatment."
TSRO,TSRO:UW,BBG002S9PQF4,AstraZeneca/Merck's Lynparza Gets FDA Nod for Label Expansion,2017-08-18 15:42:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qv2SmLyIZY4/astrazenecamercks-lynparza-gets-fda-nod-for-label-expansion-cm833892,AstraZeneca plc AZN and partner Merck amp Co Inc MRK announced that the FDA has approved a new tablet formulation for ovarian cancer drug Lynparza while also broadening its U S label AstraZeneca s shares are up 11 5 so far this year comparing unfavorably with an increase of 13 7
TSRO,TSRO:UW,BBG002S9PQF4,Featured Company News - Moleculin Biotech Acquires Active Drug Compound for the Treatment of Brain Cancer,2017-08-18 11:00:00 +0000,https://finance.yahoo.com/news/featured-company-news-moleculin-biotech-110000365.html?.tsrc=rss,"Research Desk Line-up: Tesaro Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 18, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Moleculin ..."
TSRO,TSRO:UW,BBG002S9PQF4,See what the IHS Markit Score report has to say about TESARO Inc.,2017-08-16 12:05:19 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120519177.html?.tsrc=rss,Short interest is high for TSRO with between 15 and 20% of shares on loan.  This means that investors who seek to profit from falling equity prices are currently targeting TSRO.  ETFs that hold TSRO had net inflows of $1.34 billion over the last one-month.
TSRO,TSRO:UW,BBG002S9PQF4,"Clovis (CLVS) Focuses on Label Expansion, Rubraca Impresses",2017-08-15 15:42:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XKIdC7gfMzg/clovis-clvs-focuses-on-label-expansion-rubraca-impresses-cm832221,We issued an updated research report on Boulder CO based Clovis Oncology Inc CLVS on Aug 14 Rubraca has shown impressive growth trend in 2017 on the back of the company s commercialization efforts Rubraca sales doubled sequentially in the second quarter Rubraca sales were 14 6 million
TSRO,TSRO:UW,BBG002S9PQF4,See what the IHS Markit Score report has to say about TESARO Inc.,2017-08-14 12:05:32 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120532234.html?.tsrc=rss,TESARO Inc NASDAQ/NGS:TSRO
TSRO,TSRO:UW,BBG002S9PQF4,Edited Transcript of TSRO earnings conference call or presentation 8-Aug-17 8:15pm GMT,2017-08-14 00:21:16 +0000,https://finance.yahoo.com/news/edited-transcript-tsro-earnings-conference-025636023.html?.tsrc=rss,Q2 2017 TESARO Inc Earnings Call
TSRO,TSRO:UW,BBG002S9PQF4,Biotech: Why Clovis And Tesaro Look Well Positioned,2017-08-09 13:02:00 +0000,http://finance.yahoo.com/r/cadae9b6-8b34-34c4-92db-e1103fd4e00d/biotech-why-clovis-and-tesaro-look-well-positioned-1502283741?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Morgan Stanley's Andrew Berens and his team have a note out on biotech, writing that investors should buy Clovis Oncology (CLVS) and Tesaro (TSRO) ahead of any labeling decision by the Food and Drug Administration for AstraZeneca's (AZN) Lynparza breast cancer drug.  Berens writes that he expects the most likely outcome is that the FDA will limit the label BRCA patients--or at least have less promising results outside BRCA."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro reports 2Q loss,2017-08-08 21:07:00 +0000,https://finance.yahoo.com/news/tesaro-reports-2q-loss-210700334.html?.tsrc=rss,"The Waltham, Massachusetts-based company said it had a loss of $2.82 per share. The results did not meet Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Second-Quarter 2017 Operating Results,2017-08-08 20:05:00 +0000,https://finance.yahoo.com/news/tesaro-announces-second-quarter-2017-200500290.html?.tsrc=rss,ZEJULA is the most prescribed PARP inhibitor in U.S.; Q2 net sales totaled $26 million in first quarter of availability Recently opened European niraparib EAP has enrolled 200 patients VARUBY oral launch ...
TSRO,TSRO:UW,BBG002S9PQF4,A Biotech Binary Event Playbook: How To Play Clovis And Tesaro Ahead Of Label Decision,2017-08-08 18:36:57 +0000,https://finance.yahoo.com/news/biotech-binary-event-playbook-play-183657435.html?.tsrc=rss,Morgan Stanley said in a note Tuesday it would be buyers of Clovis Oncology Inc (NASDAQ: CLVS ) and TESARO Inc (NASDAQ: TSRO ) ahead of the Lynparza label decision. AstraZeneca plc (ADR) (NYSE: AZN )'s ...
TSRO,TSRO:UW,BBG002S9PQF4,"Investor Network: TESARO, Inc. to Host Earnings Call",2017-08-08 14:00:00 +0000,https://finance.yahoo.com/news/investor-network-tesaro-inc-host-140000257.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / TESARO, Inc. (NASDAQ: TSRO ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, 2017 at 4:15 PM Eastern Time. ..."
TSRO,TSRO:UW,BBG002S9PQF4,Perrigo Company (PRGO) Q2 Earnings: What's in the Cards?,2017-08-08 05:34:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/10spu-MLrB8/perrigo-company-prgo-q2-earnings-whats-in-the-cards-cm828460,Perrigo Company plc PRGO is expected to report second quarter 2017 results before the opening bell on Aug 10 Overall the company has an average trailing four quarter positive earnings surprise of 2 47 Last quarter the company delivered a positive surprise of 7 14 Perrigo
TSRO,TSRO:UW,BBG002S9PQF4,What's in Store for Catalyst (CPRX) This Earnings Season?,2017-08-08 05:34:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mh2vVqcsbz4/whats-in-store-for-catalyst-cprx-this-earnings-season-cm828459,Catalyst Pharmaceuticals Inc CPRX is expected to report second quarter 2017 results on Aug 9 160 Last quarter the company recorded in line earnings It topped expectations in three of the last four quarters with average positive surprise of 14 59 Catalyst s share price has
TSRO,TSRO:UW,BBG002S9PQF4,Why Earnings Season Could Be Great for TESARO (TSRO),2017-08-04 15:06:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3O3yJ2Wz5Ds/why-earnings-season-could-be-great-for-tesaro-tsro-cm827172,Investors are always looking for stocks that are poised to beat at earnings season and TESARO Inc TSRO may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because TESARO is seeing favorable earnings
TSRO,TSRO:UW,BBG002S9PQF4,Why Earnings Season Could Be Great for TESARO (TSRO),2017-08-04 12:51:12 +0000,https://finance.yahoo.com/news/why-earnings-season-could-great-125112190.html?.tsrc=rss,TESARO (TSRO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
TSRO,TSRO:UW,BBG002S9PQF4,What's in Store for Intrexon (XON) in this Earnings Season?,2017-08-02 16:59:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QWpiAdpV5BQ/whats-in-store-for-intrexon-xon-in-this-earnings-season-cm825876,Intrexon Corporation XON is expected to report second quarter 2017 results on Aug 8 Last quarter the company saw a negative earnings surprise of 13 04 In fact it missed expectations thrice in the trailing four quarters and met estimates once with an average negative surprise of 13
TSRO,TSRO:UW,BBG002S9PQF4,What to Expect from Epizyme (EPZM) This Earnings Season?,2017-08-02 00:53:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KRm5L_ufqeA/what-to-expect-from-epizyme-epzm-this-earnings-season-cm825381,Epizyme Inc EPZM is scheduled to report second quarter 2017 results on Aug 4 before the opening bell Last quarter the company came up with a positive earnings surprise of 11 11 In fact its track record has been strong with Epizyme surpassing expectations in each of the trailing
TSRO,TSRO:UW,BBG002S9PQF4,Is a Beat in Store for Ionis (IONS) This Earnings Season?,2017-08-01 23:54:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hfio6F2Weyw/is-a-beat-in-store-for-ionis-ions-this-earnings-season-cm825363,We expect Ionis Pharmaceuticals Inc IONS to beat expectations when it reports second quarter 2017 results on Aug 8 Last quarter the company delivered a positive earnings surprise of 130 In fact it has pulled off a positive surprise in three of the trailing four quarters recording
TSRO,TSRO:UW,BBG002S9PQF4,Is Zoetis (ZTS) Poised for a Beat This Earnings Season?,2017-08-01 22:55:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eXLf8XXNC0E/is-zoetis-zts-poised-for-a-beat-this-earnings-season-cm825326,Zoetis Inc ZTS is scheduled to report second quarter 2017 results on Aug 8 before the market opens Zoetis has consistently surpassed earnings estimates in each of the last four quarters with an average positive surprise of 9 8 In the last quarter the company beat expectations with
TSRO,TSRO:UW,BBG002S9PQF4,What's in the Cards for Endo (ENDP) this Earnings Season?,2017-08-01 17:56:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2n6aJYokd_Q/whats-in-the-cards-for-endo-endp-this-earnings-season-cm825128,Endo International plc ENDP is expected to report second quarter 2017 results on Aug 8 before the opening bell Last quarter the company delivered a positive earnings surprise of 9 82 In fact it pulled off a positive surprise in each of the trailing four quarters recording an
TSRO,TSRO:UW,BBG002S9PQF4,What's in the Cards for Immune Design (IMDZ) in Q2 Earnings?,2017-07-31 16:58:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TO-o7JS-kis/whats-in-the-cards-for-immune-design-imdz-in-q2-earnings-cm824364,Immune Design Corp IMDZ is scheduled to report second quarter 2017 results on Aug 2 Last quarter Immune Design pulled off a positive earnings surprise of 19 35 TIn fact the company has posted a positive surprise in three of the four trailing quarters bringing the average surprise to 7
TSRO,TSRO:UW,BBG002S9PQF4,"Commit To Buy Tesaro At $85, Earn 7.2% Using Options",2017-07-31 15:55:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S4B4FXqYbS8/commit-to-buy-tesaro-at-85-earn-72-using-options-cm824314,Investors eyeing a purchase of Tesaro Inc Symbol TSRO shares but tentative about paying the going market price of 130 20 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January 2019 put
TSRO,TSRO:UW,BBG002S9PQF4,Juno Therapeutics (JUNO) Q2 Earnings: Surprise in Store?,2017-07-27 20:58:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lfHC-Er9GKc/juno-therapeutics-juno-q2-earnings-surprise-in-store-cm822837,Juno Therapeutics Inc JUNO is expected to report second quarter 2017 results on Aug 3 Last quarter the company delivered a negative earnings surprise of 9 09 Year to date Juno s shares have soared 58 9 while the industry recorded an increase of 12 The company s poor track
TSRO,TSRO:UW,BBG002S9PQF4,Waltham's Tesaro grabs $100M in cancer drug partnership with Takeda,2017-07-27 13:25:10 +0000,http://finance.yahoo.com/r/7c2de0b7-4771-3761-8cde-3d3ccaac5ec1/walthams-tesaro-grabs-100m-in-cancer-drug.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Waltham-based Tesaro is capitalizing on the early success of its new cancer drug, handing over some development and commercial rights to Takeda in a deal worth up to $340 million plus royalties.  Tesaro (TSRO) said Thursday that the once-daily pill, which is marketed in the U.S. as Zejula following an FDA approval in March, will be developed and sold by Takeda in Japan, where the drug giant is headquartered.  Under the deal, Takeda will get development and commercial rights in four additional countries — South Korea, Taiwan, Russia and Australia — for all kinds of tumors except prostate cancer."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO and Takeda Enter Into Exclusive Licensing Agreement to Develop and Commercialize Novel Cancer Therapy Niraparib in Japan,2017-07-27 11:02:02 +0000,https://finance.yahoo.com/news/tesaro-takeda-enter-exclusive-licensing-110202493.html?.tsrc=rss,"-   Takeda`s Rights Include all Potential Indications for Niraparib in Japan and Rights Excluding Prostate Cancer in South Korea, Taiwan, Russia and Australia -   TESARO to Receive $100 Million Upfront ..."
TSRO,TSRO:UW,BBG002S9PQF4,What's in Store for Conatus (CNAT) this Earnings Season?,2017-07-26 17:02:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yd_RQUvS8KQ/whats-in-store-for-conatus-cnat-this-earnings-season-cm821852,Conatus Pharmaceuticals Inc CNAT is expected to report second quarter 2017 results on Aug 2 Last quarter Conatus earnings were in line with expectations Conatus earnings history is a mixed bag The company surpassed expectations on two occasions missed expectations in one and
TSRO,TSRO:UW,BBG002S9PQF4,What's in Store for Agios Pharma (AGIO) in Q2 Earnings?,2017-07-26 16:59:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7TpzKkKYO34/whats-in-store-for-agios-pharma-agio-in-q2-earnings-cm821810,Agios Pharmaceuticals Inc AGIO is expected to report second quarter results on Aug 3 Shares have surged 38 9 so far this year comparing favorably with the 160 industry s increase of 22 3 Agios performance has been mixed with the company missing estimates twice in the
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO to Announce Second-Quarter 2017 Financial Results on August 8, 2017",2017-07-25 20:15:00 +0000,https://finance.yahoo.com/news/tesaro-announce-second-quarter-2017-201500445.html?.tsrc=rss,"WALTHAM, Mass., July 25, 2017-- TESARO, Inc. will announce its second-quarter 2017 financial results on Tuesday, August 8, 2017, after the close of the U.S. financial markets. TESARO’ s senior management ..."
TSRO,TSRO:UW,BBG002S9PQF4,"ETFs with exposure to TESARO, Inc. : July 25, 2017",2017-07-25 17:46:39 +0000,http://finance.yahoo.com/r/5c6a5f0a-145d-3c2c-b55a-f9bfa19de53a/etfs-with-exposure-to-tesaro-inc-july-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TESARO, Inc. Here are 5 ETFs with the largest exposure to TSRO-US. Comparing the performance and risk of TESARO, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Becomes Oversold (TSRO),2017-07-18 18:04:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H71d2NPYHg8/tesaro-becomes-oversold-tsro-cm817644,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
TSRO,TSRO:UW,BBG002S9PQF4,"ETFs with exposure to TESARO, Inc. : July 14, 2017",2017-07-14 21:15:33 +0000,http://finance.yahoo.com/r/fef594a5-7b29-39cd-a5a6-39bd37b80bf3/etfs-with-exposure-to-tesaro-inc-july-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TESARO, Inc. Here are 5 ETFs with the largest exposure to TSRO-US. Comparing the performance and risk of TESARO, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,Clovis (CLVS) Focuses on Rubraca Launch and Label Expansion,2017-07-13 23:47:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xt4N_QITDBw/clovis-clvs-focuses-on-rubraca-launch-and-label-expansion-cm815926,We issued an updated research report on Boulder CO based Clovis Oncology Inc CLVS on Jul 12 Clovis got a huge boost in Dec 2016 when the FDA granted accelerated approval to its PARP inhibitor Rubraca rucaparib for the treatment of advanced ovarian cancer two months earlier than
TSRO,TSRO:UW,BBG002S9PQF4,"Gainers & Losers Of July 13: PTX, ALDR, MNKD, TSRO, TOCA...",2017-07-13 21:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YOyvBLcsul8/gainers--losers-of-july-13-ptx-aldr-mnkd-tsro-toca-20170713-01350,"Gainers & Losers Of July 13: PTX, ALDR, MNKD, TSRO, TOCA..."
TSRO,TSRO:UW,BBG002S9PQF4,"Why National Beverage, Tesaro, and Community Health Systems Slumped Today",2017-07-13 20:57:00 +0000,http://finance.yahoo.com/r/76d37c80-f92c-3ab4-9fd7-55dfcdd3a8d6/why-national-beverage-tesaro-and-community-health.aspx?yptr=yahoo&.tsrc=rss,"Despite a positive day for the markets, these stocks fell. Find out why."
TSRO,TSRO:UW,BBG002S9PQF4,"Notable Thursday Option Activity: UAL, TSRO, JPM",2017-07-13 20:48:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qn7BZm3-EDw/notable-thursday-option-activity-ual-tsro-jpm-cm815831,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in United Continental Holdings Inc Symbol UAL where a total volume of 14 656 contracts has been traded thus far today a contract volume which is representative of
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Inc (TSRO) Shares Fall as Company Struggles to Find Buyer,2017-07-13 17:11:49 +0000,https://finance.yahoo.com/news/tesaro-inc-tsro-shares-fall-171149393.html?.tsrc=rss,"TESARO Inc (NASDAQ:TSRO) shares fell sharply today as the company has been unable to find a buyer.  The biotech company said it does not comment on market rumors, but sources familiar with the matter report that Tesaro has been unable to find a suitable takeover candidate.  Back in late May, the Wall Street Journal reported that Tesaro was seeking a company to buy the biotech corporation, which had a $7.4 billion market value at the time."
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro May Beat, But It's Not A Buy, Says Janney",2017-07-13 15:28:00 +0000,http://finance.yahoo.com/r/72ac885a-39d3-33bf-9ec7-7904bc6a56e1/tesaro-may-beat-but-its-not-a-buy-says-janney-1499959686?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Tesar0 (TSRO) will report second-quarter earnings in early August, and while Janney Capital's Debjit Chattopadhyay writes that the company is poised to report better-than-expected results thanks to a near-term monopoly, he doesn't think investors should buy into the stock.  Chattopadhyay reiterated a Neutral rating on the stock Thursday.  More detail from the note:  While our revenue expectations are largely in-line with consensus for 2018, $418M vs. $425M, we expect growth to moderate thereafter and we are at least $400M below consensus for FY2021  primarily driven by competitive matrix and modest expectations for the CINV franchise."
TSRO,TSRO:UW,BBG002S9PQF4,Sale process for biotech Tesaro seen unlikely to result in deal,2017-07-13 14:34:22 +0000,https://finance.yahoo.com/news/sale-process-biotech-tesaro-seen-143422984.html?.tsrc=rss,"Biotech company Tesaro&apos;s sale process is unlikely to result in a deal, sources familiar with the situation told CNBC."
TSRO,TSRO:UW,BBG002S9PQF4,Sale process for biotech Tesaro seen unlikely to result in deal,2017-07-13 14:34:22 +0000,http://finance.yahoo.com/r/ba0026a0-e785-362f-9706-d8c687985be1/104584302?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104584302&yptr=yahoo&.tsrc=rss,"Biotech company Tesaro's sale process is unlikely to result in a deal, sources familiar with the situation told CNBC."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. (TSRO) Is Sinking On Reports That Sale Is Unlikely,2017-07-13 09:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8zoU_JAVM5w/tesaro-inc-tsro-is-sinking-on-reports-that-sale-is-unlikely-20170713-00722,Tesaro Inc. (TSRO) Is Sinking On Reports That Sale Is Unlikely
TSRO,TSRO:UW,BBG002S9PQF4,"Is the Options Market Predicting a Spike in TESARO, Inc. (TSRO) Stock?",2017-07-11 13:01:01 +0000,https://finance.yahoo.com/news/options-market-predicting-spike-tesaro-130101788.html?.tsrc=rss,"Options Market is Predicting a Spike in TESARO, Inc. (TSRO) Stock on the back of its surging implied volatility."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro: Why Gabelli Sees 20%+ Upside,2017-07-07 14:45:00 +0000,http://finance.yahoo.com/r/dd02305d-ca74-34dc-bcd8-b2f14c1361ea/tesaro-why-gabelli-sees-20-upside-1499438763?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Tesaro (TSRO) is up more than 50% in the past year, but Gabelli thinks there’s more room for the biotech to run. Analyst Jing He initiated coverage of the stock with a Buy rating, noting that the stock ..."
TSRO,TSRO:UW,BBG002S9PQF4,Sum Up The Pieces: IHE Could Be Worth $185,2017-07-07 14:44:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HGZP08ahBiA/sum-up-the-pieces-ihe-could-be-worth-185-cm812903,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
TSRO,TSRO:UW,BBG002S9PQF4,Bullish Two Hundred Day Moving Average Cross - TSRO,2017-07-03 17:46:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UQ9Dapsr3Ro/bullish-two-hundred-day-moving-average-cross-tsro-cm811360,In trading on Monday shares of Tesaro Inc Symbol TSRO crossed above their 200 day moving average of 142 10 changing hands as high as 143 45 per share Tesaro Inc shares are currently trading up about 1 9 on the day The chart below shows the one year performance of TSRO shares versus
TSRO,TSRO:UW,BBG002S9PQF4,"3 Stocks That Turned $8,000 Into at Least $25,600 in Just One Year",2017-06-29 16:06:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x9eb1uMbeck/3-stocks-that-turned-8000-into-at-least-25600-in-just-one-year-cm809992,We may all want to get rich quick but smart investors understand that slow and steady wins the race Just as you don t start off as a CEO but have to work your way up the company ladder having as a goal the chance to hit it big on a stock is not a reasonable way to look at the
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Joins OCRFA as Presenting Sponsor of the 2017 Ovarian Cancer National Conference,2017-06-29 13:00:00 +0000,https://finance.yahoo.com/news/tesaro-joins-ocrfa-presenting-sponsor-130000806.html?.tsrc=rss,"WALTHAM, Mass., June 29, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, is proud to support the Ovarian Cancer Research Fund Alliance as the Presenting Sponsor of the 2017 Ovarian ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. breached its 50 day moving average in a Bearish Manner : TSRO-US : June 28, 2017",2017-06-28 13:07:48 +0000,http://finance.yahoo.com/r/2d71c8a5-7562-3e0b-bc83-c51781c1ccd6/tesaro-inc-breached-its-50-day-moving-average-in-a-bearish-manner-tsro-us-june-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for TESARO, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Lonnie Moulder and Mary Lynne Hedley Named EY Entrepreneurs of the Year® New England,2017-06-28 13:00:00 +0000,https://finance.yahoo.com/news/tesaro-announces-lonnie-moulder-mary-130000414.html?.tsrc=rss,"WALTHAM, Mass., June 28, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, is proud to announce Lonnie Moulder, CEO, and Mary Lynne Hedley, Ph.D., President and COO, have been named EY ..."
TSRO,TSRO:UW,BBG002S9PQF4,Is It Too Late to Buy Clovis Oncology Stock?,2017-06-27 20:51:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c1OkPNIvEm0/is-it-too-late-to-buy-clovis-oncology-stock-cm809030,In April I listed Clovis Oncology NASDAQ CLVS as a cancer drug stock that could make you rich In the two and a half months since then the biotech stock is up around 65 That s a pretty good start to becoming rich Clovis big gain stemmed from the company s announcement
TSRO,TSRO:UW,BBG002S9PQF4,"How Things Look for Opko Health, Inc. in 3 Charts",2017-06-26 20:26:00 +0000,http://finance.yahoo.com/r/1f83eda0-7266-3ec7-aed0-35759199342e/how-things-look-for-opko-health-inc-in-3-charts.aspx?yptr=yahoo&.tsrc=rss,"It hasn&apos;t been a great year so far for Opko Health, but the future could be brighter."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Joins Healthcare Businesswomen’s Association as Corporate Partner,2017-06-26 20:15:00 +0000,https://finance.yahoo.com/news/tesaro-joins-healthcare-businesswomen-association-201500990.html?.tsrc=rss,"WALTHAM, Mass., June 26, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, is proud to support the Healthcare Businesswomen’ s Association as a Corporate Partner. HBA is the leading global ..."
TSRO,TSRO:UW,BBG002S9PQF4,Could Tesaro Overcome Clovis&apos; Lead On Combos With Merck & Co.?,2017-06-20 20:15:34 +0000,http://finance.yahoo.com/r/70afb7df-c293-387c-8509-71c79add6a57/could-tesaro-scuttle-clovis-lead-on-combos-with-merck-bristol-roche?src=A00220&yptr=yahoo&.tsrc=rss,"Tesaro&apos;s Zejula would likely outperform drugs from Clovis and AstraZeneca in immuno-oncology combinations with Merck, Bristol or Roche."
TSRO,TSRO:UW,BBG002S9PQF4,Clovis Up Nearly 50% on Solid Data from Ovarian Cancer Study,2017-06-20 17:21:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sMAgauodimk/clovis-up-nearly-50-on-solid-data-from-ovarian-cancer-study-cm805792,Clovis Oncology Inc CLVS shares soared nearly 50 on Monday after it announced positive top line results from a pivotal late stage maintenance study on its newly launched ovarian cancer drug Rubraca Promising progression free survival PFS and safety results from the pivotal
TSRO,TSRO:UW,BBG002S9PQF4,Biotech ETFs: Still Riding High,2017-06-20 16:21:00 +0000,http://finance.yahoo.com/r/d2498f70-dd3c-3481-9e56-9cdf22c2e396/biotech-etfs-still-riding-high-1497975722?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The biotechnology-stock rally continues. The SPDR S&P Biotech (XBI) and the iShares Nasdaq Biotechnology (IBB), among the highest-flying exchange-traded funds yesterday, both hit their 52-week highs on ..."
TSRO,TSRO:UW,BBG002S9PQF4,Clovis Up Nearly 50% on Solid Data from Ovarian Cancer Study,2017-06-20 15:10:03 +0000,https://finance.yahoo.com/news/clovis-nearly-50-solid-data-151003305.html?.tsrc=rss,"Clovis Oncology, Inc. (CLVS) shares soared nearly 50% on Monday after it announced positive top-line results from a pivotal late-stage maintenance study on its newly launched ovarian cancer drug, Rubraca."
TSRO,TSRO:UW,BBG002S9PQF4,Here's what's behind the biotech breakout,2017-06-19 21:28:00 +0000,https://finance.yahoo.com/video/heres-whats-behind-biotech-breakout-212800606.html?.tsrc=rss,CNBC's Meg Tirrell reports on the biotech surge from Clovis and Tesaro as they compete in the same medical space.
TSRO,TSRO:UW,BBG002S9PQF4,Biotech Flew Nearly 50% On Strong Trial — But Is Its Drug Better?,2017-06-19 20:38:36 +0000,http://finance.yahoo.com/r/2382afb2-991a-3b4f-8957-dba27d6fe41e/this-biotech-flew-50-on-a-strong-trial-but-is-its-drug-really-better?src=A00220&yptr=yahoo&.tsrc=rss,"Clovis&apos; Rubraca isn&apos;t wildly different from Tesaro&apos;s Zejula in ovarian cancer, analysts said Monday."
TSRO,TSRO:UW,BBG002S9PQF4,Clovis Oncology's Rubraca Notches Key Trial Win,2017-06-19 20:20:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CMckR_nvcuI/clovis-oncologys-rubraca-notches-key-trial-win-cm805317,Clovis Oncology s NASDAQ CLVS Rubraca is already approved for use in ovarian cancer patients who have seen their disease return following two or more chemotherapies Soon the Food and Drug Administration may clear its use in patients following one or more treatments
TSRO,TSRO:UW,BBG002S9PQF4,Clovis Oncology&apos;s Rubraca Notches Key Trial Win,2017-06-19 18:21:00 +0000,http://finance.yahoo.com/r/64eb0bd7-5e74-32ec-975e-19b4574fc6f6/clovis-oncologys-rubraca-notches-key-trial-win.aspx?yptr=yahoo&.tsrc=rss,The addressable market for Rubraca could be about to get bigger.
TSRO,TSRO:UW,BBG002S9PQF4,Here's Why Clovis Oncology (CLVS) Stock Skyrocketed Today,2017-06-19 18:19:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rJoOKWhSuts/heres-why-clovis-oncology-clvs-stock-skyrocketed-today-cm805243,Shares of Clovis Oncology CLVS opened more than 40 higher on Monday morning after the company announced positive results in a late stage trial involving its Rubraca therapy an outcome that could help widen the use of the drug and give Clovis a competitive edge Clovis said that Rubraca
TSRO,TSRO:UW,BBG002S9PQF4,Biotech Stocks To Watch And Pharma Industry News,2017-06-19 18:18:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
TSRO,TSRO:UW,BBG002S9PQF4,Why Tesaro Inc. Stock Briefly Dipped Today,2017-06-19 17:22:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cLdXjmUaOsM/why-tesaro-inc-stock-briefly-dipped-today-cm805195,What happened Tesaro NASDAQ TSRO a mid cap oncology company saw its shares dip by as much as 10 6 in early morning trading today on more than double the average volume Although the company s shares have since rebounded and are only down by 2 95 as of 10 30 a m
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro: Is The Selloff Overdone?,2017-06-19 16:37:00 +0000,http://finance.yahoo.com/r/e35002e9-bbf3-36b1-8499-a2f8fe811b06/tesaro-is-the-selloff-overdone-1497890262?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The initial panic that surrounded shares of Tesaro (TSRO) this morning appears to have eased back quite a bit.  Tesaro is one of three leaders in the market for so-called PARP inhibitors, a new class of cancer drug.  Earlier today, rival Clovis Oncology (CLVS) released data for its drug Rubraca that fueled worries about Tesaro’s hold on the market."
TSRO,TSRO:UW,BBG002S9PQF4,Why Clovis Oncology Stock Is Soaring Today,2017-06-19 16:23:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Fgc1aURadM/why-clovis-oncology-stock-is-soaring-today-cm805104,What happened Shares of Clovis Oncology NASDAQ CLVS opened up trading today 46 higher than they were at Friday s close The drugmaker s stock is surging as a result of the successful Phase 3 readout for its 160 BRCA mutant ovarian cancer drug Rubraca in a confirmatory study
TSRO,TSRO:UW,BBG002S9PQF4,Why Cancer Biotech Clovis Oncology’s Stock Is Soaring,2017-06-19 15:48:06 +0000,https://finance.yahoo.com/news/why-cancer-biotech-clovis-oncology-154806507.html?.tsrc=rss,Impressive ovarian cancer drug data could make life hard for its rivals.
TSRO,TSRO:UW,BBG002S9PQF4,Why Tesaro Inc. Stock Briefly Dipped Today,2017-06-19 15:45:00 +0000,http://finance.yahoo.com/r/097c109c-4019-3e58-8629-ad97dcfe7edd/why-tesaro-inc-stock-briefly-dipped-today.aspx?yptr=yahoo&.tsrc=rss,An emerging competitive threat caused Tesaro&apos;s stock to briefly dip today.
TSRO,TSRO:UW,BBG002S9PQF4,Why Clovis Oncology Stock Is Soaring Today,2017-06-19 15:00:00 +0000,http://finance.yahoo.com/r/caf2574f-6ff7-3e0d-983d-6b47db77c5d3/why-clovis-oncology-stock-is-soaring-today.aspx?yptr=yahoo&.tsrc=rss,"The drugmaker&apos;s ovarian cancer treatment, Rubraca, hit another major clinical milestone."
TSRO,TSRO:UW,BBG002S9PQF4,"Pre-Market Most Active for Jun 19, 2017 :  AEG, RICE, CLVS, AUY, QQQ, NVDQ, VRX, RIGL, HL, TSRO, KR, JD",2017-06-19 12:59:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JhzwvVCoHcI/pre-market-most-active-for-jun-19-2017-aeg-rice-clvs-auy-qqq-nvdq-vrx-rigl-hl-tsro-kr-jd-cm804906,The NASDAQ 100 Pre Market Indicator is up 32 17 to 5 713 65 The total Pre Market volume is currently 7 766 242 shares traded The following are the most active stocks for the pre market session Aegon NV AEG is 0 03 at 5 06 with 1 120 700 shares traded AEG s
TSRO,TSRO:UW,BBG002S9PQF4,New test may turn AZ's Lynparza into precision drug for prostate cancer,2017-06-18 23:01:00 +0000,https://finance.yahoo.com/news/test-may-turn-azs-lynparza-230100457.html?.tsrc=rss,"Scientists have developed a new  three-in-one blood test that has the potential to turn  AstraZeneca's drug Lynparza into a precision medicine  for prostate cancer.  Lynparza, which is already approved for ovarian and recently  produced good results in breast cancer, is currently in clinical  development against prostate tumours.  Researchers at the Institute of Cancer Research (ICR) in  London said on Monday their new test was able to pick out which  men with advanced disease were likely to benefit from the drug,  while also checking that those taking it were responding."
TSRO,TSRO:UW,BBG002S9PQF4,3 Biotech Stocks That Could Become M&A Targets,2017-06-17 12:20:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fp5gOJQfjGM/3-biotech-stocks-that-could-become-ma-targets-cm804682,Biotech firms Mallinckrodt PLC NYSE MNK Tesaro Inc NASDAQ TSRO and Incyte Corp NASDAQ INCY could all be M amp A targets and if buyers appear for them owning their shares could pay off However these are risky stocks and there s no guarantee that deals
TSRO,TSRO:UW,BBG002S9PQF4,3 Biotech Stocks That Could Become M&A Targets,2017-06-17 10:42:00 +0000,http://finance.yahoo.com/r/42ea15c0-553d-30ff-b63b-10096d826a49/3-biotech-stocks-that-could-become-ma-targets.aspx?yptr=yahoo&.tsrc=rss,"There are reasons to think other drugmakers might see Mallinckrodt, Tesaro, and Incyte as tempting acquisitions, which makes them potential opportunities for risk-tolerant investors."
TSRO,TSRO:UW,BBG002S9PQF4,"Can AstraZeneca Keep Up As Clovis, Tesaro Unveil Blockbuster Drugs?",2017-06-16 20:41:01 +0000,http://finance.yahoo.com/r/9709ede1-9b26-34d9-a31d-dd6edd399ea2/can-astrazeneca-keep-up-as-clovis-tesaro-unveil-blockbuster-drugs?src=A00220&yptr=yahoo&.tsrc=rss,"Clovis and Tesaro could each deliver blockbuster ovarian cancer drugs and grab takeover interest, an analyst said Friday."
TSRO,TSRO:UW,BBG002S9PQF4,Here's Why Clovis (CLVS) Stock is Up Almost 350% in One Year,2017-06-16 16:10:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-InYC0mN8p4/heres-why-clovis-clvs-stock-is-up-almost-350-in-one-year-cm804391,Shares of Clovis Oncology Inc CLVS continue to witness an upside The uptrend started in the third quarter of 2016 In fact shares of this small biotech company are up a massive 343 7 in the past one year outperforming the 4 3 decrease registered by the Zacks classified Biomed
TSRO,TSRO:UW,BBG002S9PQF4,"ETFs with exposure to TESARO, Inc. : June 15, 2017",2017-06-15 19:34:20 +0000,http://finance.yahoo.com/r/3250f335-e648-3e7c-9756-66733b4c1d86/etfs-with-exposure-to-tesaro-inc-june-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TESARO, Inc. Here are 5 ETFs with the largest exposure to TSRO-US. Comparing the performance and risk of TESARO, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : June 14, 2017",2017-06-14 12:21:50 +0000,http://finance.yahoo.com/r/ddf34be6-005d-3224-9f71-697ba0ab89aa/tesaro-inc-breached-its-50-day-moving-average-in-a-bullish-manner-tsro-us-june-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for TESARO, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,Will Tesaro Be the Focus of the Next Biotech Bidding War?,2017-06-13 21:07:00 +0000,http://finance.yahoo.com/r/86903ca0-de94-3093-9e3c-a4fca5fafb6b/will-tesaro-be-the-focus-of-the-next-biotech-biddi.aspx?yptr=yahoo&.tsrc=rss,"Tesaro&apos;s management knows a thing or two about biotech M&A, and they&apos;re entertaining offers."
TSRO,TSRO:UW,BBG002S9PQF4,Today's Research Reports on Stocks to Watch: Gilead Sciences and Tesaro,2017-06-13 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000773.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 13, 2017 / Gilead Sciences announced over the weekend that it has submitted an NDA application to the FDA for an investigational regimen of Bictegravir, Emtricitabine and ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro: What the Heck Just Happened?,2017-06-09 17:00:00 +0000,http://finance.yahoo.com/r/e6897005-31c3-35e5-a13d-1d7993b7ab67/tesaro-what-the-heck-just-happened-1497027640?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Tesaro (TSRO) were down as much as 10.5% this morning, before bouncing back to roughly flat in early afternoon trading.  This morning, a link circulated that showed Johnson & Johnson's (JNJ) Janssen Research & Development had ""suspended participant recruitment"" in a study of Tesaro's Niraparib.  The market assumed the worst--that the study had been put on hold--and shares of Tesaro tumbled."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro stock dips 10% on ‘probably a nothing burger’,2017-06-09 16:35:15 +0000,https://finance.yahoo.com/news/tesaro-stock-dips-10-probably-163515581.html?.tsrc=rss,A clinical trial’s recruitment suspension prompted investor worries.
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro stock dips 10% on ‘probably a nothing burger’,2017-06-09 16:35:15 +0000,http://finance.yahoo.com/r/6876212b-61b6-3436-ac0c-cafa5b848fe8/Story.aspx?guid=F7B8B49E-4D2A-11E7-8F25-FFB46009C8A4&siteid=yhoof2&yptr=yahoo&.tsrc=rss,A clinical trial’s recruitment suspension prompted investor worries.
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. (TSRO) Is Accelerating To The Downside,2017-06-09 10:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XORcjah78Yk/tesaro-inc-tsro-is-accelerating-to-the-downside-20170609-00519,Tesaro Inc. (TSRO) Is Accelerating To The Downside
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Participation at Goldman Sachs 38th Annual Global Healthcare Conference,2017-06-07 20:30:00 +0000,https://finance.yahoo.com/news/tesaro-announces-participation-goldman-sachs-203000105.html?.tsrc=rss,"WALTHAM, Mass., June 07, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced its participation at the Goldman Sachs 38th Annual Global Healthcare Conference, to be held ..."
TSRO,TSRO:UW,BBG002S9PQF4,Sum Up The Pieces: BBH Could Be Worth $138,2017-06-06 15:04:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eYDDLOKk1zs/sum-up-the-pieces-bbh-could-be-worth-138-cm799307,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
TSRO,TSRO:UW,BBG002S9PQF4,"Corporate News Blog - Puma Biotech Announced Positive Results from PB272 Phase-II Data at the ASCO, 2017",2017-06-06 12:15:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-puma-biotech-121500287.html?.tsrc=rss,"Research Desk Line-up: Tesaro Post Earnings Coverage LONDON, UK / ACCESSWIRE / June 6, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for biopharmaceutical ..."
TSRO,TSRO:UW,BBG002S9PQF4,"​Bluebird and Radius gain, while Blueprint and Tesaro fall, at ASCO cancer summit",2017-06-06 10:30:12 +0000,http://finance.yahoo.com/r/ef1ee849-2e9c-3415-93e7-50e292c95b20/bluebird-and-radius-gain-while-blueprint-and.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Some local biotechs are among the biggest stock market gainers — and losers — so far at this week's closely-watched annual conference in Chicago on cancer drug research.  The annual meeting of the American Society of Clinical Oncology, which began Friday and runs through Tuesday, has featured presentations by companies from across the globe on some of the most promising cancer treatments currently in clinical trials.  The conference comes at a time when oncology R&D is booming: according to one recent report, the number of late-stage cancer drugs has increased by 45 percent over the last decade, while the size and duration of pivotal trials has decreased."
TSRO,TSRO:UW,BBG002S9PQF4,"ETFs with exposure to TESARO, Inc. : June 5, 2017",2017-06-05 18:52:10 +0000,http://finance.yahoo.com/r/628fdf6b-35e0-37ab-9d88-2d1b18f8682d/etfs-with-exposure-to-tesaro-inc-june-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TESARO, Inc. Here are 5 ETFs with the largest exposure to TSRO-US. Comparing the performance and risk of TESARO, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,"Notes From ASCO 2017: Tesaro, Amgen, Others Report New Data",2017-06-05 17:48:02 +0000,https://finance.yahoo.com/news/notes-asco-2017-tesaro-amgen-174802731.html?.tsrc=rss,The 2017 American Society of Clinical Oncology annual meeting is taking place in Chicago from last Friday through Tuesday. There have already been several companies that have updated shareholders with ...
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro: What's Tearing At The Stock?,2017-06-05 16:49:00 +0000,http://finance.yahoo.com/r/fb6f2913-79c3-3c20-b8e5-de06cf7a6c73/tesaro-whats-tearing-at-the-stock-1496681351?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Another biotech company’s share price is suffering an ASCO hangover.  Tesaro (TSRO) fell 5% in recent market action despite some pretty bullish research notes about its ovarian cancer drug Zejula.  Oppenheimer raised its price target to $199 a share from $183 a share on the strength of the Zejula launch.
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Provides Business and Pipeline Update at ASCO Investor Briefing,2017-06-03 22:30:00 +0000,https://finance.yahoo.com/news/tesaro-provides-business-pipeline-asco-223000861.html?.tsrc=rss,Initial TOPACIO data for niraparib plus KEYTRUDA ® is indicative of potentially synergistic anti-tumor activity in platinum-resistant ovarian cancer Phase 1 results for TSR-042 show anti-PD-1 activity ...
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. :TSRO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017",2017-06-02 14:00:36 +0000,http://finance.yahoo.com/r/72a9fdaf-fed9-389c-8f50-48fc6068544e/tesaro-inc-tsro-us-earnings-analysis-q1-2017-by-the-numbers-june-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis TESARO, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of TESARO, Inc. – Clovis Oncology, Inc., ZIOPHARM Oncology, Inc., Amgen Inc., Cerulean Pharma, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Insys Therapeutics, Inc. and Pfizer Inc. (CLVS-US, ZIOP-US, ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : June 1, 2017",2017-06-01 12:20:41 +0000,http://finance.yahoo.com/r/92ce193b-aced-3f86-a826-838175f0a813/tesaro-inc-breached-its-50-day-moving-average-in-a-bullish-manner-tsro-us-june-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for TESARO, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,​Tesaro shares jump on report the cancer drug firm is eyeing a sale,2017-06-01 10:55:08 +0000,http://finance.yahoo.com/r/2b858b4d-cc26-33e0-9def-0f5762ed2ec3/tesaro-shares-jump-on-report-the-cancer-drug-firm.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Tesaro rose Wednesday following a report that the Waltham cancer drug developer is exploring a sale that could value the company at more than $9 billion.  The Wall Street Journal reported that Tesaro (TSRO) has “asked for initial offers in recent weeks,” but that potential suitors have expressed only “lukewarm” interest so far.  Shares of Tesaro spiked 10 percent immediately after the report was published before declining, and closed the day up 4 percent."
TSRO,TSRO:UW,BBG002S9PQF4,"&quot;Fast Money&quot; final trades: QCOM, PANW & more",2017-05-31 21:59:00 +0000,https://finance.yahoo.com/video/fast-money-final-trades-qcom-215900173.html?.tsrc=rss,"The “Fast Money” traders discuss their final trades for the day including Qualcomm, Twitter, Palo Alto Networks, Tesaro."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Spikes On Rumors It&apos;s Seeking A Takeover,2017-05-31 21:23:57 +0000,http://finance.yahoo.com/r/37eef6e4-ca21-307f-ad30-173dc170b842/tesaro-spikes-on-rumors-its-seeking-a-takeover?src=A00220&yptr=yahoo&.tsrc=rss,Tesaro stock spiked more than 4% Wednesday on rumors it&apos;s seeking takeover bids two months after its ovarian cancer drug Zejula won approval.
TSRO,TSRO:UW,BBG002S9PQF4,Biotech Musical Chairs: Who Leads Next,2017-05-31 10:00:00 +0000,http://finance.yahoo.com/r/798fae83-dc19-360c-a154-7db0f1650f11/biotech-musical-chairs-who-leads-next-ibb-nbix?partner=YahooSA&yptr=yahoo&.tsrc=rss,The biotech sector as measured by the iShares Nasdaq Biotech ETF is down another 1.40% today.
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Announces Presentations of Abstracts at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting,2017-05-25 20:15:00 +0000,https://finance.yahoo.com/news/tesaro-announces-presentations-abstracts-2017-201500561.html?.tsrc=rss,"Investor briefing to be webcast from Chicago on June 3, 2017 at 6:15 PM CT WALTHAM, Mass., May 25, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced the presentation of ..."
TSRO,TSRO:UW,BBG002S9PQF4,Insider Buying: The Evidence,2017-05-24 15:30:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nWMhO0YEX8E/insider-buying-the-evidence-cm793927,Earlier this week I highlighted stocks that have seen a significant amount of insider buying over the past three months as insider buying is widely considered a great indicator for management sentiment regarding a company s outlook Earlier this week I highlighted stocks that have seen
TSRO,TSRO:UW,BBG002S9PQF4,"Clovis' (CLVS) PARP Inhibtor Shows Promise, Risks Remain",2017-05-22 15:15:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t5DLe4koMvQ/clovis-clvs-parp-inhibtor-shows-promise-risks-remain-cm792584,On May 19 we issued an updated research report on Boulder CO based Clovis Oncology Inc CLVS Clovis is a biopharmaceutical company focused on the development and commercialization of treatments targeting specific subsets of cancer population So far this year Clovis share price has
TSRO,TSRO:UW,BBG002S9PQF4,"National Survey Shows Resource, Emotional and Support Needs of the Ovarian Cancer Community",2017-05-22 13:01:00 +0000,https://finance.yahoo.com/news/national-survey-shows-emotional-support-130100323.html?.tsrc=rss,"WALTHAM, Mass., May 22, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced the results of the Our Way Forward survey– a national survey of patients and healthcare providers ..."
TSRO,TSRO:UW,BBG002S9PQF4,Conference Spotlights Drug Giant Donnybrooks In Cancer Treatments,2017-05-18 19:44:45 +0000,http://finance.yahoo.com/r/fe46b8b5-dce5-35cf-9497-7339351dd0e6/conference-spotlights-lilly-pfizer-merck-bristol-donnybrooks-in-cancer?src=A00220&yptr=yahoo&.tsrc=rss,"Preliminary data highlights breast, ovarian, lung and skin cancer data to presented during the American Society of Clinical Oncology meeting next month."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. – Value Analysis (NASDAQ:TSRO) : May 18, 2017",2017-05-18 18:20:35 +0000,http://finance.yahoo.com/r/214ebe58-82ba-3c9c-b75b-f139bbd377f6/tesaro-inc-value-analysis-nasdaqtsro-may-18-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives TESARO, Inc. a score of 25. Our analysis is based on comparing TESARO, Inc. with the following peers – Clovis Oncology, Inc., ZIOPHARM Oncology, Inc., Amgen Inc., Cerulean Pharma, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Insys Therapeutics, Inc. and Pfizer Inc. (CLVS-US, ZIOP-US, AMGN-US, CERU-US, ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,Industry News And Stocks To Watch,2017-05-18 14:18:38 +0000,http://finance.yahoo.com/r/967e6bbb-f7b7-35a3-a9fe-d7b3be3ea79e/industry-news-and-stocks-to-watch?src=A00220&yptr=yahoo&.tsrc=rss,"Track the latest news and stocks to watch across the tech, retail, finance and other industries."
TSRO,TSRO:UW,BBG002S9PQF4,Did AstraZeneca Rival Just Launch A Potential Blockbuster Drug?,2017-05-17 21:05:29 +0000,http://finance.yahoo.com/r/291d105f-b6df-3ba0-ba52-e6922c429a46/did-this-astrazeneca-rival-just-launch-a-potential-blockbuster-drug?src=A00220&yptr=yahoo&.tsrc=rss,"An analyst upgraded Clovis ahead of a key study for its ovarian cancer drug, which he said holds up against another from AstraZeneca."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : May 17, 2017",2017-05-17 12:07:15 +0000,http://finance.yahoo.com/r/77fb50f1-95a9-343e-9b86-3430bee60ffd/tesaro-inc-breached-its-50-day-moving-average-in-a-bullish-manner-tsro-us-may-17-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for TESARO, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
TSRO,TSRO:UW,BBG002S9PQF4,Edited Transcript of TSRO earnings conference call or presentation 9-May-17 8:15pm GMT,2017-05-16 09:11:06 +0000,https://finance.yahoo.com/news/edited-transcript-tsro-earnings-conference-025436638.html?.tsrc=rss,Q1 2017 TESARO Inc Earnings Call
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Partners With Clinigen to Initiate European Managed Access Program for Niraparib in Patients With Recurrent Ovarian Cancer,2017-05-11 06:01:00 +0000,http://finance.yahoo.com/news/tesaro-partners-clinigen-initiate-european-060100935.html?.tsrc=rss,"WALTHAM, Mass., May 11, 2017-- TESARO Inc. and Clinigen Group plc’ s Idis Managed Access division have partnered to launch a Managed Access Program in Europe for the investigational PARP 1/ 2 inhibitor, ..."
TSRO,TSRO:UW,BBG002S9PQF4,Edited Transcript of TSRO earnings conference call or presentation 9-May-17 8:15pm GMT,2017-05-11 01:35:47 +0000,http://finance.yahoo.com/news/edited-transcript-tsro-earnings-conference-025436638.html?.tsrc=rss,Q1 2017 TESARO Inc Earnings Call
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro reports 1Q loss,2017-05-09 20:44:53 +0000,http://finance.yahoo.com/news/tesaro-reports-1q-loss-204453504.html?.tsrc=rss,"On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of $2.55. The results did not meet Wall Street expectations. The average estimate of 13 analysts surveyed by Zacks Investment ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces First-Quarter 2017 Operating Results,2017-05-09 20:05:00 +0000,http://finance.yahoo.com/news/tesaro-announces-first-quarter-2017-200500236.html?.tsrc=rss,"FDA for the maintenance treatment of women with recurrent ovarian cancer, regardless of BRCA or biomarker status; commercial launch underway ZEJULA added to the NCCN Clinical Practice Guidelines in Oncology ..."
TSRO,TSRO:UW,BBG002S9PQF4,"Earnings Reaction History: TESARO, Inc., 100.0% Follow-Through Indicator, 5.1% Sensitive",2017-05-09 19:40:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KEK8eXEitlw/earnings-reaction-history-tesaro-inc-1000-follow-through-indicator-51-sensitive-cm786771,Expected Earnings Release 05 09 2017 After hoursExpected Earnings Release 05 09 2017 After hours Avg Extended Hours Dollar Volume 3 560 171Avg Extended Hours Dollar Volume 3 560 171 TESARO Inc TSRO is due to issue its quarterly earnings report in the upcoming extended
TSRO,TSRO:UW,BBG002S9PQF4,"After-Hours Earnings Report for May 9, 2017 :  DIS, PCLN, NVDA, EA, SLF, MCHP, FNV, REG, JAZZ, DOX, ZAYO, TSRO",2017-05-09 18:53:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KSqso8AcVos/after-hours-earnings-report-for-may-9-2017-dis-pcln-nvda-ea-slf-mchp-fnv-reg-jazz-dox-zayo-tsro-cm786723,The following companies are expected to report earnings after hours on 05 09 2017 Visit our Earnings Calendar for a full list of expected earnings releases Walt Disney Company DIS is reporting for the quarter ending March 31 2017 The media company
TSRO,TSRO:UW,BBG002S9PQF4,"Investor Network: TESARO, Inc. to Host Earnings Call",2017-05-09 14:15:00 +0000,http://finance.yahoo.com/news/investor-network-tesaro-inc-host-141500277.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / TESARO, Inc. (NASDAQ: TSRO ) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 4:15 PM Eastern Time. To listen to the ..."
TSRO,TSRO:UW,BBG002S9PQF4,"KITE Plunges, Take Sector With It",2017-05-08 17:29:00 +0000,http://finance.yahoo.com/r/d954ed25-a03a-3ab2-b79c-70f7d0e1c69f/kite-plunges-take-sector-it-kite-ibb?partner=YahooSA&yptr=yahoo&.tsrc=rss,Kite stock plunged after it reported a clinical study death and worse-than-expected Q1 losses.
TSRO,TSRO:UW,BBG002S9PQF4,"Neurocrine Biosciences’ new drug may cost patients more than $10,000 a month, twice as much as expected",2017-05-01 12:51:42 +0000,http://finance.yahoo.com/r/5570d0dd-4906-3f2c-81ad-15d349ba1d05/Story.aspx?guid=3DE44326-2AA7-11E7-85A0-6A869C5876AE&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Neurocrine Biosciences has priced its drug Ingrezza, the first approved for adults with the neurological disorder tardive dyskinesia, above even Wall Street’s presumably elevated expectations—at about ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDA,2017-05-01 12:30:00 +0000,http://finance.yahoo.com/news/tesaro-announces-submission-investigational-drug-123000941.html?.tsrc=rss,"WALTHAM, Mass., May 01, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced the submission of an Investigational New Drug Application for TSR-033 to the U.S. TSR-033 is ..."
TSRO,TSRO:UW,BBG002S9PQF4,Drug Trials Heating Up In The Breast and Ovarian Cancer Treatment Space,2017-04-27 16:55:21 +0000,http://finance.yahoo.com/news/drug-trials-heating-breast-ovarian-165521618.html?.tsrc=rss,"The next generation of breast and ovarian cancer treatment is attacking the deadly disease from all angles. That is no more evident than in the glut of pharmaceutical companies racing to develop, test, ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Initiates Registrational Development Program for Anti-PD-1 Antibody TSR-042,2017-04-27 12:15:00 +0000,http://finance.yahoo.com/news/tesaro-initiates-registrational-development-program-121500247.html?.tsrc=rss,TSR-042 is the first TESARO immuno-oncology candidate to enter a registration program Ongoing clinical trial expanded to enroll patients with endometrial cancer Patient-centric administration schedule ...
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Approval of VARUBY® (Oral Rolapitant Tablets) by European Commission,2017-04-26 12:31:01 +0000,http://finance.yahoo.com/news/tesaro-announces-approval-varuby-oral-123101285.html?.tsrc=rss,VARUBY provides protection for delayed chemotherapy-induced nausea and vomiting (CINV) with a single dose as part of an antiemetic regimen Up to 50% of patients undergoing highly or moderately emetogenic ...
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc Bulls Need a Reality Check,2017-04-25 21:06:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m7JJtnvEgnc/tesaro-inc-bulls-need-a-reality-check-cm779029,Tesaro Inc NASDAQ TSRO enjoyed its best summer ever last year but lately this biotech has had a case of the blues Following a peak in February the stock has lost more than a quarter of its value Despite the recent slide investors should remain braced for further downside
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Announces Participation in Two Investor Conferences,2017-04-25 20:15:00 +0000,http://finance.yahoo.com/news/tesaro-announces-participation-two-investor-201500676.html?.tsrc=rss,"WALTHAM, Mass., April 25, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The Leerink Boston Biopharma Bus Tour ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO to Announce First-Quarter 2017 Financial Results on May 9, 2017",2017-04-25 20:15:00 +0000,http://finance.yahoo.com/news/tesaro-announce-first-quarter-2017-201500333.html?.tsrc=rss,"WALTHAM, Mass., April 25, 2017-- TESARO, Inc. will announce its first-quarter 2017 financial results on Tuesday, May 9, 2017, after the close of the U.S. financial markets. TESARO’ s senior management ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc Bulls Need a Reality Check,2017-04-25 19:43:00 +0000,http://finance.yahoo.com/r/f4370afe-e0df-3f41-b158-c2fb70a538d8/tesaro-inc-bulls-need-a-reality-check.aspx?yptr=yahoo&.tsrc=rss,Has the market overestimated the odds of success for Tesaro&apos;s fancy new cancer drug?
TSRO,TSRO:UW,BBG002S9PQF4,Biotech M&A Plunges as Trump Attacks Drug Companies,2017-04-24 10:00:00 +0000,http://finance.yahoo.com/r/36c0c78b-f409-3b03-9601-3f8a62e5a04c/biotech-ma-plunges-trump-attacks-drug-companies?partner=YahooSA&yptr=yahoo&.tsrc=rss,Biotech M&A activity has fallen.
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro's Path to a Billion-Dollar Blockbuster Begins With Pricing,2017-04-21 13:05:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZP6A9S7B3Rs/tesaros-path-to-a-billion-dollar-blockbuster-begins-with-pricing-cm776881,Tesaro NASDAQ TSRO won FDA approval of its new cancer drug Zejula in March and this week management reported that Zejula is now available at a dose of 200 mg per day with a list price of 9 833 per month The price is in the ballpark of existing drugs in Zejula s class and
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro&apos;s Path to a Billion-Dollar Blockbuster Begins With Pricing,2017-04-21 11:21:00 +0000,http://finance.yahoo.com/r/2afc87f8-d8c3-3b80-8022-3fff1121f105/tesaros-path-to-a-billion-dollar-blockbuster-begin.aspx?yptr=yahoo&.tsrc=rss,"Tesaro has set the price of its newly launched PARP inhibitor, Zejula, at nearly $10,000 per month."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro stock dives 7% after drug pricing snafu,2017-04-21 10:59:44 +0000,http://finance.yahoo.com/r/abe28e63-81bb-34f4-971e-d10c8c02794b/Story.aspx?guid=B02576A6-25B8-11E7-B1CB-9E0646962565&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The price is “a sticker shock” but will probably come closer to $119,000-a-year, one analyst said."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro’s Zejula Flops as H&S Pattern Emerges,2017-04-21 10:52:00 +0000,http://finance.yahoo.com/r/53eed85c-ad7f-3740-8f5d-7f66f04f283a/tesaros-zejula-flops-hs-pattern-emerges-tsro-clvs?partner=YahooSA&yptr=yahoo&.tsrc=rss,A look at Tesaro's recent decline and the bearish head and shoulders pattern emerging in its chart.
TSRO,TSRO:UW,BBG002S9PQF4,"Noteworthy Thursday Option Activity: WMT, KCG, TSRO",2017-04-20 19:04:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_BOF8F-eC1M/noteworthy-thursday-option-activity-wmt-kcg-tsro-cm776609,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Wal Mart Stores Inc Symbol WMT where a total volume of 48 049 contracts has been traded thus far today a contract volume which is representative of approximately 4
TSRO,TSRO:UW,BBG002S9PQF4,AbbVie's PARP Inhibitor Comes Up Empty,2017-04-20 19:03:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MhiMo2VnZ58/abbvies-parp-inhibitor-comes-up-empty-cm776587,AbbVie s NYSE ABBV attempt to expand the use of a new class of cancer drugs into new indications has failed to pan out according to management The company announced yesterday that two trials evaluating its PARP inhibitor veliparib came up short of their primary endpoints
TSRO,TSRO:UW,BBG002S9PQF4,AbbVie&apos;s PARP Inhibitor Comes Up Empty,2017-04-20 17:21:00 +0000,http://finance.yahoo.com/r/94a3e85b-772e-3d65-a6ad-d18d1982219f/abbvies-parp-inhibitor-comes-up-empty.aspx?yptr=yahoo&.tsrc=rss,The drugmaker reported that veliparib failed to outperform standard treatment in breast cancer and non-small-cell lung cancer trials.
TSRO,TSRO:UW,BBG002S9PQF4,"Commit To Buy Tesaro At $70, Earn 7.7% Using Options",2017-04-20 17:04:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WL77jTcR8QM/commit-to-buy-tesaro-at-70-earn-77-using-options-cm776520,Investors considering a purchase of Tesaro Inc Symbol TSRO stock but tentative about paying the going market price of 134 32 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Availability of Zejula™ (Niraparib) for Patients With Recurrent Ovarian Cancer in the U.S.,2017-04-19 20:15:00 +0000,http://finance.yahoo.com/news/tesaro-announces-availability-zejula-niraparib-201500090.html?.tsrc=rss,ZEJULA is the first and only PARP inhibitor to be approved for the maintenance treatment of women with recurrent ovarian cancer ZEJULA is the only PARP inhibitor that has demonstrated a clinically meaningful ...
TSRO,TSRO:UW,BBG002S9PQF4,3 Stocks With Shopify-Like Return Potential,2017-04-19 19:03:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bZDxaflw4Gs/3-stocks-with-shopify-like-return-potential-cm775999,Shares of Shopify NYSE SHOP a company that provides an e commerce platform for merchants have exploded over the past year up about 130 This return was driven by extremely rapid growth with Shopify growing revenue by a staggering 90 in 2016 Investors are betting
TSRO,TSRO:UW,BBG002S9PQF4,3 Stocks With Shopify-Like Return Potential,2017-04-19 17:41:00 +0000,http://finance.yahoo.com/r/341fca0c-cf22-35de-a0b7-814c68f597d9/3-stocks-with-shopify-like-return-potential.aspx?yptr=yahoo&.tsrc=rss,These stocks could be in for big gains if things go right.
TSRO,TSRO:UW,BBG002S9PQF4,Traders say mergers and acquisitions could bring boost to biotech stocks,2017-04-13 22:44:42 +0000,http://finance.yahoo.com/r/04e4e408-3a4d-3292-a298-621db1990b9f/104403902?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104403902&yptr=yahoo&.tsrc=rss,"The ""Fast Money"" traders weigh biotechnology stocks as the sector gears up for blockbuster drugs and possible mergers."
TSRO,TSRO:UW,BBG002S9PQF4,These 3 Stocks Have Tripled Over the Past Year,2017-04-13 13:57:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fJDASjBmC48/these-3-stocks-have-tripled-over-the-past-year-cm773659,Gains for the stock market add up over the years but a few stocks give you extremely strong short term performance Over the past year some stocks have tripled in value and Teck Resources NYSE TECK Tesaro NASDAQ TSRO and Blucora NASDAQ BCOR are among those
TSRO,TSRO:UW,BBG002S9PQF4,These 3 Stocks Have Tripled Over the Past Year,2017-04-13 12:48:00 +0000,http://finance.yahoo.com/r/45f4c19a-96a7-3332-998d-9c29551e0724/these-3-stocks-have-tripled-over-the-past-year.aspx?yptr=yahoo&.tsrc=rss,Find out why these big winners have done so well and whether they can climb further.
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro: Good News Is Already Baked Into The Stock,2017-04-10 18:34:00 +0000,http://finance.yahoo.com/r/27b2b973-f38c-3fd6-82ab-ea5522537295/tesaro-good-news-is-already-baked-into-the-stock?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Tesaro (TSRO) has been on a wild ride of late, gaining more than 200% in the past year on takeout speculation, but also taking big hits on data about its cancer treatment. On Monday, Janney Montgomery ..."
TSRO,TSRO:UW,BBG002S9PQF4,Why Clovis Oncology's Stock Edged Higher in March,2017-04-07 22:54:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kk-9Zq02SHA/why-clovis-oncologys-stock-edged-higher-in-march-cm771643,What happened According to data from S amp P Global Market Intelligence shares of Clovis Oncology NASDAQ CLVS gained 7 42 in March The drugmaker s shares are now up almost 28 so far this year due to the Food and Drug Administration s FDA approval of its 160
TSRO,TSRO:UW,BBG002S9PQF4,Why Clovis Oncology&apos;s Stock Edged Higher in March,2017-04-07 20:53:00 +0000,http://finance.yahoo.com/r/5dd541b9-3fc4-3c45-bee3-8cf226cc2d65/why-clovis-oncologys-stock-edged-higher-in-march.aspx?yptr=yahoo&.tsrc=rss,"Investors are clearly excited about Clovis&apos; new ovarian cancer drug, but this enthusiasm may be overdone at this point."
TSRO,TSRO:UW,BBG002S9PQF4,Medidata & TESARO Win CARE &apos;Clinical Partnership&apos; Award,2017-04-07 13:22:01 +0000,http://finance.yahoo.com/news/medidata-tesaro-win-care-apos-132201473.html?.tsrc=rss,"Medidata Solutions Inc. (MDSO) recently announced the receipt of the &apos;Clinical Partnership of the Year&apos; award at the second annual Clinical and Research Excellence (CARE) Awards, courtesy of its &apos;unique technology collaboration&apos; with TESARO."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Wins Awards for Clinical Development Team of the Year and Clinical Partnership of the Year,2017-04-07 12:30:00 +0000,http://finance.yahoo.com/news/tesaro-wins-awards-clinical-development-123000308.html?.tsrc=rss,"WALTHAM, Mass., April 07, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, has been recognized with two Clinical and Research Excellence Awards. Pharma/Biotech Product Development Team ..."
TSRO,TSRO:UW,BBG002S9PQF4,Oversold Conditions For Tesaro (TSRO),2017-04-05 21:54:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/957uR3pUNng/oversold-conditions-for-tesaro-tsro-cm770440,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
TSRO,TSRO:UW,BBG002S9PQF4,Peek Under The Hood: BBH Has 14% Upside,2017-04-05 13:24:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZMqfUqllHww/peek-under-the-hood-bbh-has-14-upside-cm769995,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
TSRO,TSRO:UW,BBG002S9PQF4,[$$] Beaten-Down Biotechs May Be Worth Buying,2017-04-04 15:05:00 +0000,http://finance.yahoo.com/r/fbd1819b-97a9-3c1e-a1f5-27590ead42ea/beaten-down-biotechs-may-be-worth-buying-1491318338?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  We also think all the biotech companies highlighted below represent interesting opportunities where sentiment is negative (Gilead Sciences, Alexion Pharmaceuticals and Alnylam Pharmaceuticals) or under significant debate (Tesaro, Gilead)."
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro's Zejula Nabs Early OK, But What's Next?",2017-04-04 14:24:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bJPwZfRy92k/tesaros-zejula-nabs-early-ok-but-whats-next-cm769479,Patients with ovarian cancer who have responded to platinum based chemotherapy may soon be prescribed Tesaro s NASDAQ TSRO Zejula as a maintenance therapy to help prevent the cancer s return The decision by the FDA to approve Zejula three months ahead of schedule was
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro&apos;s Zejula Nabs Early OK, But What&apos;s Next?",2017-04-04 13:02:00 +0000,http://finance.yahoo.com/r/b48486fa-7bf8-32c7-a544-a0a5ab5820c6/tesaros-zejula-nabs-early-ok-but-whats-next.aspx?yptr=yahoo&.tsrc=rss,"Zejula got an FDA go-ahead months early, and it may become the top-selling drug in its class."
TSRO,TSRO:UW,BBG002S9PQF4,4 FDA Decisions to Watch Out for in Apr 2017,2017-04-03 11:41:11 +0000,http://finance.yahoo.com/news/4-fda-decisions-watch-apr-114111333.html,4 FDA Decisions to Watch Out for in Apr 2017
TSRO,TSRO:UW,BBG002S9PQF4,Healthcare Winners and Losers Following the AHCA's Failure,2017-04-02 20:35:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GTIXvN4UdXk/healthcare-winners-and-losers-following-the-ahcas-failure-cm768819,After Republicans in Congress failed to get enough support they shelved a vote in the House of Representatives on the American Health Care Act AHCA last month If the AHCA had eventually passed Congress it would have significantly reshaped the healthcare sector and shaken
TSRO,TSRO:UW,BBG002S9PQF4,Healthcare Winners and Losers Following the AHCA's Failure,2017-04-02 19:02:00 +0000,http://finance.yahoo.com/r/85bc2e5f-d219-3496-83ae-2ec47184cc84/healthcare-winners-and-losers-following-the-ahcas.aspx?yptr=yahoo&.tsrc=rss,The failed attempt to repeal and replace Obamacare last month has big implications for healthcare investors.
TSRO,TSRO:UW,BBG002S9PQF4,Healthcare Winners and Losers Following the AHCA's Failure,2017-04-02 19:02:00 +0000,https://www.fool.com/investing/2017/04/02/healthcare-winners-and-losers-following-the-ahcas.aspx,Healthcare Winners and Losers Following the AHCA's Failure
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits",2017-03-31 20:17:34 +0000,http://biz.yahoo.com/e/170331/tsro8-k.html,"TESARO, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Nets Surprise Early Approval,2017-03-29 15:00:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JEwZs1TckUo/tesaro-nets-surprise-early-approval-cm767147,Tesaro s NASDAQ TSRO 160 ovarian cancer drug niraparib will begin competing for prescriptions earlier than expected Niraparib which will be sold under the brand name Zejula notched FDA approval on Monday more than three months ahead of its June 30 decision date The
TSRO,TSRO:UW,BBG002S9PQF4,What Makes Tesaro (TSRO) a Strong Sell?,2017-03-29 14:01:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WIE_m9OUJ5c/what-makes-tesaro-tsro-a-strong-sell-cm767175,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Nets Surprise Early Approval,2017-03-29 13:21:00 +0000,https://www.fool.com/investing/2017/03/29/tesaro-nets-surprise-early-approval.aspx,Tesaro Nets Surprise Early Approval
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Nets Surprise Early Approval,2017-03-29 13:21:00 +0000,http://finance.yahoo.com/r/f20c3c2b-89b4-3a61-b855-75fddb4205d0/tesaro-nets-surprise-early-approval.aspx?yptr=yahoo&.tsrc=rss,"Tesaro's cancer-fighting drug, niraparib, nabbed FDA approval roughly three months ahead of schedule."
TSRO,TSRO:UW,BBG002S9PQF4,What Makes Tesaro (TSRO) a Strong Sell?,2017-03-29 12:42:12 +0000,http://finance.yahoo.com/news/makes-tesaro-tsro-strong-sell-124212587.html?.tsrc=rss,Tesaro (TSRO) is one stock you should avoid as it has seen a significant price decline and negative earnings estimate revisions.
TSRO,TSRO:UW,BBG002S9PQF4,What Makes Tesaro (TSRO) a Strong Sell?,2017-03-29 12:42:12 +0000,http://finance.yahoo.com/news/makes-tesaro-tsro-strong-sell-124212587.html,What Makes Tesaro (TSRO) a Strong Sell?
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro won’t reveal price of its ovarian cancer drug. But it’ll likely be near $14,000 a month",2017-03-29 12:29:44 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=E83851D8-13B3-11E7-BCC7-456FC1EDA05D&siteid=yhoof2,"Tesaro won’t reveal price of its ovarian cancer drug. But it’ll likely be near $14,000 a month"
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro won’t reveal price of its ovarian cancer drug. But it’ll likely be near $14,000 a month",2017-03-29 12:29:44 +0000,http://finance.yahoo.com/r/f9b0c0ab-4c8c-38a1-a7ba-64425caab184/Story.aspx?guid=E83851D8-13B3-11E7-BCC7-456FC1EDA05D&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The company could be delaying price information because it’ll be higher than expected, according to some."
TSRO,TSRO:UW,BBG002S9PQF4,"Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study",2017-03-29 12:15:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-regeneron-tesaro-121512031.html,"Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study"
TSRO,TSRO:UW,BBG002S9PQF4,"Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study",2017-03-29 12:15:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-regeneron-tesaro-121512031.html?.tsrc=rss,Key updates this week include the FDA approval of Tesaro's (TSRO) PARP inhibitor and Regeneron's eczema drug.
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Wins FDA Approval for Ovarian Cancer Drug Zejula,2017-03-28 23:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/foeZBBVDAM0/tesaro-wins-fda-approval-for-ovarian-cancer-drug-zejula-cm766956,Tesaro Inc TSRO recently announced that the FDA has approved its oral once daily poly ADP ribose polymerase PARP inhibitor Zejula niraparib for the maintenance treatment of women suffering from recurrent epithelial ovarian fallopian tube or primary peritoneal cancer who are in
TSRO,TSRO:UW,BBG002S9PQF4,"Why Tesaro Inc (TSRO) Stock Roared, Then Reversed",2017-03-28 22:58:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gFRuin8HO50/why-tesaro-inc-tsro-stock-roared-then-reversed-cm766960,InvestorPlace Stock Market News Stock Advice amp Trading Tips Tesaro Inc 160 NASDAQ TSRO stock has seen a strange day of trading 160 marked by a big open followed by a collapse near the close Source Shutterstock Specifically TSRO stock climbed higher Tuesday on
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Wins FDA Approval for Ovarian Cancer Drug Zejula,2017-03-28 22:03:10 +0000,http://finance.yahoo.com/news/tesaro-wins-fda-approval-ovarian-220310182.html,Tesaro Wins FDA Approval for Ovarian Cancer Drug Zejula
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Wins FDA Approval for Ovarian Cancer Drug Zejula,2017-03-28 22:03:10 +0000,http://finance.yahoo.com/news/tesaro-wins-fda-approval-ovarian-220310182.html?.tsrc=rss,"TESARO, Inc. (TSRO) recently announced that the FDA has approved its oral, once-daily poly(ADP-ribose) polymerase (PARP) inhibitor Zejula for ovarian cancer in women."
TSRO,TSRO:UW,BBG002S9PQF4,Why Clovis' Advantage Might Squash Tesaro In Ovarian Cancer,2017-03-28 20:19:53 +0000,http://www.investors.com/news/technology/why-clovis-advantage-might-squash-tesaro-in-ovarian-cancer/?src=A00220A,Why Clovis' Advantage Might Squash Tesaro In Ovarian Cancer
TSRO,TSRO:UW,BBG002S9PQF4,Why Clovis' Advantage Might Squash Tesaro In Ovarian Cancer,2017-03-28 20:19:53 +0000,http://finance.yahoo.com/r/2aeb7684-98dd-3bdc-b486-5f26a77edeca/why-clovis-advantage-might-squash-tesaro-in-ovarian-cancer?src=A00220A&yptr=yahoo&.tsrc=rss,"Clovis' Rubraca label is &quot;cleanest,&quot; an analyst said Tuesday, a day after the FDA approved Tesaro's Zejula in ovarian cancer."
TSRO,TSRO:UW,BBG002S9PQF4,"Amazon, Red Hat, Tesaro Price Targets Raised; Snap Started At Hold",2017-03-28 20:15:33 +0000,http://www.investors.com/news/amazon-pt-raised-red-hat-pt-raised-after-earnings-snap-started-at-hold/?src=A00220A,"Amazon, Red Hat, Tesaro Price Targets Raised; Snap Started At Hold"
TSRO,TSRO:UW,BBG002S9PQF4,"Amazon, Red Hat, Tesaro Price Targets Raised; Snap Started At Hold",2017-03-28 20:15:33 +0000,http://finance.yahoo.com/r/2788b4b3-a63e-3559-ace4-705598ecbbba/amazon-pt-raised-red-hat-pt-raised-after-earnings-snap-started-at-hold?src=A00220A&yptr=yahoo&.tsrc=rss,Amazon's price target was raised Tuesday while Snapchat's parent Snap was started with a hold rating.
TSRO,TSRO:UW,BBG002S9PQF4,"Notable Tuesday Option Activity: TSRO, AAP, CAB",2017-03-28 16:59:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_j9Kjcs0JEA/notable-tuesday-option-activity-tsro-aap-cab-cm766728,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Tesaro Inc Symbol TSRO where a total of 6 290 contracts have traded so far representing approximately 629 000 underlying shares That amounts to about 52 3 of TSRO s average
TSRO,TSRO:UW,BBG002S9PQF4,"Amazon buys Middle East online retailer, Tencent takes stake in Tesla, American Airlines buys China Southern stake",2017-03-28 15:10:34 +0000,http://finance.yahoo.com/video/amazon-buys-middle-east-online-151034359.html?.tsrc=rss,"Amazon, Tesla, Ford, American Airlines, Darden Restaurants and Tesaro are among the stocks to watch."
TSRO,TSRO:UW,BBG002S9PQF4,Instant Analysis: Tesaro Receives a Big Thumbs-Up From the FDA,2017-03-28 15:01:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W-RI_QXiASQ/instant-analysis-tesaro-receives-a-big-thumbs-up-from-the-fda-cm766530,What happened The U S Food and Drug Administration approved Tesaro Inc s NASDAQ TSRO Zejula niraparib an oral cancer therapy that produced compelling results in trials supporting its application for the treatment of ovarian and related cancers Although an approval
TSRO,TSRO:UW,BBG002S9PQF4,"Amazon buys Middle East online retailer, Tencent takes stake in Tesla, American Airlines buys China Southern stake",2017-03-28 14:30:49 +0000,http://finance.yahoo.com/news/amazon-buys-middle-east-online-retailer-tencent-takes-stake-in-tesla-american-airlines-buys-china-southern-stake-143049519.html,"Amazon buys Middle East online retailer, Tencent takes stake in Tesla, American Airlines buys China Southern stake"
TSRO,TSRO:UW,BBG002S9PQF4,"Amazon buys Middle East online retailer, Tencent takes stake in Tesla, American Airlines buys China Southern stake",2017-03-28 14:30:49 +0000,http://finance.yahoo.com/news/amazon-buys-middle-east-online-retailer-tencent-takes-stake-in-tesla-american-airlines-buys-china-southern-stake-143049519.html?.tsrc=rss,"Amazon (AMZN) confirmed it’s buying the biggest online retailer in the Middle East—Dubai-based Souq.com.  Terms of the deal were not released, but Reuters reports that Amazon is paying less than the $800 million counteroffer made by a state-backed firm in Dubai.  American Airlines (AAL) is spreading its wings in China."
TSRO,TSRO:UW,BBG002S9PQF4,Instant Analysis: Tesaro Receives a Big Thumbs-Up From the FDA,2017-03-28 13:49:00 +0000,http://finance.yahoo.com/r/5ffcebec-cb3f-3d48-bab7-466a10efcf31/instant-analysis-tesaros-receives-a-big-thumbs-up.aspx?yptr=yahoo&.tsrc=rss,"Although niraparib's approval seemed imminent, the broad label is far better than expected."
TSRO,TSRO:UW,BBG002S9PQF4,Instant Analysis: Tesaro Receives a Big Thumbs-Up From the FDA,2017-03-28 13:49:00 +0000,https://www.fool.com/investing/2017/03/28/instant-analysis-tesaros-receives-a-big-thumbs-up.aspx,Instant Analysis: Tesaro Receives a Big Thumbs-Up From the FDA
TSRO,TSRO:UW,BBG002S9PQF4,BUZZ-AstraZeneca cancer drug faces new competition from Tesaro,2017-03-28 10:42:58 +0000,http://uk.finance.yahoo.com/news/buzz-astrazeneca-cancer-drug-faces-104258481.html,BUZZ-AstraZeneca cancer drug faces new competition from Tesaro
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Secures FDA Nod for Ovarian Cancer Drug,2017-03-28 08:15:00 +0000,http://www.investopedia.com/news/tesaro-secures-fda-nod-ovarian-cancer-drug-tsro-azn/?partner=YahooSA,Tesaro Secures FDA Nod for Ovarian Cancer Drug
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Secures FDA Nod for Ovarian Cancer Drug,2017-03-28 08:15:00 +0000,http://finance.yahoo.com/r/b66f5381-d1a5-30ba-9f4d-a266570be0b3/tesaro-secures-fda-nod-ovarian-cancer-drug-tsro-azn?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Zejula's early approval means a tough fight for AstraZeneca's Lynparza, which has been one of the bestsellers for ovarian cancer"
TSRO,TSRO:UW,BBG002S9PQF4,"FDA Nod For TSRO, DÃ©jÃ  Vu For ARQL, FOMX Plunges On Trial Data, SELB Abuzz",2017-03-28 04:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pzEgcbmaO5Y/fda-nod-for-tsro-d%C3%A3j%C3%A3%C2%A0-vu-for-arql-fomx-plunges-on-trial-data-selb-abuzz-20170328-00134,"FDA Nod For TSRO, DÃ©jÃ  Vu For ARQL, FOMX Plunges On Trial Data, SELB Abuzz"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro wins FDA approval for potential blockbuster cancer drug,2017-03-28 00:42:15 +0000,http://www.bizjournals.com/boston/news/2017/03/27/tesaro-wins-approval-for-potential-blockbuster.html?ana=yahoo,Tesaro wins FDA approval for potential blockbuster cancer drug
TSRO,TSRO:UW,BBG002S9PQF4,"After-hours buzz: RHT, DRI, TSRO & more",2017-03-27 21:52:32 +0000,http://www.cnbc.com/id/104367405?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104367405,"After-hours buzz: RHT, DRI, TSRO & more"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Announces FDA Approval Of Zejula For Women With Recurrent Ovarian Cancer,2017-03-27 21:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HlWpvCcqksA/tesaro-announces-fda-approval-of-zejula-for-women-with-recurrent-ovarian-cancer-20170327-01277,Tesaro Announces FDA Approval Of Zejula For Women With Recurrent Ovarian Cancer
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro Creeps Up On Rivals With Cancer Drug OK, But Merger Unlikely",2017-03-27 20:33:30 +0000,http://www.investors.com/news/technology/why-tesaros-odds-of-being-acquired-have-tanked-as-astrazeneca-looms/?src=A00220A,"Tesaro Creeps Up On Rivals With Cancer Drug OK, But Merger Unlikely"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro stock rises 6% on news that its ovarian cancer drug was approved by the FDA,2017-03-27 20:24:49 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=8CF0C612-C8EF-45E7-80CF-17C5BC260DF8&siteid=yhoof2,Tesaro stock rises 6% on news that its ovarian cancer drug was approved by the FDA
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Secures Early and Broad Approval for PARP Inhibitor in Ovarian Cancer,2017-03-27 20:07:00 +0000,https://www.thestreet.com/story/14061198/1/tesaro-secures-early-and-broad-approval-for-parp-inhibitor-in-ovarian-cancer.html?puc=yahoo&cm_ven=YAHOO,Tesaro Secures Early and Broad Approval for PARP Inhibitor in Ovarian Cancer
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces U.S. FDA Approval Of ZEJULA™ (Niraparib) For Women With Recurrent Ovarian Cancer,2017-03-27 19:47:00 +0000,http://finance.yahoo.com/news/tesaro-announces-u-fda-approval-194700528.html,"[PR Newswire] - WALTHAM, Mass., March 27, 2017 /PRNewswire/ -- TESARO, Inc. (TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ZEJULA™ (niraparib), an oral, once-daily poly(ADP-ribose) polymerase (PARP) inhibitor, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response (CR or PR) to platinum-based chemotherapy. ZEJULA is the first PARP inhibitor to be approved by the FDA that does not require BRCA mutation or other biomarker testing. TESARO anticipates launching ZEJULA in the United States in late April."
TSRO,TSRO:UW,BBG002S9PQF4,"3:47 pm Tesaro provides update, confirms FDA approval of ZEJULA, says implementing plans to initiate registration strategies in the settings of metastatic ovarian, breast and lung cancers (shares halted)",2017-03-27 19:47:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#tsro,"3:47 pm Tesaro provides update, confirms FDA approval of ZEJULA, says implementing plans to initiate registration strategies in the settings of metastatic ovarian, breast and lung cancers (shares halted)"
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Expanded Development Program for Niraparib Focused on the Treatment of Front-Line Metastatic Ovarian and Lung Cancers and Metastatic Breast Cancer,2017-03-27 19:45:00 +0000,http://finance.yahoo.com/news/tesaro-announces-expanded-development-program-194500298.html,[GlobeNewswire] - Expanded niraparib ovarian cancer program intended to potentially transform the treatment of front-line ovarian cancer New breast cancer clinical program for niraparib to address greatest area of unmet ...
TSRO,TSRO:UW,BBG002S9PQF4,AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO),2017-03-16 18:49:51 +0000,http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azns-lynparza-trial-results-positive-in-competitive-threat-to-clovis-oncology-inc-clvs-and-tesaro-inc-tsro-566916/,AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)
TSRO,TSRO:UW,BBG002S9PQF4,AstraZeneca Fires Back at Tesaro in Ovarian Cancer,2017-03-16 14:08:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HIpBAkuRGLk/astrazeneca-fires-back-at-tesaro-in-ovarian-cancer-cm761554,The PARP battle is on Following news that AstraZeneca s NYSE AZN PARP inhibiting cancer drug Lynparza delivered a big win in phase 3 studies all eyes now shift to how a potential Food and Drug Administration approval for Lynparza will reshape the commercial opportunity
TSRO,TSRO:UW,BBG002S9PQF4,AstraZeneca Fires Back at Tesaro in Ovarian Cancer,2017-03-16 12:21:00 +0000,https://www.fool.com/investing/2017/03/16/astrazeneca-fires-back-at-tesaro-in-ovarian-cancer.aspx,AstraZeneca Fires Back at Tesaro in Ovarian Cancer
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Sell-Off On AstraZeneca Ovarian Cancer Trial Overdone: Analyst,2017-03-15 20:15:32 +0000,http://www.investors.com/news/technology/tesaro-selloff-on-astrazeneca-ovarian-cancer-trial-overdone-analyst/?src=A00220A,Tesaro Sell-Off On AstraZeneca Ovarian Cancer Trial Overdone: Analyst
TSRO,TSRO:UW,BBG002S9PQF4,"Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)",2017-03-15 17:54:18 +0000,http://www.insidermonkey.com/blog/heres-what-just-happened-with-astrazeneca-plc-adr-azn-tesaro-inc-tsro-and-clovis-oncology-inc-clvs-566628/,"Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)"
TSRO,TSRO:UW,BBG002S9PQF4,AstraZeneca Ovarian Cancer Drug Succeeds in Trial,2017-03-15 17:19:00 +0000,http://www.investopedia.com/news/astrazeneca-ovarian-cancer-drug-succeeds-trial-azn/?partner=YahooSA,AstraZeneca Ovarian Cancer Drug Succeeds in Trial
TSRO,TSRO:UW,BBG002S9PQF4,Lynparza Vs. Niraparib,2017-03-15 12:32:58 +0000,http://finance.yahoo.com/news/lynparza-vs-niraparib-123258941.html,Lynparza Vs. Niraparib
TSRO,TSRO:UW,BBG002S9PQF4,Wedbush Cuts TESARO Target By 18% Following SOLO-2 Results,2017-03-15 12:03:50 +0000,http://finance.yahoo.com/news/wedbush-cuts-tesaro-target-18-120350443.html,Wedbush Cuts TESARO Target By 18% Following SOLO-2 Results
TSRO,TSRO:UW,BBG002S9PQF4,Why Tesaro is Tanking,2017-03-14 20:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/14/why-tesaro-is-tanking/?mod=yahoobarrons&ru=yahoo,Why Tesaro is Tanking
TSRO,TSRO:UW,BBG002S9PQF4,AstraZeneca ovarian cancer drug slows disease markedly in study,2017-03-14 19:40:08 +0000,http://sg.finance.yahoo.com/news/astrazeneca-ovarian-cancer-drug-slows-183551701.html,AstraZeneca ovarian cancer drug slows disease markedly in study
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Announces Presentation of Niraparib Phase 3 ENGOT-OV16/NOVA Trial Secondary Endpoint Results During SGO,2017-03-13 15:10:00 +0000,http://finance.yahoo.com/news/tesaro-announces-presentation-niraparib-phase-151000826.html,"[GlobeNewswire] - NATIONAL HARBOR, Md., March 13, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced the presentation of secondary endpoint results from the Phase 3 ENGOT-OV16/NOVA trial ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Niraparib Data Presentations at the 2017 SGO Annual Meeting on Women’s Cancer,2017-03-12 12:38:47 +0000,http://finance.yahoo.com/news/tesaro-announces-niraparib-data-presentations-123847772.html,"[GlobeNewswire] - WALTHAM, Mass., March 12, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced two niraparib presentations at the 2017 Society for Gynecologic Oncology Annual Meeting on ..."
TSRO,TSRO:UW,BBG002S9PQF4,"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.",2017-03-11 19:10:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nTuQIJvT79A/better-buy-myriad-genetics-inc-vs-opko-health-inc-cm759666,It s been a rough 12 months for Myriad Genetics NASDAQ MYGN and Opko Health NASDAQ OPK Myriad lost nearly half of its market cap during the period while Opko stock is down around 20 Could better days be ahead for these two stocks And which is the better pick
TSRO,TSRO:UW,BBG002S9PQF4,"Perceptive Advisors Llc Buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Sells ...",2017-03-11 00:11:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EnI2WYygFWA/perceptive-advisors-llc-buys-neurocrine-biosciences-aclaris-therapeutics-galapagos-nv-sells-cm759336,Perceptive Advisors Llc New Purchases GLPG AVDL ACOR IRTC CTMX BCRX ATRS JAZZ ALNY PPHMP Added Positions NBIX ACRS FOLD ANIP AVXS GBT ARDX VBIV ZGNX XNCR Reduced Positions SRPT AERI CRBP ABMD SUPN AGEN BPMC NDRM AGTC
TSRO,TSRO:UW,BBG002S9PQF4,Blog Coverage CEL-SCI Provides Update on Late-stage Multikine Head and Neck Cancer Study,2017-03-08 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-cel-sci-provides-131500902.html,"[Accesswire] - Upcoming AWS Coverage on TESARO Post-Earnings Results LONDON, UK / ACCESSWIRE / March 8, 2017 / Active Wall St. blog coverage looks at the headline from CEL-SCI Corp. (NYSE: CVM ) as the Company announced ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. :TSRO-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017",2017-03-06 17:05:30 +0000,http://www.capitalcube.com/blog/index.php/tesaro-inc-tsro-us-earnings-analysis-2016-by-the-numbers-march-6-2017/,"TESARO, Inc. :TSRO-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Financials",2017-03-04 18:04:16 +0000,http://finance.yahoo.com/q/is?s=tsro,"TESARO, INC. Financials"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. :TSRO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017",2017-03-03 15:35:53 +0000,http://www.capitalcube.com/blog/index.php/tesaro-inc-tsro-us-earnings-analysis-q4-2016-by-the-numbers-march-3-2017/,"TESARO, Inc. :TSRO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017"
TSRO,TSRO:UW,BBG002S9PQF4,"XBI, CLVS, KITE, TSRO: Large Inflows Detected at ETF",2017-03-02 17:12:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jmMZ2Tyw1_U/xbi-clvs-kite-tsro-large-inflows-detected-at-etf-cm755447,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 232 5 million dollar inflow that s a 8 2 increase week over week in outstanding
TSRO,TSRO:UW,BBG002S9PQF4,Do Options Traders Know Something About Tesaro (TSRO) Stock We Don't?,2017-03-02 16:17:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d8hsRl3vP_s/do-options-traders-know-something-about-tesaro-tsro-stock-we-dont-cm755406,Investors in Tesaro Inc TSRO need to pay close attention to the stock based on moves in the options market lately That is because the March 17 th 2017 105 Put had some of the highest implied volatility of all equity options today What is Implied Volatility Implied volatility
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Shares Could Jump On A Buyout Offer,2017-03-02 15:23:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/02/tesaro-shares-could-jump-on-a-buyout-offer/?mod=yahoobarrons&ru=yahoo,Tesaro Shares Could Jump On A Buyout Offer
TSRO,TSRO:UW,BBG002S9PQF4,Do Options Traders Know Something About Tesaro (TSRO) Stock We Don't?,2017-03-02 13:52:01 +0000,http://finance.yahoo.com/news/options-traders-know-something-tesaro-135201753.html,Do Options Traders Know Something About Tesaro (TSRO) Stock We Don't?
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro Eyes Immuno-Oncology As AstraZeneca, Clovis Loom: Analyst",2017-03-01 21:22:09 +0000,http://www.investors.com/news/technology/tesaro-eyes-i-o-market-as-astrazeneca-clovis-rivalries-mount-leerink/,"Tesaro Eyes Immuno-Oncology As AstraZeneca, Clovis Loom: Analyst"
TSRO,TSRO:UW,BBG002S9PQF4,Edited Transcript of TSRO earnings conference call or presentation 28-Feb-17 9:15pm GMT,2017-03-01 04:33:35 +0000,http://finance.yahoo.com/news/edited-transcript-tsro-earnings-conference-043335314.html,Edited Transcript of TSRO earnings conference call or presentation 28-Feb-17 9:15pm GMT
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2017-02-28 23:55:06 +0000,http://biz.yahoo.com/e/170228/tsro8-k.html,"TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 10-K, Annual Report",2017-02-28 23:26:08 +0000,http://biz.yahoo.com/e/170228/tsro10-k.html,"TESARO, INC. Files SEC form 10-K, Annual Report"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro reports 4Q loss,2017-02-28 21:59:30 +0000,http://sg.finance.yahoo.com/news/tesaro-reports-4q-loss-215930059.html,Tesaro reports 4Q loss
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Fourth-Quarter 2016 Operating Results,2017-02-28 21:05:00 +0000,http://finance.yahoo.com/news/tesaro-announces-fourth-quarter-2016-210500957.html,[GlobeNewswire] - Niraparib NDA under review by FDA; pre-launch preparations for planned commercial launch well underway Expanded access program for niraparib open in U.S.; European EAP expected to open 1 H 2017 Positive ...
TSRO,TSRO:UW,BBG002S9PQF4,"After-Hours Earnings Report for February 28, 2017 :  CRM, ROST, PANW, UHS, TSRO, JAZZ, AR, DXCM, EPR, LOGM, ACAD, BUFF",2017-02-28 20:37:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yFc_lxio_H4/after-hours-earnings-report-for-february-28-2017-crm-rost-panw-uhs-tsro-jazz-ar-dxcm-epr-logm-acad-buff-cm754414,The following companies are expected to report earnings after hours on 02 28 2017 Visit our Earnings Calendar for a full list of expected earnings releases Salesforce com Inc CRM is reporting for the quarter ending January 31 2017 The computer
TSRO,TSRO:UW,BBG002S9PQF4,Q4 2016 TESARO Inc Earnings Release - After Market Close,2017-02-28 12:07:04 +0000,http://biz.yahoo.com/research/earncal/20170228.html?t=tsro,Q4 2016 TESARO Inc Earnings Release - After Market Close
TSRO,TSRO:UW,BBG002S9PQF4,Intrexon (XON): Will the Stock Pull a Surprise in Q4 Earnings?,2017-02-28 01:49:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Y83BE138cQ/intrexon-xon-will-the-stock-pull-a-surprise-in-q4-earnings-cm753922,Intrexon Corporation XON is scheduled to report fourth quarter 2016 results on Mar 1 after the market closes Intrexon sshare price has decreased 9 9 year to date while the Zacks classified Medical Medical Services industry gained 4 3 In the last reported quarter the
TSRO,TSRO:UW,BBG002S9PQF4,Adverum (ADVM) to Post Q4 Earnings: What's in the Cards?,2017-02-28 01:49:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h5TA_lx5ESI/adverum-advm-to-post-q4-earnings-whats-in-the-cards-cm753919,Adverum Biotechnologies Inc ADVM is expected to report fourth quarter 2016 results on Mar 2 In the last reported quarter Adverum posted a negative surprise of 20 7 Adverum has a dismal track record with the company missing estimates in three of the last four quarters bringing the
TSRO,TSRO:UW,BBG002S9PQF4,Intrexon (XON): Will the Stock Pull a Surprise in Q4 Earnings?,2017-02-27 23:20:11 +0000,http://finance.yahoo.com/news/intrexon-xon-stock-pull-surprise-232011909.html,Intrexon (XON): Will the Stock Pull a Surprise in Q4 Earnings?
TSRO,TSRO:UW,BBG002S9PQF4,Universal Health (UHS) Q4 Earnings: What's in the Cards?,2017-02-27 14:53:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DC1D_xz7tME/universal-health-uhs-q4-earnings-whats-in-the-cards-cm753544,Universal Health Services Inc UHS will release fourth quarter 2016 results on Feb 28 after the market closes Last quarter the company posted a negative earnings surprise of 4 19 Let s see how things are shaping up for this announcement Factors to be Considered this
TSRO,TSRO:UW,BBG002S9PQF4,Why Tesaro (TSRO) Might Surprise This Earnings Season,2017-02-27 14:53:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_X3u_erEN_M/why-tesaro-tsro-might-surprise-this-earnings-season-cm753537,Investors are always looking for stocks that are poised to beat at earnings season and Tesaro Inc TSRO may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Tesaro is seeing favorable earnings
TSRO,TSRO:UW,BBG002S9PQF4,Why Tesaro (TSRO) Might Surprise This Earnings Season,2017-02-27 13:32:01 +0000,http://finance.yahoo.com/news/why-tesaro-tsro-might-surprise-133201883.html,Why Tesaro (TSRO) Might Surprise This Earnings Season
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro downgraded by Robert W. Baird,2017-02-27 12:06:59 +0000,http://finance.yahoo.com/q/ud?s=TSRO,Tesaro downgraded by Robert W. Baird
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Receives Positive CHMP Opinion for VARUBY®,2017-02-27 07:01:01 +0000,http://finance.yahoo.com/news/tesaro-receives-positive-chmp-opinion-070101357.html,"[GlobeNewswire] - WALTHAM, Mass., Feb. 27, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the European Medicines Agency`s (EMA) Committee for Medicinal ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tenet Healthcare (THC) Q4 Earnings: What's in the Cards?,2017-02-24 14:53:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KgcGrO2sS7E/tenet-healthcare-thc-q4-earnings-whats-in-the-cards-cm752583,Tenet Healthcare Corporation THC will release fourth quarter 2016 results on Feb 27 after the market closes Last quarter the company posted a negative earnings surprise of 15 79 Let s see how things are shaping up for this announcement Factors to be Considered this Quarter
TSRO,TSRO:UW,BBG002S9PQF4,Tenet Healthcare (THC) Q4 Earnings: What's in the Cards?,2017-02-24 12:49:12 +0000,http://finance.yahoo.com/news/tenet-healthcare-thc-q4-earnings-124912108.html,Tenet Healthcare (THC) Q4 Earnings: What's in the Cards?
TSRO,TSRO:UW,BBG002S9PQF4,Horizon (HZNP) Q4 Earnings: Stock Likely to Disappoint?,2017-02-23 23:49:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EexAISVIypI/horizon-hznp-q4-earnings-stock-likely-to-disappoint-cm752448,Horizon Pharma plc HZNP is scheduled to report fourth quarter 2016 results on Feb 27 before the opening bell Horizon s performance has been dismal with the company missing earnings estimates in the four trailing quarters Overall the company has an average negative earnings surprise of 15
TSRO,TSRO:UW,BBG002S9PQF4,Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?,2017-02-23 23:49:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EmH81ji40XM/endocyte-ecyt-to-post-q4-earnings-whats-in-the-cards-cm752446,Endocyte Inc ECYT is expected to report fourth quarter 2016 results on Mar 1 The company has an impressive track record having beaten estimates on three of the trailing four quarters and reporting in line results in the remaining quarter Overall the company has recorded an average
TSRO,TSRO:UW,BBG002S9PQF4,Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?,2017-02-23 21:43:09 +0000,http://finance.yahoo.com/news/endocyte-ecyt-post-q4-earnings-214309313.html,Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?
TSRO,TSRO:UW,BBG002S9PQF4,"Andreas Halvorsen Buys Maker of First-in-Class Cancer Treatments, Calithera Biosciences",2017-02-23 18:49:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E8Pl3fl32Tg/andreas-halvorsen-buys-maker-of-first-in-class-cancer-treatments-calithera-biosciences-cm752251,Andreas Halvorsen Trades Portfolio CALA INCY KITE TSRO BIIB Andreas Halvorsen Premium Members This article first appeared on GuruFocus This article first appeared
TSRO,TSRO:UW,BBG002S9PQF4,Endo (ENDP) to Post Q4 Earnings: Will the Stock Disappoint?,2017-02-23 00:50:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ztenwzFoWAg/endo-endp-to-post-q4-earnings-will-the-stock-disappoint-cm751697,Endo International plc ENDP is scheduled to report fourth quarter 2016 results on Feb 28 before the opening bell The company has been consistently beating earnings expectations In fact Endo posted a positive surprise in each of the trailing four quarters with an average positive surprise
TSRO,TSRO:UW,BBG002S9PQF4,"IWO, MSCC, TSRO, OZRK: ETF Inflow Alert",2017-02-22 17:51:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PcXIo8QCecI/iwo-mscc-tsro-ozrk-etf-inflow-alert-cm751403,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 2000 Growth ETF Symbol IWO where we have detected an approximate 105 7 million dollar inflow that s a 1 3 increase week over week
TSRO,TSRO:UW,BBG002S9PQF4,Intercept (ICPT) to Post Q4 Earnings: What's in the Cards?,2017-02-22 01:06:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MOpZcR8fkc4/intercept-icpt-to-post-q4-earnings-whats-in-the-cards-cm750953,Intercept Pharmaceuticals Inc ICPT is scheduled to report fourth quarter 2016 results on Feb 23 before the market opens In the last reported quarter the company recorded a positive surprise of 3 49 Let s see how things are shaping up for this announcement Intercept s share
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Participation at Two Investor Conferences,2017-02-21 21:15:00 +0000,http://finance.yahoo.com/news/tesaro-announces-participation-two-investor-211500234.html,"[GlobeNewswire] - WALTHAM, Mass., Feb. 21, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The Raymond James 38 th Annual Institutional ..."
TSRO,TSRO:UW,BBG002S9PQF4,"AstraZeneca Could Give Pfizer, Tesaro Leg Up In Breast Cancer: Leerink",2017-02-17 21:31:05 +0000,http://www.investors.com/news/technology/astrazeneca-could-give-pfizer-tesaro-leg-up-in-breast-cancer-leerink/,"AstraZeneca Could Give Pfizer, Tesaro Leg Up In Breast Cancer: Leerink"
TSRO,TSRO:UW,BBG002S9PQF4,"Clovis, Tesaro Soar on Astrazeneca Phase Three News",2017-02-17 18:38:00 +0000,https://www.thestreet.com/story/14007046/1/clovis-tesaro-soar-on-astrazeneca-phase-three-news.html?puc=yahoo&cm_ven=YAHOO,"Clovis, Tesaro Soar on Astrazeneca Phase Three News"
TSRO,TSRO:UW,BBG002S9PQF4,Two Great Stock Ideas in the IBB Biotech ETF,2017-02-15 19:44:00 +0000,http://www.investopedia.com/articles/investing/021517/looking-best-stock-ideas-ibb-acad-exel.asp?partner=YahooSA,Two Great Stock Ideas in the IBB Biotech ETF
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro to Announce Fourth-Quarter 2016 Financial Results on February 28, 2017",2017-02-14 21:05:00 +0000,http://finance.yahoo.com/news/tesaro-announce-fourth-quarter-2016-210500403.html,"[GlobeNewswire] - WALTHAM, Mass., Feb. 14, 2017-- TESARO, Inc. will announce its fourth-quarter 2016 financial results on Tuesday, February 28, 2017, after the close of the U.S. financial markets. TESARO’ s senior management ..."
TSRO,TSRO:UW,BBG002S9PQF4,"Morgan Stanley, Twitter, Tesaro: Doug Kass' Views",2017-02-13 06:00:00 +0000,https://www.thestreet.com/story/13998995/1/morgan-stanley-twitter-tesaro-doug-kass-views.html?puc=yahoo&cm_ven=YAHOO,"Morgan Stanley, Twitter, Tesaro: Doug Kass' Views"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro's Rumored Sale Could Fetch North Of $200 Per Share: Analysts,2017-02-10 21:21:20 +0000,http://www.investors.com/news/technology/tesaros-rumored-sale-could-fetch-north-of-200-per-share-analysts/,Tesaro's Rumored Sale Could Fetch North Of $200 Per Share: Analysts
TSRO,TSRO:UW,BBG002S9PQF4,Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017,2017-02-10 21:20:07 +0000,http://www.fool.com/investing/2017/02/10/heres-why-ma-has-tesaros-stock-soaring-40-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017
TSRO,TSRO:UW,BBG002S9PQF4,Leerink Cuts Tesaro To Hold After Takeover Speculation Rally,2017-02-10 19:09:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/10/leerink-cuts-tesaro-to-hold-after-takeover-speculation-rally/?mod=yahoobarrons&ru=yahoo,Leerink Cuts Tesaro To Hold After Takeover Speculation Rally
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Explores Possible Sale With Investment Bank,2017-02-10 16:36:00 +0000,http://www.investopedia.com/news/tesaro-mulls-sale-amid-takeover-rumors-tsro/?partner=YahooSA,Tesaro Explores Possible Sale With Investment Bank
TSRO,TSRO:UW,BBG002S9PQF4,"Analysts' Actions -- Ford, Intel, Twitter, Viacom and More",2017-02-10 13:08:00 +0000,http://finance.yahoo.com/news/analysts-actions-ford-intel-twitter-130800905.html,"Analysts' Actions -- Ford, Intel, Twitter, Viacom and More"
TSRO,TSRO:UW,BBG002S9PQF4,"Why Panera Bread, Tesaro, and Universal Corp. Jumped Today",2017-02-08 23:18:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/khs8i7XBF9M/why-panera-bread-tesaro-and-universal-corp-jumped-today-cm745208,The stock market was narrowly mixed on Wednesday with the Dow Jones Industrials losing ground but the S amp P 500 and Nasdaq Composite posting modest gains on the day Earnings season has had positive effects on some stocks and negative ones on others but the
TSRO,TSRO:UW,BBG002S9PQF4,"Why Panera Bread, Tesaro, and Universal Corp. Jumped Today",2017-02-08 21:51:00 +0000,http://www.fool.com/investing/2017/02/08/why-panera-bread-tesaro-and-universal-corp-jumped.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Panera Bread, Tesaro, and Universal Corp. Jumped Today"
TSRO,TSRO:UW,BBG002S9PQF4,"Gainers & Losers Of The Day: ATOS, APOP, TSRO, GALE, ACUR...",2017-02-08 21:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BapMwjkgJC8/gainers--losers-of-the-day-atos-apop-tsro-gale-acur-20170208-01649,"Gainers & Losers Of The Day: ATOS, APOP, TSRO, GALE, ACUR..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Rockets To All-Time High On Rumored Takeover Interest,2017-02-08 21:15:31 +0000,http://www.investors.com/news/technology/tesaro-rockets-to-all-time-high-on-rumored-takeover-interest/,Tesaro Rockets To All-Time High On Rumored Takeover Interest
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro shares skyrocket on report of buyout interest from drugmakers,2017-02-08 18:45:05 +0000,http://www.bizjournals.com/boston/news/2017/02/08/tesaro-shares-skyrocket-on-report-of-buyout.html?ana=yahoo,Tesaro shares skyrocket on report of buyout interest from drugmakers
TSRO,TSRO:UW,BBG002S9PQF4,Biotech Tesaro Climbs on Takeout Reports,2017-02-08 17:49:00 +0000,https://www.thestreet.com/story/13994924/1/biotech-tesaro-climbs-on-takeout-reports.html?puc=yahoo&cm_ven=YAHOO,Biotech Tesaro Climbs on Takeout Reports
TSRO,TSRO:UW,BBG002S9PQF4,Exclusive: Cancer drugmaker Tesaro attracts takeover interest - sources,2017-02-08 17:10:26 +0000,http://finance.yahoo.com/news/exclusive-cancer-drug-maker-tesaro-165332695.html,Exclusive: Cancer drugmaker Tesaro attracts takeover interest - sources
TSRO,TSRO:UW,BBG002S9PQF4,iShares Russell 2000 Growth ETF Experiences Big Outflow,2017-02-06 17:19:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WBH-1dXfZO8/ishares-russell-2000-growth-etf-experiences-big-outflow-cm743691,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 2000 Growth ETF Symbol IWO where we have detected an approximate 55 3 million dollar outflow that s a 0 7 decrease week over week
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Announces Participation at Two Investor Conferences,2017-02-02 21:15:00 +0000,http://finance.yahoo.com/news/tesaro-announces-participation-two-investor-211500462.html,"[GlobeNewswire] - WALTHAM, Mass., Feb. 02, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The 6 th Annual Leerink Partners Global ..."
TSRO,TSRO:UW,BBG002S9PQF4,Are Options Traders Betting on a Big Move in Tesaro (TSRO) Stock?,2017-02-01 15:35:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dtcefOi2Pv8/are-options-traders-betting-on-a-big-move-in-tesaro-tsro-stock-cm741479,Investors in Tesaro Inc TSRO need to pay close attention to the stock based on moves in the options market lately That is because the March 2nd 2017 140 Put had some of the highest implied volatility of all equity options today What is Implied Volatility Implied volatility
TSRO,TSRO:UW,BBG002S9PQF4,Are Options Traders Betting on a Big Move in Tesaro (TSRO) Stock?,2017-02-01 13:45:01 +0000,http://finance.yahoo.com/news/options-traders-betting-big-move-134501277.html,Are Options Traders Betting on a Big Move in Tesaro (TSRO) Stock?
TSRO,TSRO:UW,BBG002S9PQF4,"Clovis Oncology Inc (CLVS)’s Ovarian Cancer Drug Faces Stiff Competition From AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO)",2017-01-31 17:59:43 +0000,http://www.insidermonkey.com/blog/clovis-oncology-inc-clvss-ovarian-cancer-drug-faces-stiff-competition-from-astrazeneca-plc-adr-azn-tesaro-inc-tsro-529367/,"Clovis Oncology Inc (CLVS)’s Ovarian Cancer Drug Faces Stiff Competition From AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO)"
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro, AstraZeneca Could Shrink Clovis' Ovarian Cancer Drug Pool",2017-01-30 21:12:10 +0000,http://www.investors.com/news/technology/tesaro-astrazeneca-could-shrink-clovis-ovarian-cancer-drug-pool/,"Tesaro, AstraZeneca Could Shrink Clovis' Ovarian Cancer Drug Pool"
TSRO,TSRO:UW,BBG002S9PQF4,Here's the Reason Behind TESARO Inc.'s Sudden 12% Move Higher,2017-01-26 21:32:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uQ9cHfc20f4/heres-the-reason-behind-tesaro-incs-sudden-12-move-higher-cm738950,Image source Getty Images What happened Shares of TESARO NASDAQ TSRO a biopharmaceutical company that s primarily focused on developing therapies to treat cancer surged as much as 12 during Thursday s trading session after reports surfaced that French drugmaker
TSRO,TSRO:UW,BBG002S9PQF4,Here's the Reason Behind TESARO Inc.'s Sudden 12% Move Higher,2017-01-26 20:28:42 +0000,http://www.fool.com/investing/2017/01/26/heres-the-reason-behind-tesaro-incs-sudden-12-move.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's the Reason Behind TESARO Inc.'s Sudden 12% Move Higher
TSRO,TSRO:UW,BBG002S9PQF4,Johnson & Johnson's Most Exciting Opportunity,2017-01-26 17:33:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bBOsqst4LfI/johnson-johnsons-most-exciting-opportunity-cm738803,Johnson amp Johnson s NYSE JNJ fourth quarter financials this week suggest that cancer drugs will be the biggest driver of the company s success in 2017 Can cancer drug sales continue to soar Here s why cancer drugs could be Johnson amp Johnson s most exciting opportunity
TSRO,TSRO:UW,BBG002S9PQF4,Biotech Stocks Facing FDA Decision In February,2017-01-26 04:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dqQ5wiKja1s/biotech-stocks-facing-fda-decision-in-february-20170126-00181,Biotech Stocks Facing FDA Decision In February
TSRO,TSRO:UW,BBG002S9PQF4,Strange: Bullish TSRO Analysts Actually See -2.06% Downside,2017-01-25 15:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w06GBaB0vZg/strange-bullish-tsro-analysts-actually-see-206-downside-cm737876,Analyst ratings can sometimes be complicated and we here at ETF Channel have noticed a bit of a paradox with Tesaro Inc Symbol TSRO The average 12 month price target for TSRO averaging the work of 11 analysts reveals an average price target of 139 64 share That s a whopping 2 06
TSRO,TSRO:UW,BBG002S9PQF4,"Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017",2017-01-20 12:00:47 +0000,http://www.investors.com/news/technology/biotech-stocks-might-catalyze-or-plunge-on-4-key-sectors-in-2017/,"Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017"
TSRO,TSRO:UW,BBG002S9PQF4,"Commit To Buy Tesaro At $80, Earn 11.2% Using Options",2017-01-19 19:38:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QAMkqNurRYY/commit-to-buy-tesaro-at-80-earn-112-using-options-cm735600,Investors considering a purchase of Tesaro Inc Symbol TSRO stock but tentative about paying the going market price of 150 18 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Announces Opening of Niraparib Expanded Access Program for U.S. Patients With Ovarian Cancer,2017-01-17 13:01:00 +0000,http://finance.yahoo.com/news/tesaro-announces-opening-niraparib-expanded-130100249.html,"[GlobeNewswire] - WALTHAM, Mass., Jan. 17, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced the opening of an expanded access program in the United States for the investigational PARP ..."
TSRO,TSRO:UW,BBG002S9PQF4,"Noteworthy Friday Option Activity: TSRO, ESPR, LOPE",2017-01-13 22:37:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YTIYkbpaTa0/noteworthy-friday-option-activity-tsro-espr-lope-cm733523,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Tesaro Inc Symbol TSRO where a total of 4 924 contracts have traded so far representing approximately 492 400 underlying shares That amounts to about 63 of TSRO s average
TSRO,TSRO:UW,BBG002S9PQF4,Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference,2017-01-13 21:16:00 +0000,http://www.investors.com/news/technology/trumps-disastrous-pharma-view-doesnt-rattle-healthcare-conference/,Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference
TSRO,TSRO:UW,BBG002S9PQF4,The Three Most Important Questions For TESARO Inc (TSRO) Shareholders Right Now,2017-01-13 16:13:35 +0000,http://www.insidermonkey.com/blog/the-three-most-important-questions-for-tesaro-inc-tsro-shareholders-right-now-518370/,The Three Most Important Questions For TESARO Inc (TSRO) Shareholders Right Now
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Varubi IV Gets Complete Response Letter in the U.S.,2017-01-13 14:39:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JZwBiNSsazw/tesaro-varubi-iv-gets-complete-response-letter-in-the-us-cm733154,TESARO Inc TSRO announced that it has received a Complete Response Letter CRL from the FDA regarding its New Drug Application NDA for Varubi IV rolapitant IV The company was seeking approval of rolapitant IV for the prevention of delayed nausea and vomiting associated with initial
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Varubi IV Gets Complete Response Letter in the U.S.,2017-01-13 12:42:12 +0000,http://finance.yahoo.com/news/tesaro-varubi-iv-gets-complete-124212187.html,TESARO Varubi IV Gets Complete Response Letter in the U.S.
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Stock Rebounds Despite FDA Holdup On Anti-Nausea Med,2017-01-12 21:14:03 +0000,http://www.investors.com/news/technology/tesaro-stock-rebounds-despite-fda-holdup-on-anti-nausea-med/,Tesaro Stock Rebounds Despite FDA Holdup On Anti-Nausea Med
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-01-12 14:22:54 +0000,http://biz.yahoo.com/e/170112/tsro8-k.html,"TESARO, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
TSRO,TSRO:UW,BBG002S9PQF4,Latest drug by Waltham drugmaker Tesaro rejected by FDA,2017-01-12 12:15:05 +0000,http://www.bizjournals.com/boston/news/2017/01/12/latest-drug-by-waltham-drugmaker-tesaro-rejected.html?ana=yahoo,Latest drug by Waltham drugmaker Tesaro rejected by FDA
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Receives Complete Response Letter for Rolapitant IV from U.S. FDA,2017-01-12 04:30:00 +0000,http://finance.yahoo.com/news/tesaro-receives-complete-response-letter-043000759.html,[GlobeNewswire] - No concerns raised by FDA related to the rolapitant IV efficacy or safety profile and additional clinical studies are not required Investor conference call and webcast scheduled for tomorrow at 8:30AM ...
TSRO,TSRO:UW,BBG002S9PQF4,"FDA Says No To TSRO, Ablynx On Track, MYL Leads In Herceptin Biosim Race In U.S.",2017-01-12 02:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e2PAyGRhbvo/fda-says-no-to-tsro-ablynx-on-track-myl-leads-in-herceptin-biosim-race-in-us-20170112-00039,"FDA Says No To TSRO, Ablynx On Track, MYL Leads In Herceptin Biosim Race In U.S."
TSRO,TSRO:UW,BBG002S9PQF4,FDA Refuses To Approve Tesaro''s Intravenous Formulation Of Rolapitant,2017-01-12 02:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hmndM0_Ec2o/fda-refuses-to-approve-tesaros-intravenous-formulation-of-rolapitant-20170112-00031,FDA Refuses To Approve Tesaro''s Intravenous Formulation Of Rolapitant
TSRO,TSRO:UW,BBG002S9PQF4,4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal,2017-01-10 14:27:02 +0000,http://finance.yahoo.com/news/4-stocks-focus-biotech-m-142702106.html,4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition",2017-01-09 14:03:34 +0000,http://biz.yahoo.com/e/170109/tsro8-k.html,"TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition"
TSRO,TSRO:UW,BBG002S9PQF4,6 Major FDA Decisions and Biopharma Catalysts Coming in January and February,2017-01-06 15:25:51 +0000,http://finance.yahoo.com/news/6-major-fda-decisions-biopharma-152551867.html,6 Major FDA Decisions and Biopharma Catalysts Coming in January and February
TSRO,TSRO:UW,BBG002S9PQF4,What We’re Watching In Biotech For January: Otonomy Inc (OTIC) And TESARO Inc (TSRO),2017-01-03 20:16:45 +0000,http://www.insidermonkey.com/blog/what-were-watching-in-biotech-for-january-otonomy-inc-otic-and-tesaro-inc-tsro-514373/,What We’re Watching In Biotech For January: Otonomy Inc (OTIC) And TESARO Inc (TSRO)
TSRO,TSRO:UW,BBG002S9PQF4,Forget Gilead Sciences Inc.: These 2 Stocks Doubled Last Year,2017-01-03 15:08:01 +0000,http://www.fool.com/investing/2017/01/02/forget-gilead-sciences-inc-these-2-stocks-doubled.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Forget Gilead Sciences Inc.: These 2 Stocks Doubled Last Year
TSRO,TSRO:UW,BBG002S9PQF4,Forget Gilead Sciences Inc.: These 2 Stocks Doubled Last Year,2017-01-02 16:58:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RCGqfx5p3RM/forget-gilead-sciences-inc-these-2-stocks-doubled-last-year-cm728387,Long term holders of Gilead Sciences NASDAQ GILD enjoyed some market thumping gains in years past but concern over sagging hepatitis C antiviral sales caused the stock to slide about 26 5 in 2016 Despite a generally bleak year for Gilead and for biotech stocks in general
TSRO,TSRO:UW,BBG002S9PQF4,Steven Cohen's Assets With Highest Returns,2016-12-31 14:56:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7zOPUF8HaOo/steven-cohens-assets-with-highest-returns-cm728214,Steven Cohen Trades Portfolio a billionaire hedge fund investor is the founder of SAC Capital Advisors a Stamford Connecticut based hedge fund The following are the best performers of his investments this year Steven Cohen Trades Portfolio a billionaire hedge
TSRO,TSRO:UW,BBG002S9PQF4,Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?,2016-12-30 21:36:24 +0000,http://www.investors.com/research/ibd-industry-themes/which-top-5-biotech-performers-are-slated-for-triple-digit-gains/,Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?
TSRO,TSRO:UW,BBG002S9PQF4,Why Opko Health Inc. Stock Is Sinking Today,2016-12-30 18:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-G0KtFSZsPM/why-opko-health-inc-stock-is-sinking-today-cm728044,Image source Getty Images What happened Shares of Opko Health Inc NASDAQ OPK a multinational pharmaceutical and diagnostics company are down 16 1 as of 11 18 a m EST Friday An announcement that its human growth hormone candidate which is partnered with
TSRO,TSRO:UW,BBG002S9PQF4,Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?,2016-12-30 17:45:24 +0000,http://www.investors.com/news/technology/which-top-5-biotech-performers-are-slated-for-triple-digit-gains/,Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?
TSRO,TSRO:UW,BBG002S9PQF4,7 Key FDA Decisions and Catalysts Expected in January and February,2016-12-30 12:45:32 +0000,http://247wallst.com/healthcare-business/2016/12/30/7-key-fda-decisions-and-catalysts-expected-in-january-and-february/,7 Key FDA Decisions and Catalysts Expected in January and February
TSRO,TSRO:UW,BBG002S9PQF4,Let’s call this the no-fault stock market,2016-12-29 15:53:33 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9DA54F78-90C8-49E8-A224-D4E11824E797&siteid=yhoof2,Let’s call this the no-fault stock market
TSRO,TSRO:UW,BBG002S9PQF4,Biotech Stocks Facing FDA Decision In January,2016-12-29 05:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0PaWkzXTG0o/biotech-stocks-facing-fda-decision-in-january-20161229-00031,Biotech Stocks Facing FDA Decision In January
TSRO,TSRO:UW,BBG002S9PQF4,Eight Milestones Of 2016 In The War On Cancer,2016-12-28 13:35:00 +0000,http://www.forbes.com/sites/arleneweintraub/2016/12/28/eight-milestones-of-2016-in-the-war-on-cancer/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Eight Milestones Of 2016 In The War On Cancer
TSRO,TSRO:UW,BBG002S9PQF4,"Take-Two A Top Pick, Tesaro A Buy, Ritchie Bros. Downgraded",2016-12-27 21:18:35 +0000,http://www.investors.com/news/take-two-a-top-pick-tesaro-a-buy-ritchie-bros-downgraded/,"Take-Two A Top Pick, Tesaro A Buy, Ritchie Bros. Downgraded"
TSRO,TSRO:UW,BBG002S9PQF4,"The Zacks Analyst Blog Highlights: CoLucid Pharmaceuticals, Exelixis, TESARO and Achaogen",2016-12-23 16:58:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yr0VXQSPsBE/the-zacks-analyst-blog-highlights-colucid-pharmaceuticals-exelixis-tesaro-and-achaogen-cm725714,For Immediate Release Chicago IL December 23 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
TSRO,TSRO:UW,BBG002S9PQF4,"The Zacks Analyst Blog Highlights: CoLucid Pharmaceuticals, Exelixis, TESARO and Achaogen",2016-12-23 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-colucid-143002218.html,"The Zacks Analyst Blog Highlights: CoLucid Pharmaceuticals, Exelixis, TESARO and Achaogen"
TSRO,TSRO:UW,BBG002S9PQF4,4 Biotech Stocks that More than Doubled in 2016,2016-12-22 17:01:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f97Na7O0HQY/4-biotech-stocks-that-more-than-doubled-in-2016-cm725153,2016 has not been a great year for biotech stocks which were under intense pressure with issues like increasing political and media focus on high price tags for drugs and the changing competitive scenario weighing on the sector While there has always been dissatisfaction about the high
TSRO,TSRO:UW,BBG002S9PQF4,4 Biotech Stocks that More than Doubled in 2016,2016-12-22 14:28:02 +0000,http://finance.yahoo.com/news/4-biotech-stocks-more-doubled-142802878.html,4 Biotech Stocks that More than Doubled in 2016
TSRO,TSRO:UW,BBG002S9PQF4,"Biotech Stock Roundup: Conatus Soars on Novartis Deal, Early FDA Nod for Clovis Drug",2016-12-21 17:02:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c_VJiHA4VFo/biotech-stock-roundup-conatus-soars-on-novartis-deal-early-fda-nod-for-clovis-drug-cm724634,Conatus CNAT is ending the year on a high note with the company signing a lucrative deal with Swiss pharma giant Novartis Investors applauded the deal sending the company s shares soaring 141 3 Meanwhile Gilead GILD was hit by a jury decision awarding 2 54 billion to Merck in a
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. – Value Analysis (NASDAQ:TSRO) : December 21, 2016",2016-12-21 15:03:34 +0000,http://www.capitalcube.com/blog/index.php/tesaro-inc-value-analysis-nasdaqtsro-december-21-2016/,"TESARO, Inc. – Value Analysis (NASDAQ:TSRO) : December 21, 2016"
TSRO,TSRO:UW,BBG002S9PQF4,"Biotech Stock Roundup: Conatus Soars on Novartis Deal, Early FDA Nod for Clovis Drug",2016-12-21 14:25:02 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-conatus-soars-142502788.html,"Biotech Stock Roundup: Conatus Soars on Novartis Deal, Early FDA Nod for Clovis Drug"
TSRO,TSRO:UW,BBG002S9PQF4,"AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date",2016-12-20 23:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nKXhi36iXl0/akba-inks-blockbuster-deal-agn-on-buying-spree-tsro-gets-fda-date-20161220-01025,"AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Ovarian Cancer Drug Gets Priority Review After FDA OKs Clovis Med,2016-12-20 21:25:51 +0000,http://www.investors.com/news/technology/tesaro-drags-up-clovis-astrazeneca-on-fda-review-of-ovarian-cancer-med/,Tesaro Ovarian Cancer Drug Gets Priority Review After FDA OKs Clovis Med
TSRO,TSRO:UW,BBG002S9PQF4,A Tesaro Catalyst the Markets Seem to Have Overlooked,2016-12-20 15:19:38 +0000,http://finance.yahoo.com/news/tesaro-catalyst-markets-seem-overlooked-151938375.html,A Tesaro Catalyst the Markets Seem to Have Overlooked
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro NDA for ovarian cancer treatment granted priority review,2016-12-20 13:19:50 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=21E42374-B7FF-4F15-8C88-DEB04CDA0AE3&siteid=yhoof2,Tesaro NDA for ovarian cancer treatment granted priority review
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Announces Priority Review Designation for Niraparib NDA,2016-12-20 13:00:00 +0000,http://finance.yahoo.com/news/tesaro-announces-priority-review-designation-130000530.html,"[GlobeNewswire] - Niraparib New Drug Application accepted for review by FDA with a PDUFA goal date of June 30, 2017 Niraparib Expanded Access Program expected to open in U.S. in January 2017 WALTHAM, Mass., Dec. 20, 2016-- ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. breached its 50 day moving average in a Bearish Manner : TSRO-US : December 20, 2016",2016-12-20 12:39:02 +0000,http://www.capitalcube.com/blog/index.php/tesaro-inc-breached-its-50-day-moving-average-in-a-bearish-manner-tsro-us-december-20-2016/,"TESARO, Inc. breached its 50 day moving average in a Bearish Manner : TSRO-US : December 20, 2016"
TSRO,TSRO:UW,BBG002S9PQF4,US FDA clears ovarian cancer drug for hard-to-treat disease,2016-12-19 22:04:25 +0000,http://sg.finance.yahoo.com/news/us-fda-clears-ovarian-cancer-211343543.html,US FDA clears ovarian cancer drug for hard-to-treat disease
TSRO,TSRO:UW,BBG002S9PQF4,"XBI, EFZ: Big ETF Outflows",2016-12-16 16:58:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YLwd2o9LV4Q/xbi-efz-big-etf-outflows-cm722533,Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the SPDR S amp P Biotech ETF XBI where 1 700 000 units were destroyed or a 3 8 decrease week over week Among the largest underlying components of XBI
TSRO,TSRO:UW,BBG002S9PQF4,Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win,2016-12-07 21:32:38 +0000,http://www.investors.com/news/technology/ariad-pharma-could-draw-ma-fire-ahead-of-second-cancer-drug-win/,Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win
TSRO,TSRO:UW,BBG002S9PQF4,"Pioneer Investments Continues to Buy Alibaba, 8 Others",2016-12-07 21:22:40 +0000,http://finance.yahoo.com/news/pioneer-investments-continues-buy-alibaba-212240424.html,"Pioneer Investments Continues to Buy Alibaba, 8 Others"
TSRO,TSRO:UW,BBG002S9PQF4,Do Hedge Funds Love TESARO Inc (TSRO)?,2016-12-07 16:55:32 +0000,http://www.insidermonkey.com/blog/do-hedge-funds-love-tesaro-inc-tsro-2-500007/,Do Hedge Funds Love TESARO Inc (TSRO)?
TSRO,TSRO:UW,BBG002S9PQF4,Read This Before You Buy Biotech Stocks,2016-12-06 18:19:57 +0000,http://www.fool.com/investing/2016/12/05/read-this-before-you-buy-biotech-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Read This Before You Buy Biotech Stocks
TSRO,TSRO:UW,BBG002S9PQF4,The 5 Best Biotech Stocks of 2016,2016-11-30 15:02:23 +0000,http://www.fool.com/investing/2016/11/29/the-best-biotech-stocks-of-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The 5 Best Biotech Stocks of 2016
TSRO,TSRO:UW,BBG002S9PQF4,The 5 Best Biotech Stocks of 2016,2016-11-29 21:54:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nxr66jvKvn0/the-5-best-biotech-stocks-of-2016-cm715355,There have been better years for biotech stocks than 2016 has turned out to be Concerns about a potential crackdown on excessive drug pricing cast a dark cloud over most drugmakers However despite headwinds for the broader industry some biotech stocks performed very well Here s
TSRO,TSRO:UW,BBG002S9PQF4,"Hedge Funds Continue Trading In and Out of DST Systems, Inc. (DST)",2016-11-27 20:25:16 +0000,http://www.insidermonkey.com/blog/hedge-funds-continue-trading-in-and-out-of-dst-systems-inc-dst-493132/,"Hedge Funds Continue Trading In and Out of DST Systems, Inc. (DST)"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Announces Participation in Three Investor Conferences,2016-11-21 21:11:16 +0000,http://www.publicnow.com/view/CBD6D2A4D631270540FACC10D6DD65EDA4D25E76,"[at noodls] - WALTHAM, Mass., Nov. 21, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits",2016-11-18 20:01:29 +0000,http://biz.yahoo.com/e/161118/tsro8-k.html,"TESARO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits"
TSRO,TSRO:UW,BBG002S9PQF4,"ETFs with exposure to TESARO, Inc. : November 18, 2016",2016-11-18 18:41:17 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-tesaro-inc-november-18-2016/,"ETFs with exposure to TESARO, Inc. : November 18, 2016"
TSRO,TSRO:UW,BBG002S9PQF4,"XBI, IONS, TSRO, SRPT: Large Inflows Detected at ETF",2016-11-18 17:51:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UkTMtKeoK_8/xbi-ions-tsro-srpt-large-inflows-detected-at-etf-cm711315,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 456 0 million dollar inflow that s a 15 7 increase week over week in
TSRO,TSRO:UW,BBG002S9PQF4,Gilead Sciences: Buy 'Regeneron Lite'…Or Just Buy Regeneron?,2016-11-18 15:24:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/18/gilead-sciences-buy-regeneron-lite-or-just-buy-regeneron/?mod=yahoobarrons&ru=yahoo,Gilead Sciences: Buy 'Regeneron Lite'…Or Just Buy Regeneron?
TSRO,TSRO:UW,BBG002S9PQF4,3 Stocks to Add to Your Portfolio as Biotech M&A Hopes Rise,2016-11-17 15:51:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/haGDFsP1dtc/3-stocks-to-add-to-your-portfolio-as-biotech-ma-hopes-rise-cm710528,2016 has not been a great year for mergers and acquisitions M amp As in the pharma and biotech sector although some headline deals like the Pfizer PFE Medivation and the Teva Actavis Generics acquisitions were completed this year While expectations were high that this year too the pharma
TSRO,TSRO:UW,BBG002S9PQF4,"3 Potential Acquisition Targets for Gilead Sciences, Inc.",2016-11-17 11:59:07 +0000,http://www.fool.com/investing/2016/11/16/3-potential-acquisition-targets-for-gilead-science.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"3 Potential Acquisition Targets for Gilead Sciences, Inc."
TSRO,TSRO:UW,BBG002S9PQF4,"Hey Gilead, Stop Developing Drugs and Start Buying Biotech Companies -- Now!",2016-11-17 11:36:00 +0000,https://www.thestreet.com/story/13897080/1/hey-gilead-stop-developing-drugs-and-start-buying-biotech-companies-now.html?puc=yahoo&cm_ven=YAHOO,"Hey Gilead, Stop Developing Drugs and Start Buying Biotech Companies -- Now!"
TSRO,TSRO:UW,BBG002S9PQF4,"3 Potential Acquisition Targets for Gilead Sciences, Inc.",2016-11-16 23:50:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RBBv4V-di4A/3-potential-acquisition-targets-for-gilead-sciences-inc-cm710330,Gilead Sciences NASDAQ GILD is looking to make a deal That s basically what the biotech s executives said in Gilead s third quarter earnings call on Nov 1 160 Which companies might be good acquisition targets for Gilead While many investors put Incyte high on the
TSRO,TSRO:UW,BBG002S9PQF4,Here’s Another Discount Entry Opportunity: TESARO Inc (TSRO),2016-11-16 19:50:54 +0000,http://www.insidermonkey.com/blog/heres-another-discount-entry-opportunity-tesaro-inc-tsro-488549/,Here’s Another Discount Entry Opportunity: TESARO Inc (TSRO)
TSRO,TSRO:UW,BBG002S9PQF4,"Why Tesaro, Inc. Is Tumbling 10.7% Today",2016-11-15 22:51:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nVRyiKmfBCU/why-tesaro-inc-is-tumbling-107-today-cm709726,Image source Getty Images What happened Following news of a 160 public offering of 1 75 million shares of its common stock shares in Tesaro Inc NASDAQ TSRO are slipping 10 7 at 3 30 p m EST Tuesday So what Ahead of an FDA decision next year on its ovarian
TSRO,TSRO:UW,BBG002S9PQF4,"Why Tesaro, Inc. Is Tumbling 10.7% Today",2016-11-15 21:15:23 +0000,http://www.fool.com/investing/2016/11/15/why-tesaro-inc-is-tumbling-10-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Tesaro, Inc. Is Tumbling 10.7% Today"
TSRO,TSRO:UW,BBG002S9PQF4,"Health Care Sector Update for 11/15/2016: AMRN,JNP,AGN,TSRO",2016-11-15 18:49:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h05FbLcVNd8/health-care-sector-update-for-11152016-amrnjnpagntsro-cm709600,Top Health Care StocksTop Health Care Stocks JNJ 0 61 JNJ 0 61 PFE 1 34 PFE 1 34 MRK 0 77 MRK 0 77 ABT 0 40 ABT 0 40 AMGN 0 29 AMGN 0 29 Health care stocks were narrowly lower this afternoon with the NYSE Health Care Index slipping about 0 3 while shares of health care companies
TSRO,TSRO:UW,BBG002S9PQF4,"Trending Stocks: TESARO, American Airlines, Delta, and More",2016-11-15 16:01:27 +0000,http://www.insidermonkey.com/blog/trending-stocks-tesaro-american-airlines-delta-and-more-488177/,"Trending Stocks: TESARO, American Airlines, Delta, and More"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. stock drops 11% after announcing public offering at $135 per share,2016-11-15 14:42:32 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=240FF377-E74F-4CD6-979E-FFD8544B0BD2&siteid=yhoof2,Tesaro Inc. stock drops 11% after announcing public offering at $135 per share
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Pricing of Public Offering of Common Stock,2016-11-15 14:38:11 +0000,http://www.publicnow.com/view/8DBA264A4113571FC349809DCCAAD1B3AEF2BCD6,"[at noodls] - WALTHAM, Mass., Nov. 15, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has priced an underwritten public offering of an aggregate of 1,750,000 shares of its common stock at ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. (TSRO) Is Sinking After Stock Offering,2016-11-15 09:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nPChVToD4uQ/tesaro-inc-tsro-is-sinking-after-stock-offering-20161115-00768,Tesaro Inc. (TSRO) Is Sinking After Stock Offering
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. (TSRO) Is Sinking After Stock Offering,2016-11-15 09:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AzgY-v7zwHE/tesaro-inc-tsro-is-sinking-after-stock-offering-20161115-00767,Tesaro Inc. (TSRO) Is Sinking After Stock Offering
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Proposed Public Offering of Common Stock,2016-11-14 21:07:14 +0000,http://www.publicnow.com/view/BF8814F835DBC79A13AA2D62C6A90F9C84E5D99B,"[at noodls] - WALTHAM, Mass., Nov. 14, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) announced today that it has commenced an underwritten public offering of 1,750,000 shares of its common stock. In connection ..."
TSRO,TSRO:UW,BBG002S9PQF4,Buy the SPDR S&P Biotech (ETF) (XBI) TODAY – Here’s Why,2016-11-09 15:53:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ujFvmFFX-2A/buy-the-spdr-sp-biotech-etf-xbi-today-heres-why-cm706398,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The SPDR S amp P Biotech ETF 160 NYSEARCA XBI and a host of biotech stocks and funds are surging this morning and that makes them stick out like a sore thumb Source Pixelbay Modified
TSRO,TSRO:UW,BBG002S9PQF4,Biotechs Climb For Third Straight Day; Which Leaders Are Buyable?,2016-11-08 21:03:18 +0000,http://www.investors.com/news/technology/biotechs-climb-for-third-straight-day-which-leaders-are-buyable/,Biotechs Climb For Third Straight Day; Which Leaders Are Buyable?
TSRO,TSRO:UW,BBG002S9PQF4,Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed,2016-11-08 17:53:44 +0000,http://www.insidermonkey.com/blog/big-bet-on-sarepta-therapeutics-inc-srpt-lifts-perceptive-advisors-q3-returns-see-how-other-investments-performed-485488/,Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed
TSRO,TSRO:UW,BBG002S9PQF4,"Which Four Biotechs Are Derisked, Buyable Ahead of Election Day?",2016-11-07 21:29:22 +0000,http://www.investors.com/news/technology/which-four-biotechs-are-derisked-buyable-ahead-of-election-day/,"Which Four Biotechs Are Derisked, Buyable Ahead of Election Day?"
TSRO,TSRO:UW,BBG002S9PQF4,Cormorant Asset Management’s Bets on Alder Biopharmaceuticals Inc (ALDR) and Other Healthcare Stocks Show Strong Returns,2016-11-07 20:23:27 +0000,http://www.insidermonkey.com/blog/cormorant-asset-managements-bets-on-alder-biopharmaceuticals-inc-aldr-and-other-healthcare-stocks-show-strong-returns-485299/,Cormorant Asset Management’s Bets on Alder Biopharmaceuticals Inc (ALDR) and Other Healthcare Stocks Show Strong Returns
TSRO,TSRO:UW,BBG002S9PQF4,"ETF’s with exposure to TESARO, Inc. : November 7, 2016",2016-11-07 18:05:16 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-tesaro-inc-november-7-2016/,"ETF’s with exposure to TESARO, Inc. : November 7, 2016"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. :TSRO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016",2016-11-04 14:32:02 +0000,http://www.capitalcube.com/blog/index.php/tesaro-inc-tsro-us-earnings-analysis-q3-2016-by-the-numbers-november-4-2016/,"TESARO, Inc. :TSRO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 10-Q, Quarterly Report",2016-11-04 13:20:15 +0000,http://biz.yahoo.com/e/161104/tsro10-q.html,"TESARO, INC. Files SEC form 10-Q, Quarterly Report"
TSRO,TSRO:UW,BBG002S9PQF4,Edited Transcript of TSRO earnings conference call or presentation 3-Nov-16 8:15pm GMT,2016-11-04 03:17:23 +0000,http://finance.yahoo.com/news/edited-transcript-tsro-earnings-conference-031723181.html,Edited Transcript of TSRO earnings conference call or presentation 3-Nov-16 8:15pm GMT
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro reports 3Q loss,2016-11-03 21:05:51 +0000,http://sg.finance.yahoo.com/news/tesaro-reports-3q-loss-210551403.html,Tesaro reports 3Q loss
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Third-Quarter 2016 Operating Results,2016-11-03 20:22:20 +0000,http://www.publicnow.com/view/58D1FA8ADC25BA2DEC6A929CBC68DCFE40EA0B50,"[at noodls] - Niraparib rolling NDA submission to FDA complete, MAA accepted for review by EMA Pre-launch planning ongoing to support four potential product launches in 2017 across U.S. and Europe Positive Phase 3 NOVA ..."
TSRO,TSRO:UW,BBG002S9PQF4,Read this press release »,2016-11-03 20:09:39 +0000,http://www.publicnow.com/view/9C91891109DC6F09C3D16795E5A728761F7206F2,"[at noodls] - October 20, 2016 Tesaro to Announce Third-Quarter 2016 Financial Results on November 3, 2016 WALTHAM, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its third-quarter ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-11-03 20:04:18 +0000,http://biz.yahoo.com/e/161103/tsro8-k.html,"TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
TSRO,TSRO:UW,BBG002S9PQF4,"Biotech Stock Roundup: Amgen Down on Enbrel Sales, Regeneron's Sarilumab Faces Delay",2016-11-03 12:49:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-amgen-down-124912131.html,"Biotech Stock Roundup: Amgen Down on Enbrel Sales, Regeneron's Sarilumab Faces Delay"
TSRO,TSRO:UW,BBG002S9PQF4,Q3 2016 TESARO Inc Earnings Release - After Market Close,2016-11-03 11:07:05 +0000,http://biz.yahoo.com/research/earncal/20161103.html?t=tsro,Q3 2016 TESARO Inc Earnings Release - After Market Close
TSRO,TSRO:UW,BBG002S9PQF4,4 stocks to watch,2016-11-02 18:37:53 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=C2E1D926-A94C-49DC-8129-F84F76F34346&siteid=yhoof2,4 stocks to watch
TSRO,TSRO:UW,BBG002S9PQF4,4 Medical And Biotech Stocks to Watch,2016-11-02 14:48:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_w1gwupOUDI/4-medical-and-biotech-stocks-to-watch-cm702453,"By Harry Boxer   Here are 4 bullish charts in the medical and biotech arena, which is starting to heat up again.  Exelixis, Inc. ( EXEL ), which has been in a declining wedge off its September top, made a new low for the move intraday on Tuesday before snapping back to close up 39 cents, or 3.68%, to 10.98, on 4.6"
TSRO,TSRO:UW,BBG002S9PQF4,"PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA",2016-11-02 04:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z38L-536a5M/ptn-surges-on-trial-data-pfe-dumps-cholesterol-drug-watch-out-for-prta-20161102-00006,"PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA"
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro Announces Submission of Niraparib New Drug Application for Platinum-Sensitive, Recurrent Ovarian Cancer",2016-11-01 20:49:40 +0000,http://www.publicnow.com/view/13BAF93F5D139BFF46E0EE1B30ABF4D7A367C620,"[at noodls] - WALTHAM, Mass., Nov. 01, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has completed the niraparib rolling New Drug Application ..."
TSRO,TSRO:UW,BBG002S9PQF4,Radius Health (RDUS): Will It Disappoint in Q3 Earnings?,2016-11-01 14:16:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RhqXirjbnr8/radius-health-rdus-will-it-disappoint-in-q3-earnings-cm701660,Radius Health Inc RDUS is scheduled to report third quarter 2016 financial results on Nov 3 before the market closes Last quarter the company recorded a negative earnings surprise of 3 06 Radius Health has a disappointing track record so far The company has missed estimates in all of
TSRO,TSRO:UW,BBG002S9PQF4,Keryx (KERX) Q3 Earnings Preview: Stock to Beat Estimates?,2016-11-01 13:16:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NBIUMKsM0QM/keryx-kerx-q3-earnings-preview-stock-to-beat-estimates-cm701617,Keryx Biopharmaceuticals Inc KERX is expected to report third quarter 2016 results on Nov 3 Let s see how things are shaping up for this announcement Factors Influencing This Quarter Apart from license fees Keryx s top line comprises revenues generated by its only marketed
TSRO,TSRO:UW,BBG002S9PQF4,Intercept (ICPT) Q3 Earnings Preview: What's in the Cards?,2016-11-01 13:16:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sNBFeM5NHTE/intercept-icpt-q3-earnings-preview-whats-in-the-cards-cm701605,Intercept Pharmaceuticals Inc ICPT is scheduled to report third quarter 2016 results on Nov 3 before market opens In the last reported quarter the company recorded a positive surprise of 16 49 Let s see how things are shaping up for this announcement Factors at
TSRO,TSRO:UW,BBG002S9PQF4,Radius Health (RDUS): Will It Disappoint in Q3 Earnings?,2016-11-01 13:13:01 +0000,http://finance.yahoo.com/news/radius-health-rdus-disappoint-q3-131301441.html,Radius Health (RDUS): Will It Disappoint in Q3 Earnings?
TSRO,TSRO:UW,BBG002S9PQF4,5 Healthcare Stocks Poised to Trump Q3 Earnings,2016-10-31 22:15:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iisq-O1OdeA/5-healthcare-stocks-poised-to-trump-q3-earnings-cm701421,The past few months have been pretty rough for the healthcare sector with the drug pricing issue taking the center stage once again This time it was the massive price hike of Mylan N V s MYL severe allergy treatment EpiPen that sparked controversies With no possibility of dying down
TSRO,TSRO:UW,BBG002S9PQF4,5 Healthcare Stocks Poised to Trump Q3 Earnings,2016-10-31 19:55:07 +0000,http://finance.yahoo.com/news/5-healthcare-stocks-poised-trump-195507008.html,5 Healthcare Stocks Poised to Trump Q3 Earnings
TSRO,TSRO:UW,BBG002S9PQF4,Talazoparib and Pidilizumab May Prove Complementary to Pfizer’s Existing Oncology Drugs,2016-10-31 14:04:15 +0000,http://marketrealist.com/2016/10/talazoparib-pidilizumab-may-prove-complementary-pfizers-existing-oncology-drugs/?utm_source=yahoo&utm_medium=feed,Talazoparib and Pidilizumab May Prove Complementary to Pfizer’s Existing Oncology Drugs
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Presentation of Niraparib Data at the 2016 IGCS Biennial Meeting,2016-10-31 12:00:00 +0000,http://finance.yahoo.com/news/tesaro-announces-presentation-niraparib-data-120000336.html,"[GlobeNewswire] - WALTHAM, Mass., Oct. 31, 2016-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced the presentation of data from the ENGOT-OV16/NOVA trial of niraparib at the 2016 International ..."
TSRO,TSRO:UW,BBG002S9PQF4,"Noteworthy ETF Inflows: XBI, SRPT, TSRO, INCY",2016-10-28 16:32:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2tRE81Bhb0w/noteworthy-etf-inflows-xbi-srpt-tsro-incy-cm700265,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 111 4 million dollar inflow that s a 5 0 increase week over week in outstanding
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Drug Makes EU Marketing Progress (TSRO),2016-10-28 05:33:00 +0000,http://www.investopedia.com/news/tesaro-cancer-drug-accepted-eu-review-tsro/?partner=YahooSA,Tesaro Drug Makes EU Marketing Progress (TSRO)
TSRO,TSRO:UW,BBG002S9PQF4,"CEMP Plunges, ALDR Promises Data In 1H 2017, AERI Withdraws NDA, AZN, CYH Abuzz",2016-10-28 03:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U_Tgg0vOzIQ/cemp-plunges-aldr-promises-data-in-1h-2017-aeri-withdraws-nda-azn-cyh-abuzz-20161028-00086,"CEMP Plunges, ALDR Promises Data In 1H 2017, AERI Withdraws NDA, AZN, CYH Abuzz"
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Acceptance for Review of Niraparib Marketing Authorization Application by EMA,2016-10-27 20:16:29 +0000,http://www.publicnow.com/view/80E7717CB954F87C18514E794230EF93F79485C2,"[at noodls] - WALTHAM, Mass., Oct. 27, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Marketing Authorisation Application (MAA) for niraparib ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro's Ovarian Cancer Drug Has Edge Vs. AstraZeneca's: Analyst,2016-10-26 20:36:49 +0000,http://www.investors.com/news/technology/tesaros-commercial-advantage-could-topple-astrazeneca-cancer-drug/,Tesaro's Ovarian Cancer Drug Has Edge Vs. AstraZeneca's: Analyst
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Participation in Three Investor Conferences,2016-10-24 20:21:08 +0000,http://www.publicnow.com/view/D074F4B080EBEE04E4F8FC9EAFA68550342C82BE,"[at noodls] - WALTHAM, Mass., Oct. 24, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The ..."
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro to Announce Third-Quarter 2016 Financial Results on November 3, 2016",2016-10-20 20:19:16 +0000,http://www.publicnow.com/view/7A57E7DBEADDE4B15B66224268634D840F810BD0,"[at noodls] - WALTHAM, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its third-quarter 2016 financial results on Thursday, November 3, 2016, after the close of the U.S. financial ..."
TSRO,TSRO:UW,BBG002S9PQF4,41 Billion Reasons Why Gilead Sciences Might Need New Management,2016-10-20 19:52:32 +0000,http://www.fool.com/investing/2016/10/19/41-billion-reasons-why-gilead-sciences-might-need.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,41 Billion Reasons Why Gilead Sciences Might Need New Management
TSRO,TSRO:UW,BBG002S9PQF4,"Commit To Buy Tesaro At $70, Earn 9.9% Using Options",2016-10-20 17:28:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lMcjmDJKi8g/commit-to-buy-tesaro-at-70-earn-99-using-options-cm696116,Investors eyeing a purchase of Tesaro Inc Symbol TSRO shares but tentative about paying the going market price of 112 95 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January 2018 put
TSRO,TSRO:UW,BBG002S9PQF4,SPDR S&P Biotech ETF Experiences Big Outflow,2016-10-20 16:25:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MYrlh9Yd0kM/spdr-sp-biotech-etf-experiences-big-outflow-cm696022,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 70 6 million dollar outflow that s a 3 0 decrease week over week from 40 200 000
TSRO,TSRO:UW,BBG002S9PQF4,41 Billion Reasons Why Gilead Sciences Might Need New Management,2016-10-19 21:47:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1P7LkyVKK6s/41-billion-reasons-why-gilead-sciences-might-need-new-management-cm695624,Gilead Sciences NASDAQ GILD may have a management problem at least if the market s sentiment toward this top biotech is a reliable indicator After all ever since 160 John Milligan replaced John Martin as Chief Executive Officer last March Gilead s shares have
TSRO,TSRO:UW,BBG002S9PQF4,Is Opko Health On the Cusp of a Big Year?,2016-10-14 22:42:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GMOm-jsTdFI/is-opko-health-on-the-cusp-of-a-big-year-cm693720,Image source Getty Images Opko Health s NASDAQ OPK billionaire CEO Phillip Frost has been busy The legendary healthcare entrepreneur best known for selling his IVAX Labs to Teva Pharmaceutical for 7 4 billion in 2006 160 is 160 on a spending spree that he
TSRO,TSRO:UW,BBG002S9PQF4,"Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO",2016-10-12 14:21:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xRxdEZs_O1o/biotech-stock-roundup-alnylam-slumps-on-revusiran-update-tesaro-impresses-at-esmo-cm692293,Alnylam ALNY focused on developing novel therapeutics based on RNA interference RNAi saw its shares slump on its decision to discontinue the development of a late stage pipeline candidate Meanwhile several biotech companies were present at the congress of the European Society for
TSRO,TSRO:UW,BBG002S9PQF4,"Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO",2016-10-12 12:39:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-alnylam-slumps-123912498.html,"Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO"
TSRO,TSRO:UW,BBG002S9PQF4,These 3 Little Biotechs Just Scored Big,2016-10-11 22:18:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pyRjAHTcHKQ/these-3-little-biotechs-just-scored-big-cm692087,Image source Getty Images Last weekend was more exciting than most for the medical community This year s European Society for Medical Oncology meeting contained a deluge of data from biopharmas both big and small While surprising developments from the industry s biggest
TSRO,TSRO:UW,BBG002S9PQF4,These 3 Little Biotechs Just Scored Big,2016-10-11 20:30:11 +0000,http://www.fool.com/investing/2016/10/11/these-3-little-biotechs-just-scored-big.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Little Biotechs Just Scored Big
TSRO,TSRO:UW,BBG002S9PQF4,Tesoro Soars on Cancer Drug Results (TSRO),2016-10-11 16:04:00 +0000,http://www.investopedia.com/news/tesoro-soars-positive-cancer-drug-results-tsro/?partner=YahooSA,Tesoro Soars on Cancer Drug Results (TSRO)
TSRO,TSRO:UW,BBG002S9PQF4,​Analysts hike outlook for Waltham’s Tesaro after ovarian cancer drug data,2016-10-11 15:23:15 +0000,http://www.bizjournals.com/boston/blog/bioflash/2016/10/analysts-hike-outlook-for-waltham-s-tesaro-after.html?ana=yahoo,​Analysts hike outlook for Waltham’s Tesaro after ovarian cancer drug data
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. Is Flying High Today (and Could Go Higher From Here),2016-10-11 12:21:32 +0000,http://www.fool.com/investing/2016/10/10/could-tesaro-inc-be-ready-to-fly.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Tesaro Inc. Is Flying High Today (and Could Go Higher From Here)
TSRO,TSRO:UW,BBG002S9PQF4,"Why Alphabet Inc (GOOG), Mylan NV (MYL) And Tesaro Inc (TSRO) Are 3 of Today’s Best Stocks",2016-10-10 23:18:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o5IkaKTv-xo/why-alphabet-inc-goog-mylan-nv-myl-and-tesaro-inc-tsro-are-3-of-todays-best-stocks-cm691363,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips A day after the second presidential debate stocks rose on speculation that the Organization of Petroleum Exporting Countries will move to limit oil production sparking a rally in the
TSRO,TSRO:UW,BBG002S9PQF4,"Why Myriad Genetics, Inc. Got Crushed Today",2016-10-10 23:18:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YlD6vfGL2vo/why-myriad-genetics-inc-got-crushed-today-cm691362,Image source Getty Images What happened Myriad Genetics NASDAQ MYGN fell 11 6 today after Tesaro NASDAQ TSRO presented data at the European Society for Medical Oncology 160 that suggest Myriad Genetics companion diagnostic test might not be necessary
TSRO,TSRO:UW,BBG002S9PQF4,What Happened in the Stock Market Today,2016-10-10 22:19:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z1on0N-bvhY/what-happened-in-the-stock-market-today-cm691349,Image source Getty Images Stocks slipped from their morning highs in the afternoon but still logged solid gains on Monday The Dow Jones Industrial Average DJINDICES DJI and the S amp P 500 SNPINDEX GSPC indexes both added nearly 0 5 Today s stock
TSRO,TSRO:UW,BBG002S9PQF4,"Why Myriad Genetics, Inc. Got Crushed Today",2016-10-10 21:43:20 +0000,http://www.fool.com/investing/2016/10/10/why-myriad-genetics-inc-got-crushed-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Myriad Genetics, Inc. Got Crushed Today"
TSRO,TSRO:UW,BBG002S9PQF4,"Notable Monday Option Activity: TSRO, CSOD, OA",2016-10-10 21:17:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rOf-vEwL55Y/notable-monday-option-activity-tsro-csod-oa-cm691312,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Tesaro Inc Symbol TSRO where a total volume of 17 416 contracts has been traded thus far today a contract volume which is representative of approximately 1 7
TSRO,TSRO:UW,BBG002S9PQF4,What Happened in the Stock Market Today,2016-10-10 21:04:00 +0000,http://www.fool.com/investing/2016/10/10/what-happened-in-the-stock-market-today.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,What Happened in the Stock Market Today
TSRO,TSRO:UW,BBG002S9PQF4,"Why Tesaro, Inc. Is Skyrocketing 20% Today",2016-10-10 20:18:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Omg3EPZ9FQ/why-tesaro-inc-is-skyrocketing-20-today-cm691275,Image source Getty Images What happened After the company offered more details on data from a phase 3 trial of niraparib in ovarian cancer patients shares in Tesaro Inc NASDAQ TSRO are rallying 20 today So what In June management announced that niraparib
TSRO,TSRO:UW,BBG002S9PQF4,"Health Care Sector Update for 10/10/2016: TSRO,MCUR,BMY",2016-10-10 20:18:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xgQ9QFKdi4I/health-care-sector-update-for-10102016-tsromcurbmy-cm691306,Top Health Care StocksTop Health Care Stocks JNJ 0 50 JNJ 0 50 PFE 0 13 PFE 0 13 MRK 1 28 MRK 1 28 ABT 1 66 ABT 1 66 AMGN 0 45 AMGN 0 45 Health care stocks were rising this afternoon with the NYSE Health Care Index climbing about 0 3 while shares of health care companies in
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro Bolts On Ovarian Cancer Win Vs. AstraZeneca, AbbVie",2016-10-10 20:12:24 +0000,http://www.investors.com/news/technology/tesaro-bolts-on-ovarian-cancer-win-vs-astrazeneca-abbvie/,"Tesaro Bolts On Ovarian Cancer Win Vs. AstraZeneca, AbbVie"
TSRO,TSRO:UW,BBG002S9PQF4,Best Stocks of 2016: Globant SA (GLOB) Emerges as Digital Transformation Leader,2016-10-10 19:19:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aSEsW1KWnzo/best-stocks-of-2016-globant-sa-glob-emerges-as-digital-transformation-leader-cm691225,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Editor s Note This article is part of our Best Stocks for 2016 contest Jon Markman s pick for the contest is 160 Globant SA 160 NYSE
TSRO,TSRO:UW,BBG002S9PQF4,"Why Tesaro, Inc. Is Skyrocketing 20% Today",2016-10-10 19:09:25 +0000,http://www.fool.com/investing/2016/10/10/why-tesaro-inc-is-skyrocketing-20-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Tesaro, Inc. Is Skyrocketing 20% Today"
TSRO,TSRO:UW,BBG002S9PQF4,"Street Talk: MAT, AEO & more",2016-10-10 18:44:00 +0000,http://finance.yahoo.com/video/street-talk-mat-aeo-more-184400772.html,"Street Talk: MAT, AEO & more"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. Is Flying High Today (and Could Go Higher From Here),2016-10-10 18:19:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zXQ4Z0K8RMg/tesaro-inc-is-flying-high-today-and-could-go-higher-from-here-cm691201,Image source Getty Images If you re looking for a biotech 160 to 160 add high flying gains to 160 your portfolio 160 check out Tesaro Inc NASDAQ TSRO Tesaro 160 could be headed for lift off 160 after 160 rival Clovis Oncology NASDAQ CLVS 160
TSRO,TSRO:UW,BBG002S9PQF4,Analyst: Three things are pushing Mylan higher,2016-10-10 18:10:00 +0000,http://finance.yahoo.com/video/analyst-three-things-pushing-mylan-181000626.html,Analyst: Three things are pushing Mylan higher
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro: Priced for a Takeover?,2016-10-10 17:51:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/10/tesaro-priced-for-a-takeover/?mod=yahoobarrons&ru=yahoo,Tesaro: Priced for a Takeover?
TSRO,TSRO:UW,BBG002S9PQF4,"Even High-Flying Tesaro and Its Ovarian Cancer Drug Has a Bear Thesis. Here It Is, Explained",2016-10-10 17:22:00 +0000,https://www.thestreet.com/story/13847520/1/even-high-flying-tesaro-and-its-ovarian-cancer-drug-has-a-bear-thesis-here-it-is-explained.html?puc=yahoo&cm_ven=YAHOO,"Even High-Flying Tesaro and Its Ovarian Cancer Drug Has a Bear Thesis. Here It Is, Explained"
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro Inc (TSRO) Soars on Trial Data, Analyst Upgrades",2016-10-10 17:18:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tVC4sQQJTOM/tesaro-inc-tsro-soars-on-trial-data-analyst-upgrades-cm691161,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Tesaro Inc 160 NASDAQ TSRO has kept investors salivating waiting for the markets to open all weekend as the small oncology focused biotech posted solid results in
TSRO,TSRO:UW,BBG002S9PQF4,Midday Update: Rally in Oil and Presidential Debate Drives Stocks Higher,2016-10-10 17:18:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kdwa9mZUMSM/midday-update-rally-in-oil-and-presidential-debate-drives-stocks-higher-cm691186,The major averages were all sharply higher on Monday as a rally in oil and the outcome of the latest presidential debate drove the Dow Jones Industrial Average to a two week high All eleven sectors of the S amp P 500 were in the green with the energy sector out in front while only eight of the
TSRO,TSRO:UW,BBG002S9PQF4,"Here’s Why Mylan, Diamondback Energy, TESARO and Two Other Stocks Are Surging Today",2016-10-10 16:54:55 +0000,http://www.insidermonkey.com/blog/heres-why-mylan-diamondback-energy-tesaro-and-two-other-stocks-are-surging-today-480037/,"Here’s Why Mylan, Diamondback Energy, TESARO and Two Other Stocks Are Surging Today"
TSRO,TSRO:UW,BBG002S9PQF4,Analysts Chase Tesaro Targets and Ratings Higher,2016-10-10 16:05:29 +0000,http://finance.yahoo.com/news/analysts-chase-tesaro-targets-ratings-160529824.html,Analysts Chase Tesaro Targets and Ratings Higher
TSRO,TSRO:UW,BBG002S9PQF4,"Pre-Market Most Active for Oct 10, 2016 :  TWTR, BCS, NOK, BMY, MYL, AAPL, AEG, TEF, TVIX, XIV, QQQ, TSRO",2016-10-10 12:57:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OgkrWMJ6M7c/pre-market-most-active-for-oct-10-2016-twtr-bcs-nok-bmy-myl-aapl-aeg-tef-tvix-xiv-qqq-tsro-cm690877,The NASDAQ 100 Pre Market Indicator is up 16 1 to 4 880 62 The total Pre Market volume is currently 12 169 666 shares traded The following are the most active stocks for the pre market session Twitter Inc TWTR is 2 59 at 17 26 with 5 621 579 shares traded TWTR
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. (TSRO) Has Jumped To A New High On Phase 3 Study Results,2016-10-10 09:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8WpKrOS8KAY/tesaro-inc-tsro-has-jumped-to-a-new-high-on-phase-3-study-results-20161010-00383,Tesaro Inc. (TSRO) Has Jumped To A New High On Phase 3 Study Results
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro's ovarian cancer drug benefits all patients in study,2016-10-08 08:33:45 +0000,http://finance.yahoo.com/news/tesaros-ovarian-cancer-drug-benefits-083345531.html,Tesaro's ovarian cancer drug benefits all patients in study
TSRO,TSRO:UW,BBG002S9PQF4,TESARO and ENGOT Announce Presentation of Successful Niraparib Phase 3 ENGOT-OV16/NOVA Trial Results During ESMO 2016,2016-10-08 06:33:08 +0000,http://www.publicnow.com/view/73582B068BE15DA187A86F02958002BC0AB2A405,"[at noodls] - Simultaneous presentation of data at ESMO and publication online in the New England Journal of Medicine TESARO Investor Webcast to be Held at 7:00 PM CET / 1:00 PM EDT COPENHAGEN, Oct. 08, 2016 (GLOBE ..."
TSRO,TSRO:UW,BBG002S9PQF4,Myriad's myChoice® HRD Test Identifies Patients with Ovarian Cancer Who May Benefit from Treatment with Niraparib,2016-10-08 06:31:02 +0000,http://finance.yahoo.com/news/myriads-mychoice-hrd-test-identifies-063102604.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 08, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that its myChoice ® HRD test identified ..."
TSRO,TSRO:UW,BBG002S9PQF4,Myriad’s myChoice® HRD Test Identifies Patients with Ovarian Cancer Who May Benefit from Treatment with Niraparib,2016-10-08 06:30:00 +0000,http://finance.yahoo.com/news/myriad-mychoice-hrd-test-identifies-063000155.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 08, 2016-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that its myChoice ® HRD test identified more than double the number of ..."
TSRO,TSRO:UW,BBG002S9PQF4,"Tesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial Shows",2016-10-08 06:16:00 +0000,https://www.thestreet.com/story/13846437/1/tesaro-drug-delays-recurrence-of-ovarian-cancer-new-clinical-trial-shows.html?puc=yahoo&cm_ven=YAHOO,"Tesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial Shows"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro ovarian cancer drug shows broad benefits in study,2016-10-08 06:15:01 +0000,http://finance.yahoo.com/news/tesaro-ovarian-cancer-drug-shows-061501170.html,Tesaro ovarian cancer drug shows broad benefits in study
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Cancer Drug’s Results May Challenge Need for Myriad Test,2016-10-08 06:15:00 +0000,http://www.bloomberg.com/news/articles/2016-10-08/tesaro-cancer-drug-s-results-may-challenge-need-for-myriad-test?cmpid=yhoo.headline,Tesaro Cancer Drug’s Results May Challenge Need for Myriad Test
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat",2016-09-29 11:24:24 +0000,http://biz.yahoo.com/e/160929/tsro8-k.html,"TESARO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO and Zai Lab Announce Collaboration, Development and License Agreement",2016-09-29 11:10:11 +0000,http://www.publicnow.com/view/C42E7EE32534CB2A2199FDAA550D5D39B0209032,[at noodls] - Collaboration enables the clinical development of niraparib in China by Zai Lab TESARO retains right to co-market in China and receives option to license up to two novel immuno-oncology programs outside ...
TSRO,TSRO:UW,BBG002S9PQF4,[video]Takeover Chatter Around Clovis May Be Overdone,2016-09-23 13:28:00 +0000,https://www.thestreet.com/story/13750094/1/takeover-chatter-around-clovis-may-be-overdone.html?puc=yahoo&cm_ven=YAHOO,[video]Takeover Chatter Around Clovis May Be Overdone
TSRO,TSRO:UW,BBG002S9PQF4,AstraZeneca Withdraws Cediranib Marketing Application in EU,2016-09-22 15:23:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/POpVfnRTw0k/astrazeneca-withdraws-cediranib-marketing-application-in-eu-cm683116,AstraZeneca plc AZN announced that the company has decided to withdraw its Marketing Authorisation Application MAA for cediranib in the EU because of certain outstanding questions by the regulatory agency remaining at such a late stage in the review process The company was looking to
TSRO,TSRO:UW,BBG002S9PQF4,"'Blockbuster Franchises' Spark M&A Fever For Sarepta, Ariad, Biotechs",2016-09-21 20:32:58 +0000,http://www.investors.com/news/technology/blockbuster-franchises-spark-ma-fever-for-sarepta-ariad-biotechs/,"'Blockbuster Franchises' Spark M&A Fever For Sarepta, Ariad, Biotechs"
TSRO,TSRO:UW,BBG002S9PQF4,Is Tesaro Another M&A Target? The Charts Say It Is,2016-09-21 15:15:00 +0000,http://realmoney.thestreet.com/articles/09/21/2016/tesaro-another-ma-target-charts-say-it?puc=yahoo&cm_ven=YAHOO,Is Tesaro Another M&A Target? The Charts Say It Is
TSRO,TSRO:UW,BBG002S9PQF4,"Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy",2016-09-20 20:21:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YawhPysiZmE/forget-sarepta-therapeutics-here-are-3-other-biotech-stocks-to-buy-cm682236,Image source Stockmonkeys com via Flickr When the FDA approved 160 Sarepta Therapeutics NASDAQ SRPT controversial Duchenne muscular dystrophy drug Exondys 51 it caused shares in the company to surge 74 a market cap of 2 4 billion may fairly value it now If so
TSRO,TSRO:UW,BBG002S9PQF4,"Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy",2016-09-20 19:01:06 +0000,http://www.fool.com/investing/2016/09/20/forget-sarepta-therapeutics-here-are-3-other-biote.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy"
TSRO,TSRO:UW,BBG002S9PQF4,Looking Ahead To The Potentially Game Changing TESARO Inc (TSRO) Data,2016-09-14 13:35:43 +0000,http://www.insidermonkey.com/blog/looking-ahead-to-the-potentially-game-changing-tesaro-inc-tsro-data-474440/,Looking Ahead To The Potentially Game Changing TESARO Inc (TSRO) Data
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Gets Fast Track Designation for Ovarian Cancer Drug,2016-09-13 19:47:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uTvfC_jIFNE/tesaro-gets-fast-track-designation-for-ovarian-cancer-drug-cm678988,Tesaro Inc TSRO announced that the FDA has granted Fast Track designation to its pipeline candidate niraparib for the treatment of patients with recurrent platinum sensitive ovarian fallopian tube or primary peritoneal cancer Tesaro has initiated a rolling submission of a New
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Gets Fast Track Designation for Ovarian Cancer Drug,2016-09-13 17:35:05 +0000,http://finance.yahoo.com/news/tesaro-gets-fast-track-designation-173505215.html,Tesaro Gets Fast Track Designation for Ovarian Cancer Drug
TSRO,TSRO:UW,BBG002S9PQF4,"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift",2016-09-13 03:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9erYE7-344M/rprx-on-track-across-the-pond-cerc-gets-funded-data-gives-fomx-a-facelift-20160913-00097,"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift"
TSRO,TSRO:UW,BBG002S9PQF4,"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift",2016-09-13 03:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-EPzd1eDAnQ/rprx-on-track-across-the-pond-cerc-gets-funded-data-gives-fomx-a-facelift-20160913-00098,"RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift"
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. – Value Analysis (NASDAQ:TSRO) : September 12, 2016",2016-09-12 17:44:41 +0000,http://www.capitalcube.com/blog/index.php/tesaro-inc-value-analysis-nasdaqtsro-september-12-2016/,"TESARO, Inc. – Value Analysis (NASDAQ:TSRO) : September 12, 2016"
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Receives FDA Fast Track Designation for Niraparib and Initiates Rolling NDA Submission,2016-09-12 12:18:07 +0000,http://www.publicnow.com/view/110B90B693D47CA0A2BD5E9C1637AD5E06536D4C,"[at noodls] - WALTHAM, Mass., Sept. 12, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted ..."
TSRO,TSRO:UW,BBG002S9PQF4,Gilead Sciences: What is PARP?,2016-09-09 19:46:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/09/gilead-sciences-what-is-parp/?mod=yahoobarrons&ru=yahoo,Gilead Sciences: What is PARP?
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : September 9, 2016",2016-09-09 12:10:32 +0000,http://www.capitalcube.com/blog/index.php/tesaro-inc-breached-its-50-day-moving-average-in-a-bullish-manner-tsro-us-september-9-2016/,"TESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : September 9, 2016"
TSRO,TSRO:UW,BBG002S9PQF4,Clovis Oncology Up As FDA Skips Review Panel For New Drug,2016-09-08 20:49:15 +0000,http://www.investors.com/news/technology/clovis-oncology-up-as-fda-skips-review-panel-for-new-drug/,Clovis Oncology Up As FDA Skips Review Panel For New Drug
TSRO,TSRO:UW,BBG002S9PQF4,"Notable Thursday Option Activity: TSRO, TSCO, PCYG",2016-09-08 19:17:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FZ_i--872bg/notable-thursday-option-activity-tsro-tsco-pcyg-cm676455,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Tesaro Inc Symbol TSRO where a total of 8 445 contracts have traded so far representing approximately 844 500 underlying shares That amounts to about 96 of TSRO s average
TSRO,TSRO:UW,BBG002S9PQF4,When Gilead Sciences Speaks…,2016-09-08 17:08:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/08/when-gilead-sciences-speaks/?mod=yahoobarrons&ru=yahoo,When Gilead Sciences Speaks…
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. (TSRO) Has Spiked To The Upside,2016-09-08 10:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E5oI_Oylnug/tesaro-inc-tsro-has-spiked-to-the-upside-20160908-00745,Tesaro Inc. (TSRO) Has Spiked To The Upside
TSRO,TSRO:UW,BBG002S9PQF4,Lake Street Says Buy-Rated Tesaro Holds An Attractive Portfolio Of Cancer Therapies,2016-09-06 19:10:59 +0000,http://finance.yahoo.com/news/lake-street-says-buy-rated-191059337.html,Lake Street Says Buy-Rated Tesaro Holds An Attractive Portfolio Of Cancer Therapies
TSRO,TSRO:UW,BBG002S9PQF4,Is Bad News Necessarily a Bad Thing?,2016-09-06 17:40:00 +0000,http://realmoney.thestreet.com/articles/09/06/2016/bad-news-necessarily-bad-thing?puc=yahoo&cm_ven=YAHOO,Is Bad News Necessarily a Bad Thing?
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Six Data Presentations at the 2016 European Society for Medical Oncology (ESMO) Annual Meeting,2016-09-06 12:01:00 +0000,http://finance.yahoo.com/news/tesaro-announces-six-data-presentations-120100326.html,[GlobeNewswire] - Phase 3 results from ENGOT-OV16/NOVA trial of niraparib accepted for oral presentation during Presidential Symposium and inclusion in ESMO Press Programme TESARO to webcast Investor and Analyst Briefing ...
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Participation at Four Investor Conferences,2016-08-24 20:38:02 +0000,http://www.publicnow.com/view/FDF9F3CB08AD4CF7F5C8456107AE3E7DE440493C,"[at noodls] - WALTHAM, Mass., Aug. 24, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in four upcoming investor conferences. The ..."
TSRO,TSRO:UW,BBG002S9PQF4,"Why Zoe's Kitchen, Tuniu, and Tesaro Slumped Today",2016-08-23 22:46:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_H0EZ0FN8Ow/why-zoes-kitchen-tuniu-and-tesaro-slumped-today-cm669251,"Image source  Zoe's Kitchen.  Tuesday continued the stock market's recent trend of relatively volatility free trading, with today's bias being slightly to the upside. Major market benchmarks rose by small fractions of a"
TSRO,TSRO:UW,BBG002S9PQF4,"Why Zoe's Kitchen, Tuniu, and Tesaro Slumped Today",2016-08-23 21:14:00 +0000,http://www.fool.com/investing/2016/08/23/why-zoes-kitchen-tuniu-and-tesaro-slumped-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Zoe's Kitchen, Tuniu, and Tesaro Slumped Today"
TSRO,TSRO:UW,BBG002S9PQF4,Healthy Market Action Takes an Unhealthy Turn,2016-08-23 20:20:00 +0000,http://realmoney.thestreet.com/articles/08/23/2016/healthy-market-action-takes-unhealthy-turn?puc=yahoo&cm_ven=YAHOO,Healthy Market Action Takes an Unhealthy Turn
TSRO,TSRO:UW,BBG002S9PQF4,"Noteworthy Monday Option Activity: TSRO, WDAY, IPGP",2016-08-22 20:43:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/42Ff2W8Ten0/noteworthy-monday-option-activity-tsro-wday-ipgp-cm668657,"Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Tesaro Inc (Symbol TSRO), where a total of 3,934 contracts have traded so far, representing approximately 393,400 underlying shares. That amounts to"
TSRO,TSRO:UW,BBG002S9PQF4,Medivation Scores Premium in Sale to Pfizer,2016-08-22 18:05:00 +0000,https://www.thestreet.com/story/13681748/1/medivation-scores-premium-in-sale-to-pfizer.html?puc=yahoo&cm_ven=YAHOO,Medivation Scores Premium in Sale to Pfizer
TSRO,TSRO:UW,BBG002S9PQF4,"Nice Recovery, But Momentum Is Missing",2016-08-17 20:25:00 +0000,http://realmoney.thestreet.com/articles/08/17/2016/nice-recovery-momentum-missing?puc=yahoo&cm_ven=YAHOO,"Nice Recovery, But Momentum Is Missing"
TSRO,TSRO:UW,BBG002S9PQF4,"It May Be Dull, but That's No Reason to Be Negative",2016-08-09 14:41:00 +0000,http://realmoney.thestreet.com/articles/08/09/2016/it-may-be-dull-thats-no-reason-be-negative?puc=yahoo&cm_ven=YAHOO,"It May Be Dull, but That's No Reason to Be Negative"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro's Lonnie Moulder Is Catching Lightning in a Bottle (Again),2016-08-07 15:11:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R_MZy5UmBIQ/tesaros-lonnie-moulder-is-catching-lightning-in-a-bottle-again-cm661517,"Tesaro, Inc. (NASDAQ  TSRO) CEO Lonnie Moulder successfully launched Aloxi, a successful nausea drug, and then he sold MGI Pharma to Eisai for $3.9 billion in 2008. Then Moulder took the top spot at Abraxis Biosciences"
TSRO,TSRO:UW,BBG002S9PQF4,"Why Tesaro, Inc. Vaulted 15% in July",2016-08-07 04:16:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DrvhZoYNaHI/why-tesaro-inc-vaulted-15-in-july-cm661482,"Image source  Getty Images.  What  After reporting success in a phase 3 ovarian cancer trial at the end of June, shares in Tesaro, Inc. (NASDAQ  TSRO) spiked 15% in July, according to"
TSRO,TSRO:UW,BBG002S9PQF4,Edited Transcript of TSRO earnings conference call or presentation 4-Aug-16 8:15pm GMT,2016-08-05 21:41:36 +0000,http://finance.yahoo.com/news/edited-transcript-tsro-earnings-conference-214136102.html,Edited Transcript of TSRO earnings conference call or presentation 4-Aug-16 8:15pm GMT
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 10-Q, Quarterly Report",2016-08-05 12:10:41 +0000,http://biz.yahoo.com/e/160805/tsro10-q.html,"TESARO, INC. Files SEC form 10-Q, Quarterly Report"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro reports 2Q loss,2016-08-04 21:49:39 +0000,http://sg.finance.yahoo.com/news/tesaro-reports-2q-loss-214939014.html,Tesaro reports 2Q loss
TSRO,TSRO:UW,BBG002S9PQF4,Read this press release »,2016-08-04 20:12:12 +0000,http://www.publicnow.com/view/248B5C3AD43B33C2434F8CF8161C59BA71427787,"[at noodls] - July 21, 2016 TESARO to Announce Second-Quarter 2016 Financial Results on August 4, 2016 WALTHAM, Mass., July 21, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its second-quarter 2016 ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Announces Second-Quarter 2016 Operating Results,2016-08-04 20:12:12 +0000,http://www.publicnow.com/view/C6C5D727297F0EF5CE622219406F3BD43FAD04B4,"[at noodls] - Positive Phase 3 data reported by TESARO and ENGOT from the NOVA trial of niraparib in a broad population of patients with platinum-sensitive, recurrent ovarian cancer Pre-launch planning underway to support ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-08-04 20:03:22 +0000,http://biz.yahoo.com/e/160804/tsro8-k.html,"TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
TSRO,TSRO:UW,BBG002S9PQF4,"XBI, IONS, SRPT, TSRO: Large Outflows Detected at ETF",2016-08-04 16:56:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3thRB6csAlg/xbi-ions-srpt-tsro-large-outflows-detected-at-etf-cm660498,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P Biotech ETF (Symbol XBI) where we have detected an approximate $215.5 million dollar outflow"
TSRO,TSRO:UW,BBG002S9PQF4,Q2 2016 TESARO Inc Earnings Release - After Market Close,2016-08-04 11:07:04 +0000,http://biz.yahoo.com/research/earncal/20160804.html?t=tsro,Q2 2016 TESARO Inc Earnings Release - After Market Close
TSRO,TSRO:UW,BBG002S9PQF4,These Legendary CEO's Could Catch Lightning in a Bottle -- Again.,2016-08-01 21:53:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lAERsKD_Z-0/these-legendary-ceos-could-catch-lightning-in-a-bottle-again-cm658422,"Great management can make a big difference in whether a company succeeds, especially in the highly regulated healthcare market. While healthcare CEOs may not be as well known as CEOs in other industries, we've identified four healthcare"
TSRO,TSRO:UW,BBG002S9PQF4,"Notable ETF Inflow Detected - XBI, IONS, TSRO, BMRN",2016-07-27 16:26:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C80kgo_xj3s/notable-etf-inflow-detected-xbi-ions-tsro-bmrn-cm655721,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P Biotech ETF (Symbol XBI) where we have detected an approximate $125.8 million dollar inflow"
TSRO,TSRO:UW,BBG002S9PQF4,Gilead Has a Problem. These Three Biotechs Could Be the Solution,2016-07-22 18:08:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/07/22/gilead-has-a-problem-these-three-biotech-companies-could-be-the-solution/?mod=yahoobarrons&ru=yahoo,Gilead Has a Problem. These Three Biotechs Could Be the Solution
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO to Announce Second-Quarter 2016 Financial Results on August 4, 2016",2016-07-21 20:05:00 +0000,http://finance.yahoo.com/news/tesaro-announce-second-quarter-2016-200500951.html,"[GlobeNewswire] - WALTHAM, Mass., July 21, 2016-- TESARO, Inc. will announce its second-quarter 2016 financial results on Thursday, August 4, 2016, after the close of the U.S. financial markets. TESARO’ s senior management ..."
TSRO,TSRO:UW,BBG002S9PQF4,Here's Why Myriad Genetics Is Down 26% in 2016,2016-07-21 17:14:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jS2A1Rh7pII/heres-why-myriad-genetics-is-down-26-in-2016-cm652740,"Image source  Getty Images.  It's been a rough year for molecular diagnostics company Myriad Genetics (NASDAQ  MYGN) , which has seen its stock plummet 26% year to date, wiping out the 25%"
TSRO,TSRO:UW,BBG002S9PQF4,10 Stocks That Could Ruin Your Retirement,2016-07-15 13:00:02 +0000,http://portal.kiplinger.com/article/investing/T052-C000-S015-10-stocks-that-will-hold-back-your-retirement.html?rid=SYN-yahoo&rpageid=15165,10 Stocks That Could Ruin Your Retirement
TSRO,TSRO:UW,BBG002S9PQF4,SPDR S&P Biotech ETF Experiences Big Inflow,2016-07-12 16:48:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gK5DQutnDPQ/spdr-sp-biotech-etf-experiences-big-inflow-cm648027,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P Biotech ETF (Symbol XBI) where we have detected an approximate $60.3 million dollar inflow"
TSRO,TSRO:UW,BBG002S9PQF4,ENGOT and TESARO Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial,2016-07-08 20:21:02 +0000,http://www.publicnow.com/view/FE4C9A5D5E44217D4FE551FFB155E633B0A2B1D9,[at noodls] - The ENGOT-OV16/NOVA trial successfully achieved its primary endpoint of PFS in the germline BRCA mutant cohort The ENGOT-OV16/NOVA trial successfully achieved its primary endpoint of PFS in the non-germline ...
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits",2016-07-07 20:32:39 +0000,http://biz.yahoo.com/e/160707/tsro8-k.html,"TESARO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits"
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters,2016-07-07 20:31:08 +0000,http://www.publicnow.com/view/16C59AAC022FFD132BDF289AB2F7D34ED947C17D,"[at noodls] - WALTHAM, Mass., July 07, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) today announced the closing of its previously announced underwritten public offering of common stock. TESARO sold 5,347,500 ..."
TSRO,TSRO:UW,BBG002S9PQF4,Steven Cohen Hits Another Home Run in Oncology,2016-07-07 17:33:42 +0000,http://finance.yahoo.com/news/steven-cohen-hits-another-home-173342945.html,Steven Cohen Hits Another Home Run in Oncology
TSRO,TSRO:UW,BBG002S9PQF4,Buyout target Medivation says cancer drug could be 'best in class',2016-07-07 01:14:20 +0000,http://uk.finance.yahoo.com/news/buyout-target-medivation-says-cancer-011420113.html,Buyout target Medivation says cancer drug could be 'best in class'
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc (TSRO): Is There More Upside for Tesaro Stock?,2016-07-05 21:47:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ltLinDGmagY/tesaro-inc-tsro-is-there-more-upside-for-tesaro-stock-cm644930,"Tesaro Inc (NASDAQ  TSRO ) gave word last week that its lead ovarian cancer drug met its primary endpoint in a global pivotal trial, and TSRO"
TSRO,TSRO:UW,BBG002S9PQF4,Acadia Pharmaceuticals Inc.: Why ACAD Stock Will Be Volatile Over the Next Year,2016-07-05 21:47:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qq6Jp-rFajY/acadia-pharmaceuticals-inc-why-acad-stock-will-be-volatile-over-the-next-year-cm644920,Acadia Pharmaceuticals Inc. ( ACAD ) has been the model of inconsistency and unpredictability over the last year.   ACAD is currently trading right
TSRO,TSRO:UW,BBG002S9PQF4,A Big Breakthrough for Ovarian Cancer Patients,2016-07-03 12:45:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aprze_egJog/a-big-breakthrough-for-ovarian-cancer-patients-cm644253,Image source  Getty Images.  A savvy decision by Tesaro (NASDAQ  TSRO) to buy the rights to a novel anti tumor drug from Merck & Co. (NYSE  MRK) for $7 million up
TSRO,TSRO:UW,BBG002S9PQF4,A Big Breakthrough for Ovarian Cancer Patients,2016-07-03 11:40:00 +0000,http://www.fool.com/investing/2016/07/03/a-big-breakthrough-for-ovarian-cancer-patients.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,A Big Breakthrough for Ovarian Cancer Patients
TSRO,TSRO:UW,BBG002S9PQF4,An Overnight Double! Could These Drugmakers Be Next?,2016-07-01 19:40:00 +0000,http://www.fool.com/investing/2016/07/01/an-overnight-double-could-these-drugmakers-be-next.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,An Overnight Double! Could These Drugmakers Be Next?
TSRO,TSRO:UW,BBG002S9PQF4,Myriad Genetics myChoice Cancer Test Findings Encourage,2016-07-01 15:54:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m48sPqm9Fhs/myriad-genetics-mychoice-cancer-test-findings-encourage-cm643857,"Leading player in the molecular diagnostics and personalized medicine space, Myriad Genetics Inc.MYGN , announced that its myChoice homologous recombination deficiencies (HRD) test will effectively recognize ovarian cancer patients who are benefiting from treatment with niraparib. niraparib is an"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro (TSRO) in Focus: Stock Adds 8.6% in Session,2016-07-01 14:56:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FhnmLTMZ41Y/tesaro-tsro-in-focus-stock-adds-86-in-session-cm643810,"Tesaro, Inc.TSRO was a big mover last session, as its shares rose almost 9% on the day. The upside was driven by the pricing of underwritten public offering by the company. This led to far more shares changing hands"
TSRO,TSRO:UW,BBG002S9PQF4,​Tesaro raises $377M in largest local biotech stock offering in the past year,2016-07-01 14:07:10 +0000,http://www.bizjournals.com/boston/blog/bioflash/2016/07/tesaro-raises-377m-in-largest-local-biotech-stock.html?ana=yahoo,​Tesaro raises $377M in largest local biotech stock offering in the past year
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro (TSRO) in Focus: Stock Adds 8.6% in Session,2016-07-01 12:29:12 +0000,http://finance.yahoo.com/news/tesaro-tsro-focus-stock-adds-122912773.html,Tesaro (TSRO) in Focus: Stock Adds 8.6% in Session
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Pricing of Public Offering of Common Stock,2016-07-01 02:41:08 +0000,http://www.publicnow.com/view/FA6A393F718438AB2331E8C78DCCB20C40926341,"[at noodls] - WALTHAM, Mass., June 30, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has priced an underwritten public offering of an aggregate of 4,650,000 shares of its common stock at ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Stock Up on Successful Phase III Ovarian Cancer Trial,2016-07-01 00:47:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J3Ds7Oq7Xe4/tesaro-stock-up-on-successful-phase-iii-ovarian-cancer-trial-cm643592,"Shares of Tesaro, Inc . TSRO surged 108% after the company announced that its phase III trial, NOVA, on oncology drug niraparib successfully achieved the primary endpoint of progression free survival (PFS). The double blind, placebo controlled, international trial"
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Stock Up on Successful Phase III Ovarian Cancer Trial,2016-06-30 22:31:10 +0000,http://finance.yahoo.com/news/tesaro-stock-successful-phase-iii-223110747.html,Tesaro Stock Up on Successful Phase III Ovarian Cancer Trial
TSRO,TSRO:UW,BBG002S9PQF4,Clovis Oncology (CLVS) Jumps: Stock Adds 21.9% in Session,2016-06-30 13:54:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/adi9Po17JBo/clovis-oncology-clvs-jumps-stock-adds-219-in-session-cm643244,"Clovis Oncology, Inc.CLVS was a big mover last session, as its shares rose almost 22% on the day. The upside followed the release of Tesaro, Inc.'s TSRO positive Phase 3 clinical trial results for Niraparib, a PARP inhibitor. Clovis"
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Proposed Public Offering of Common Stock,2016-06-30 11:01:05 +0000,http://www.publicnow.com/view/4B975227ABE4342142D24E3948FA48C68408BFA2,"[at noodls] - WALTHAM, Mass., June 30, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) announced today that it has commenced an underwritten public offering of $300 million of its common stock. In connection with ..."
TSRO,TSRO:UW,BBG002S9PQF4,"Why Under Armour, Tesaro, and Diamond Resorts International Jumped Today",2016-06-29 22:48:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ysVTy3jiWkU/why-under-armour-tesaro-and-diamond-resorts-international-jumped-today-cm642936,"Image source  Under Armour.  The stock market often bounces back from severe setbacks with a one day pop, and many investors came into Wednesday's session thinking that the previous day's gains would be"
TSRO,TSRO:UW,BBG002S9PQF4,TESARO's Niraparib Significantly Improved Progression-Free Survival for Patients With Ovarian Cancer in Both Cohorts of the Phase 3 NOVA Trial,2016-06-29 11:11:07 +0000,http://www.publicnow.com/view/83D2FE90506382232956E0CD480AA3A40AD440F2,"[at noodls] - The NOVA trial successfully achieved its primary endpoint of PFS in the germline BRCA mutant cohort The NOVA trial successfully achieved its primary endpoint of PFS in the non-germline BRCA mutant cohort, ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. (TSRO) Is Soaring On Phase 3 Results For Ovarian Cancer Drug,2016-06-29 09:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HbehS3lhaIc/tesaro-inc-tsro-is-soaring-on-phase-3-results-for-ovarian-cancer-drug-20160629-00511,Tesaro Inc. (TSRO) Is Soaring On Phase 3 Results For Ovarian Cancer Drug
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro Inc. (TSRO) Is Soaring On Phase 3 Results For Ovarian Cancer Drug,2016-06-29 09:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dWREP_kISnM/tesaro-inc-tsro-is-soaring-on-phase-3-results-for-ovarian-cancer-drug-20160629-00510,Tesaro Inc. (TSRO) Is Soaring On Phase 3 Results For Ovarian Cancer Drug
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro''s Cancer Drug Meets Primary Endpoint in Late-Stage Trial,2016-06-29 07:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jcE9a23ljLs/tesaros-cancer-drug-meets-primary-endpoint-in-latestage-trial-20160629-00224,Tesaro''s Cancer Drug Meets Primary Endpoint in Late-Stage Trial
TSRO,TSRO:UW,BBG002S9PQF4,Myriad Genetics' MyChoice HRD Test Identifies Patients With Ovarian Cancer,2016-06-29 07:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x_d2V5VeAP0/myriad-genetics-mychoice-hrd-test-identifies-patients-with-ovarian-cancer-20160629-00201,Myriad Genetics' MyChoice HRD Test Identifies Patients With Ovarian Cancer
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Rolapitant Data Presentations at the 2016 MASCC/ISOO Annual Meeting on Supportive Care in Cancer,2016-06-23 22:49:03 +0000,http://www.publicnow.com/view/DFC1C5420CA339CA6CF7FC230966D1EAA261EB43,"[at noodls] - ADELAIDE, Australia, June 23, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced nine presentations of rolapitant data at the 2016 MASCC/ISOO ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Provides Pipeline Update at ASCO Investor Briefing,2016-06-04 23:18:01 +0000,http://www.publicnow.com/view/A055B80FE9812D2C9F0BEAAF3EE797B2E1501147,"[at noodls] - Rolapitant IV NDA accepted for review by FDA; PDUFA date is January 11, 2017 Sufficient PFS events reached for data analysis of both cohorts of Phase 3 niraparib NOVA trial; data expected in Q2 2016 IND ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO Congratulates Dr. Mary Lynne Hedley on Being Named Life Science ""Entrepreneur of the Year"" by the New England Venture Capital Association",2016-05-19 21:52:06 +0000,http://www.publicnow.com/view/83AF30F78A529EBA2D7A71F98048416F0BCB7BDE,"[at noodls] - WALTHAM, Mass., May 19, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to congratulate co-founder, President and COO Dr. Mary Lynne Hedley ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Five Abstracts to be Presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting,2016-05-18 22:12:03 +0000,http://www.publicnow.com/view/3A3468EB5906D7C6CC297F161D6B5E78E1AD94F3,"[at noodls] - WALTHAM, Mass., May 18, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the presentation of five abstracts at the 2016 American Society ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro reports 1Q loss,2016-05-05 23:21:38 +0000,http://sg.finance.yahoo.com/news/tesaro-reports-1q-loss-232138062.html,Tesaro reports 1Q loss
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces First-Quarter 2016 Operating Results,2016-05-05 20:21:18 +0000,http://www.publicnow.com/view/65D7FC8CF5F054ADBE27937191AC1531FEFFD685,"[at noodls] - U.S. launch of VARUBI® underway; New Drug Application (NDA) for IV formulation of rolapitant submitted Niraparib Phase 3 NOVA results anticipated in Q2 2016 are positioned to be the first data from a randomized, ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO Celebrates Oncology Nurses With Premiere of ""Heroic Hearts"" Documentary at Oncology Nursing Society (ONS) 41st Annual Congress and Launches Just Be Campaign",2016-04-27 12:11:51 +0000,http://www.publicnow.com/view/D144B25217C2CC27B80CFF4383D5E1A402146585,"[at noodls] - 158f38cf-f7d2-4db5-a42c-c13a5d30fc2a.pdf April 27, 2016 TESARO CELEBRATES ONCOLOGY NURSES WITH PREMIERE OF ""HEROIC HEARTS"" DOCUMENTARY AT ONCOLOGY NURSING SOCIETY (ONS) 41ST ANNUAL CONGRESS AND ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Submission of Investigational New Drug Application for Anti-TIM-3 Antibody TSR-022 to the U.S. FDA,2016-04-25 12:09:15 +0000,http://www.publicnow.com/view/168324CB6448786905B3C1F5984524E84436C6DB,"[at noodls] - WALTHAM, Mass., April 25, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the submission of an Investigational New Drug (IND) Application ..."
TSRO,TSRO:UW,BBG002S9PQF4,"TESARO to Announce First Quarter 2016 Financial Results on May 5, 2016",2016-04-21 20:21:13 +0000,http://www.publicnow.com/view/C7A320F9BD516D886AA9FF95EA1B40DAD63C2B1C,"[at noodls] - WALTHAM, Mass., April 21, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its first quarter 2016 financial results on Thursday, May 5, 2016, after the close of the U.S. financial markets. ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Global Prostate Cancer Collaboration and Licensing Agreement With Janssen,2016-04-06 11:19:21 +0000,http://www.publicnow.com/view/65069B9543CF80E63DB75655E8DF48F04DFC812D,"[at noodls] - Janssen to develop and commercialize niraparib for patients with prostate cancer worldwide, except in Japan TESARO to receive up to $450 million in upfront and milestone payments, plus royalties Janssen ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Appointment of Dr. Kavita Patel to Board of Directors,2016-04-04 12:07:18 +0000,http://www.publicnow.com/view/18170D920A852533D9CAC995A48838D0464F6348,"[at noodls] - WALTHAM, Mass., April 04, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the appointment of Kavita Patel, M.D., M.S., F.A.C.P. to the ..."
TSRO,TSRO:UW,BBG002S9PQF4,TESARO and MD Anderson Cancer Center Announce Immuno-Oncology Collaboration and Exclusive License Agreement,2016-03-29 12:27:25 +0000,http://www.publicnow.com/view/06B994A7B321D59D292D9DA22A73B9FADDF1F970,[at noodls] - Goal to identify novel small molecule therapeutics against undisclosed immuno-oncology targets Partnership complements TESARO's existing immuno-oncology pipeline Goal to identify first clinical candidate ...
TSRO,TSRO:UW,BBG002S9PQF4,TESARO Announces Enrollment of First Patient in Phase 1 Clinical Trial of TSR-042,2016-03-29 12:27:25 +0000,http://www.publicnow.com/view/BC38B338608FE0C6A2F38E8841D0B517DBB71E17,"[at noodls] - WALTHAM, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced it has dosed the first patient in a Phase 1, dose-escalation ..."
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro reports 4Q loss,2016-02-25 23:25:58 +0000,http://sg.finance.yahoo.com/news/tesaro-reports-4q-loss-232558992.html,Tesaro reports 4Q loss
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro reports 3Q loss,2015-10-29 22:29:26 +0000,http://sg.finance.yahoo.com/news/tesaro-reports-3q-loss-222926428.html,Tesaro reports 3Q loss
TSRO,TSRO:UW,BBG002S9PQF4,Tesaro beats 3Q profit forecasts,2014-11-06 10:04:34 +0000,http://sg.finance.yahoo.com/news/tesaro-beats-3q-profit-forecasts-100434227--finance.html,Tesaro beats 3Q profit forecasts
